VCU - Study Finder

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories

477 Study Matches

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Contact(s):

BMS Study Connect Contact Center www.BMSStudyConnect.com - Clinical.Trials@bms.com

Principal Investigator:

System ID: NCT04094610

Show full eligibility criteria

Key

Inclusion Criteria:

• Documented genetic ROS1 point mutation, fusion, or amplification or NTRK1-3 fusion as identified by local testing in a Clinical Laboratory Improvement Amendments (CLIA) laboratory in the US or equivalently accredited diagnostic lab outside the United States (US) is required.
• Phase 1: Age \<12 years; Phase 2: Age 12- 25 years
• Prior cytotoxic chemotherapy is allowed.
• Prior immunotherapy is allowed.
• Resolution of all acute toxic effects (excluding alopecia) of any prior anti-cancer therapy to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version 4.03 Grade less than or equal to 1.
• All subjects must have measurable disease by RECIST v1.1 or Response Assessment in Neuro-Oncology (RANO) criteria at time of enrollment.
• Subjects with a primary CNS tumor or CNS metastases must be neurologically stable on a stable or decreasing dose of steroids for at least 7 days prior to enrollment.
• Subjects must have a Lansky (\< 16 years) or Karnofsky (≥ 16 years) score of at least 50.
• Life expectancy greater than or equal to 12 weeks, in the investigator's opinion.
• Adequate hematologic, renal and hepatic function. Phase 2

Inclusion Criteria:

• Cohort Specific

Inclusion Criteria:

* Cohort 1: Subjects with NTRK fusion gene positive (NTRK+) advanced solid tumors (including primary CNS tumors), that are tropomyosin receptor kinase (TRK) TKI naïve; * Cohort 2: subjects with NTRK+ advanced solid tumors (including primary CNS tumors), that are TRK TKI pre-treated; * Cohort 3: subjects with advanced solid tumors with ROS1 gene fusions or other ROS1 aberrations (including amplifications and point mutations) with measurable disease.
• Subjects in Cohorts 1 and 2 must have prospectively confirmed measurable disease by BICR prior to enrollment. Key Exclusion Criteria (Phase 1 and Phase 2):
• Subjects with neuroblastoma with only bone marrow disease evaluable by bone marrow aspiration only.
• Major surgery within 14 days (2 weeks) of start of repotrectinib treatment. Central venous access (Broviac, Mediport, etc.) placement does not meet criteria for major surgery.
• Known active infections requiring ongoing treatment (bacterial, fungal, viral including HIV positivity).
• Gastrointestinal disease (e.g., Crohn's disease, ulcerative colitis, or short gut syndrome) or other malabsorption syndromes that would impact drug absorption.
• Any of the following cardiac criteria: * Mean resting corrected QT interval (ECG interval measured from the onset of the QRS complex to the end of the T wave) for heart rate (QTc) \> 480 msec obtained from three ECGs, using the screening clinic ECG machine-derived QTc value * Any clinically important abnormalities in rhythm, conduction, or morphology of resting ECG (e.g., complete left bundle branch block, third degree heart block, second degree heart block, PR interval \> 250 msec) * Any factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome, or any concomitant medication known to prolong the QT interval
• Peripheral neuropathy of CTCAE ≥grade 2.
• Subjects being treated with or anticipating the need for treatment with strong CYP3A4 inhibitors or inducers.
• Any potential allergies to repotrectinib and/or its excipients.

Interventions: DRUG: Oral repotrectinib (TPX-0005)

Conditions: Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors

Keywords: ALK, ROS1, NTRK1-3, Primary CNS tumor, anaplastic large cell lymphoma, metastatic solid tumor, advanced solid tumor, sarcoma, infantile fibrosarcoma, glioblastoma, soft tissue schwannoma, solitary fibrous tumor, glioma, inflammatory myofibroblastic tumor, pediatric

I'm interested

Share via email

Show 68 locations

Study Locations

Hide all locations

Location	Contacts
Alder Hey Children's NHS Foundation Trust Liverpool, England
Asan Medical Center Seoul,
Baylor College of Medicine Houston, Texas
Centre Hospitalier Universitaire d'Angers Angers,
Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Pellegrin Bordeaux,
Children's Health Queensland Hospital and Health Service South Brisbane, Queensland
Children's Healthcare of Atlanta - Egleston Hospital Atlanta, Georgia
Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado
Children's Hospital Los Angeles Los Angeles, California
Children's Hospital Of Eastern Ontario Ottawa, Ontario
Children's Hospital of Philadelphia-Center for Childhood Cancer Research Philadelphia, Pennsylvania
Children's Hospital of Richmond at VCU Richmond, Virginia
Clinica Universidad de Navarra Madrid,
Clinica Universidad de Navarra Madrid,
Dana Farber Cancer Institute. Boston, Massachusetts
Fondazione IRCCS - Istituto Nazionale dei Tumori Milan,
Great Ormond Street Hospital for Children NHS Foundation Trust London,
HM Sanchinarro University Hospital Madrid,
Hospital Infantil Universitario Nino Jesus Madrid,
Hospital Sant Joan de Deu Barcelona,
Hospital Universitari Vall d'Hebron Barcelona,
Hospital Universitario Virgen del Rocio Seville,
Hospital Universitario y Politécnico La Fe Valencia,
Hôpitaux Universitaires de Marseille Timone Marseille,
Institut Gustave-Roussy Villejuif, FR
Institut d Hematologie et d Oncologie Pediatriques Lyon,
KK Women's and Children's Hospital Singapore,
Levine Children's Hospital- Pediatric Neuro-Oncology Charlotte, North Carolina
Local Institution - 2102 New York, New York
Local Institution - 2104 Houston, Texas
Local Institution - 2105 Orlando, Florida
Local Institution - 2110 New Brunswick, New Jersey
Local Institution - 2112 Cleveland, Ohio
Local Institution - 2114 Hershey, Pennsylvania
Local Institution - 2120 Orlando, Florida
Local Institution - 4302 Rome,
Local Institution - 4403 Birmingham,
Local Institution - 6103 Westmead, New South Wales
Local Institution - 6104 Randwick, New South Wales
Local Institution - 6105 Barcelona,
Local Institution - 6106 Madrid,
Local Institution - 6107 Valencia,
Local Institution - 6108 Villejuif,
Local Institution - 6109 Paris,
Local Institution - 6110 Marseille,
Local Institution - 6111 Lyon, Rhone
Local Institution - 6112 Nantes,
Local Institution - 6113 Padua,
Local Institution - 6114 Torino,
Local Institution - 6303 Seoul, Seodaemun-gu
Local Institution - 6304 Seoul,
Maine Medical Center Portland, Maine
National Taiwan University Hospital Taipei,
National University Hospital Singapore,
Perth Childrens Hospital Nedlands, Western Australia
Rigshospitalet - Glostrup Copenhagen,
Royal Hosp. for Children Glasgow,
Seoul National University Hospital Seoul,
St Justine Hospital Montreal, Quebec
St. Jude Children's Research Hospital Memphis, Tennessee
Stollery Children's Hospital Edmonton, Alberta
Taipei Medical University Hospital Taipei,
The Royal Marsden NHS Foundation Trust London,
The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center Dallas, Texas
University Hospital of Wales Cardiff,
University of Calgary Calgary, Alberta
University of California at Los Angeles Los Angeles, California
Washington University School of Medicine in St. Louis St Louis, Missouri

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Contact(s):

ctrrecruit@vcu.edu

Principal Investigator:

System ID: NCT02523014

Show full eligibility criteria

* Documentation of disease: * Histologic documentation: histologically proven intracranial meningioma as documented by central pathology review * Molecular documentation: Presence of SMO, PTCH1, NF2, CDKN2A, AKT1, PIK3CA, PTEN mutations, CDKN2A copy number loss, CDK4, CDK6, CCND1, CCND2, CCND3, or CCNE1 copy number gain in tumor sample as documented specifically by the central laboratory, regardless of whether prior genotype testing outside of the central laboratory was performed * Progressive OR residual disease, as defined by the following: * Residual measurable disease: residual measurable disease immediately after surgery without requirement for progression; for grade I disease, progression pre-operatively needs to be documented, with an increase in size of the measurable primary lesion on imaging by 25% or more (bidirectional area); the change must occur between scans separated by no more than 25 months; for patients with SMO/PTCH1 mutations enrolling to receive vismodegib, the change can occur between scans separated by up to 25 months; residual measurable disease will be defined by bidimensionally measurable lesions with clearly defined margins by MRI scans, with a minimum diameter of 10 mm in both dimensions * Progressive measurable disease: progression defined as an increase in size of the measurable primary lesion on imaging by 25% or more (bidirectional area); the change must occur between scans separated by no more than 25 months * Post radiation patients: patients with measurable and progressive meningioma who have received radiation are potentially eligible, but need to show evidence of progressive disease after completion of radiation; if the progressive meningioma lesion has been radiated, at least 24 weeks must have elapsed from completion of radiation to registration; if the progressive lesion is outside of the radiation field, then an interval of at least 2 weeks must have elapsed from completion of radiation to registration * Measurable disease: measurable disease is defined by a bidimensionally measurable main lesion on MRI or computed tomography (CT) images (MRI preferred) with clearly defined margins and a minimum diameter of 10 mm in both dimensions; multifocal disease is allowed * Prior treatment * Prior medical therapy is allowed but not required * No limit on number of prior therapies * No chemotherapy, or other investigational agents within 28 days prior to registration * No other concurrent investigational agents or other meningioma-directed therapy (chemotherapy, radiation) while on study; additionally, no cases of nitrosourea or mitomycin C within 6 weeks prior to registration * For patients treated with external beam radiation, interstitial brachytherapy or radiosurgery, an interval \> 4 weeks must have elapsed from completion of radiation therapy to registration; if the progressive lesion is outside of the radiation field, then an interval of at least 2 weeks must have elapsed from completion of radiation to registration * Steroid dosing stable for at least 4 days * Recovered to Common Terminology Criteria for Adverse Events (CTCAE) grade 1 or less toxicity from other agents with exception of alopecia and fatigue * No craniotomy 28 days prior to and after registration * Not pregnant and not nursing: \* A female of childbearing potential is a sexually mature female who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months) * For patients with NF2/CDKN2A/AKT1/PIK3CA/PTEN mutation, CKDN2A copy number loss, or CDK4/CDK6/CCND1/CCND2/CCND3/CCNE1 copy number gain: Age \>= 18 years * For patients with SMO/PTCH1 mutation: Age \>= 30 years * Eastern Cooperative Oncology Group (ECOG) performance status =\< 2 * Patient history: * Patients with history of neurofibromatosis (NF) may have other stable central nervous system (CNS) tumors (schwannoma, acoustic neuroma or ependymoma) if lesions have been stable for 6 months * No metastatic meningiomas (as defined by extracranial meningiomas outside of CNS) allowed; spinal meningiomas are allowed * No history of allergic reactions attributed to compounds of similar or biologic composition to assigned study drug * No known active hepatitis B or C * No current Child Pugh class B or C liver disease * No uncontrolled gastric ulcer disease (grade 3 gastric ulcer disease within 28 days of registration) * No uncontrolled hypertension defined as blood pressure (BP) \> 140/90 * No abdominal fistula, gastrointestinal (GI) perforation, or intra-abdominal abscess within 28 days prior to registration * No major surgery within 28 days prior to registration for any patients with AKT1/PIK3CA/PTEN mutations receiving capivasertib * For patients going on to receive capivasertib (i.e. enrolled after Update #08) * Patients should not have any of the following cardiac criteria: * Any clinically important abnormalities in rhythm, conduction, or morphology of resting electrocardiogram (EKG) (e.g., complete left bundle branch block, third degree heart block) * Any factors that increase the risk of corrected QT (QTc) prolongation or risk of arrhythmic events such as heart failure, hypokalemia, potential for Torsade de Pointes, congenital long QT syndrome, family history of long QT syndrome, or unexplained sudden death under 40 years of age, or any concomitant medication known to prolong the QT interval * Experience any of the following procedures or conditions in the preceding 6 months: coronary artery bypass graft, angioplasty, vascular stent, myocardial infarction, angina pectoris, congestive heart failure New York Heart Association (NYHA) class \>= II * Uncontrolled hypertension (systolic blood pressure \[SBP\] \< 90 mmHg and/or diastolic blood pressure \[DBP\] \< 50 mmHg) * Cardiac ejection fraction outside institutional range of normal or \< 50% (whichever is higher) as measured by echocardiogram (or multigated acquisition \[MUGA\] scan if an echocardiogram can't be performed or is inconclusive); left ventricular ejection fraction (LVEF) below lower limit of normal for site * Patients should not have any of the following criteria: * With the exception of alopecia, any unresolved toxicities from prior therapy greater than Common Terminology Criteria for Adverse Events (CTCAE) grade 1 at the time of registration * Hemoglobin \< 9 g/dL (\< 5.59 mmol/L); note: any blood transfusion must be \>= 14 days prior to the determination of a hemoglobin \>= 9 g/dL (\>= 5.59 mmol/L) * Proteinuria 3+ on dipstick analysis or \> 500 mg/24 hours * Refractory nausea and vomiting, chronic gastrointestinal diseases, inability to swallow the formulated product or previous significant bowel resection that would preclude adequate absorption of capivasertib * History of hypersensitivity to active or inactive excipients of capivasertib or drugs with a similar chemical structure or class to capivasertib * Current disease or condition known to interfere with absorption, distribution, metabolism, or excretion of drugs * Past medical history of interstitial lung disease, drug-induced interstitial lung disease, radiation pneumonitis which required steroid treatment, or any evidence of clinically active interstitial lung disease * Previous allogeneic bone marrow transplant * Known immunodeficiency syndrome * Concomitant medications (only regarding NF2/CDKN2A/CDK4/CDK6/CCND1/CCND2/CCND3/CCNE1/AKT1/PIK3CA/PTEN genetic alterations): * Chronic concomitant treatment with strong inhibitors of cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) inhibitors must discontinue the drug for 14 days prior to registration on the study for patients with NF2 mutation enrolled to GSK2256098, as well as for patients with AKT1/PIK3CA/PTEN mutations enrolled to capivasertib * For NF2 patients going on to receive GSK2256098 and for patients with AKT1/PIK3CA/PTEN mutations enrolled to capivasertib: concomitant treatment with strong CYP3A4 inducers or CYP2D6 substrates is not allowed; patients must discontinue the drug 14 days prior to registration * For NF2 patients going on to receive abemaciclib: avoid concomitant use of CYP3A inducers and strong CYP3A inhibitors; use caution with coadministered moderate or weak CYP3A inhibitors * Diabetic status: * For patients with NF2 or SMO/PTCH1 mutations: No uncontrolled diabetes defined as a known diabetic with HBA1C \> 7.5 OR fasting glucose \> 140 mg/dL. * For patients with AKT1/PIK3CA/PTEN mutations: * Glycosylated hemoglobin (HbA1C) \< 8.0% (63.9 mmol/mol) * No type 1 diabetes mellitus * No requirement for insulin for routine diabetic management and control * No requirement for more than two oral hypoglycemic medications for routine diabetic management and control * Patients with a pre-existing diagnosis of type 2 diabetes mellitus must have fasting glucose \< 9.3 mmol/L (167mg/dL); fasting is defined as no caloric intake for at least 8 hours * Patients without a pre-existing diagnosis of type 2 diabetes mellitus must have fasting glucose =\< 7.0 mmol/L (126 mg/dL); fasting is defined as no caloric intake for at least 8 hours * Absolute neutrophil count (ANC) \>= 1,500/mm\^3 * Platelet count \>= 100,000/mm\^3 * Creatinine OR =\< 1.5 mg/dl x upper limit of normal (ULN) OR calculated (calc.) creatinine clearance \> 50 mL/min * Urine protein:creatinine ratio (UPC) =\< 45 mg/mmol * Total bilirubin =\< 1.5 x upper limit of normal (ULN); except in case of Gilbert's disease * Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =\< 2.5 x ULN * Sodium, potassium, total calcium (corrected for serum albumin) \& phosphorus within normal limits per institutional guidelines * QTcF \< 450 msec (QT calculated using Fridericia formula) * Mean resting heart rate (determined from EKG) 50-100 beats per minute (BMP) (must be obtained from 12-lead EKG defined by a triplicate EKG for patients assigned to the capivasertib arm; patients assigned to all other arms will require a single EKG * No uncontrolled medical comorbidities per investigator discretion (e.g. interstitial lung disease, severe dyspnea at rest or requiring oxygen therapy, history of major surgical resection involving the stomach or small bowel, or pre-existing Crohn's disease or ulcerative colitis or a preexisting chronic condition resulting in baseline Grade 2 or higher diarrhea) * ADDITIONAL REGISTRATION ELIGIBILITY CRITERIA FOR ABEMACICLIB ARM: Hemoglobin \>= 8 g/dL \* Patients may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator; initial treatment must not begin earlier than the day after the erythrocyte transfusion * ADDITIONAL REGISTRATION ELIGIBILITY CRITERIA FOR ABEMACICLIB ARM: Prior Treatment * Patients who received chemotherapy must have recovered (Common Terminology Criteria for Adverse Events \[CTCAE\] grade =\< 1) from the acute effects of chemotherapy except for residual alopecia or grade 2 peripheral neuropathy prior to registration; a washout period of at least 28 days is required between last chemotherapy dose and registration (provided the patient did not receive radiotherapy) * Patients who received adjuvant radiotherapy must have completed and fully recovered from the acute effects of radiotherapy; a washout period of at least 28 days is required between end of radiotherapy and registration * ADDITIONAL REGISTRATION ELIGIBILITY CRITERIA FOR ABEMACICLIB ARM: No active bacterial infection (requiring intravenous \[IV\] antibiotics at time of initiating study treatment), fungal infection, or detectable viral infection (such as known human immunodeficiency virus positivity or with known active hepatitis B or C \[for example, hepatitis B surface antigen positive\]); screening is not required for enrollment in the absence of symptoms * ADDITIONAL REGISTRATION ELIGIBILITY CRITERIA FOR ABEMACICLIB ARM: No personal history of any of the following conditions: syncope of cardiovascular etiology, ventricular arrhythmia of pathological origin (including, but not limited to, ventricular tachycardia and ventricular fibrillation), or sudden cardiac arrest

Interventions: DRUG: Vismodegib, DRUG: FAK Inhibitor GSK2256098, DRUG: Capivasertib, DRUG: Abemaciclib

Conditions: Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation

I'm interested

Share via email

Show 783 locations

Study Locations

Hide all locations

Location	Contacts
AMG Crystal Lake - Oncology Crystal Lake, Illinois	Site Public Contact - (advocateresearch@advocate.com)
AMG Libertyville - Oncology Libertyville, Illinois	Site Public Contact - (advocateresearch@advocatehealth.com)
Abbott-Northwestern Hospital Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Adena Regional Medical Center Chillicothe, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Advanced Breast Care Center PLLC Warren, Michigan
AdventHealth Hendersonville Hendersonville, North Carolina
AdventHealth Infusion Center Asheville Asheville, North Carolina
AdventHealth Littleton Littleton, Colorado
AdventHealth Parker Parker, Colorado
AdventHealth Porter Denver, Colorado
Advocate Christ Medical Center Oak Lawn, Illinois
Advocate Good Samaritan Hospital Downers Grove, Illinois	Site Public Contact - (Barbara.barhamand@advocatehealth.com)
Advocate Good Shepherd Hospital Barrington, Illinois
Advocate High Tech Medical Park Palos Heights, Illinois	Site Public Contact - (ncorp@aah.org)
Advocate Illinois Masonic Medical Center Chicago, Illinois
Advocate Lutheran General Hospital Park Ridge, Illinois
Advocate Outpatient Center - Oak Lawn Oak Lawn, Illinois	Site Public Contact - (ncorp@aah.org)
Advocate Sherman Hospital Elgin, Illinois
Advocate South Suburban Hospital Hazel Crest, Illinois
Alaska Breast Care and Surgery LLC Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Alaska Oncology and Hematology LLC Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Alaska Women's Cancer Care Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Alegent Health Bergan Mercy Medical Center Omaha, Nebraska	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Alegent Health Immanuel Medical Center Omaha, Nebraska	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Alegent Health Lakeside Hospital Omaha, Nebraska	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Alegent Health Mercy Hospital Council Bluffs, Iowa
Allegiance Health Jackson, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Alliance for Childhood Diseases/Cure 4 the Kids Foundation Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Alta Bates Summit Medical Center-Herrick Campus Berkeley, California
Anchorage Associates in Radiation Medicine Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Anchorage Oncology Centre Anchorage, Alaska
Anchorage Radiation Therapy Center Anchorage, Alaska
Ann M Wierman MD LTD Las Vegas, Nevada
Arizona Oncology Services Foundation Scottsdale, Arizona
Armes Family Cancer Center Findlay, Ohio
Ascension Via Christi Hospitals Wichita Wichita, Kansas
Aspirus Cancer Care - Stevens Point Stevens Point, Wisconsin
Associates In Womens Health Wichita, Kansas
Atrium Medical Center-Middletown Regional Hospital Franklin, Ohio
Aurora Bay Area Medical Group-Marinette Marinette, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora BayCare Medical Center Green Bay, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Grafton Grafton, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Kenosha South Kenosha, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee West Wauwatosa, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Racine Racine, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Southern Lakes VLCC Burlington, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Waukesha Waukesha, Wisconsin
Aurora Health Care Germantown Health Center Germantown, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Health Center-Fond du Lac Fond du Lac, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Medical Center in Summit Summit, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Saint Luke's Medical Center Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Saint Luke's South Shore Cudahy, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Sinai Medical Center Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora West Allis Medical Center West Allis, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Barnes-Jewish Hospital St Louis, Missouri
Bay Area Hospital Coos Bay, Oregon	Site Public Contact - (cherie.cox@bayareahospital.org)
Beacon Kalamazoo Kalamazoo, Michigan
Beacon Kalamazoo Cancer Center Kalamazoo, Michigan
Benefis Helena Specialty Center Helena, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Benefis Sletten Cancer Institute Great Falls, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Bethesda North Hospital Cincinnati, Ohio	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Bhadresh Nayak MD PC-Sterling Heights Sterling Heights, Michigan
Big Horn Basin Cancer Center Cody, Wyoming
Billings Clinic Cancer Center Billings, Montana	Site Public Contact - (research@billingsclinic.org)
Billings Clinic-Cody Cody, Wyoming	Site Public Contact - (research@billingsclinic.org)
Blanchard Valley Hospital Findlay, Ohio
Boca Raton Regional Hospital Boca Raton, Florida
Bozeman Health Deaconess Hospital Bozeman, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Bronson Battle Creek Battle Creek, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Bronson Methodist Hospital Kalamazoo, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
CARTI Cancer center Little Rock, Arkansas	Site Public Contact - (Research@CARTI.com)
CHI Health Good Samaritan Kearney, Nebraska	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CHI Health Saint Francis Grand Island, Nebraska	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas
California Pacific Medical Center-Pacific Campus San Francisco, California
Cambridge Medical Center Cambridge, Minnesota
Camden Clark Medical Center Parkersburg, West Virginia
Cancer Care Center at Island Hospital Anacortes, Washington
Cancer Care Center of O'Fallon O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Care Northwest - Spokane South Spokane, Washington	Site Public Contact - (research@ccnw.net)
Cancer Care Northwest-North Spokane Spokane, Washington	Site Public Contact - (research@ccnw.net)
Cancer Care Northwest-Valley Spokane, Washington	Site Public Contact - (research@ccnw.net)
Cancer Care Specialists of Illinois - Decatur Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Center at Saint Joseph's Phoenix, Arizona	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Cancer Center of Kansas - Chanute Chanute, Kansas
Cancer Center of Kansas - Dodge City Dodge City, Kansas
Cancer Center of Kansas - El Dorado El Dorado, Kansas
Cancer Center of Kansas - Fort Scott Fort Scott, Kansas
Cancer Center of Kansas - McPherson McPherson, Kansas
Cancer Center of Kansas - Newton Newton, Kansas
Cancer Center of Kansas - Parsons Parsons, Kansas
Cancer Center of Kansas - Pratt Pratt, Kansas
Cancer Center of Kansas - Salina Salina, Kansas
Cancer Center of Kansas - Wellington Wellington, Kansas
Cancer Center of Kansas - Wichita Wichita, Kansas
Cancer Center of Kansas - Winfield Winfield, Kansas
Cancer Center of Kansas-Independence Independence, Kansas
Cancer Center of Kansas-Kingman Kingman, Kansas
Cancer Center of Kansas-Liberal Liberal, Kansas
Cancer Center of Kansas-Manhattan Manhattan, Kansas
Cancer Center of Kansas-Wichita Medical Arts Tower Wichita, Kansas
Cancer Center of Western Wisconsin New Richmond, Wisconsin	Site Public Contact - (mmcorc@healthpartners.com)
Cancer Hematology Centers - Flint Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Cancer Therapy and Integrative Medicine Las Vegas, Nevada
Cancer and Blood Specialists-Henderson Henderson, Nevada
Cancer and Blood Specialists-Shadow Las Vegas, Nevada
Cancer and Blood Specialists-Tenaya Las Vegas, Nevada
Cancer and Hematology Centers of Western Michigan - Norton Shores Norton Shores, Michigan
Carle Cancer Center Urbana, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Effingham Effingham, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Mattoon/Charleston Mattoon, Illinois	Site Public Contact - (Research@carle.com)
Carle at The Riverfront Danville, Illinois	Site Public Contact - (Research@Carle.com)
Caro Cancer Center Caro, Michigan
Carson Tahoe Regional Medical Center Carson City, Nevada	Site Public Contact - (research@sncrf.org)
Case Western Reserve University Cleveland, Ohio	Site Public Contact - (CTUReferral@UHhospitals.org)
Cedars-Sinai Medical Center Los Angeles, California	Site Public Contact - (Cancer.trial.info@cshs.org)
Centerpoint Medical Center LLC Independence, Missouri
Central Care Cancer Center - Bolivar Bolivar, Missouri
Central Care Cancer Center - Great Bend Great Bend, Kansas	Site Public Contact - (aroland@kccop.org)
Central Illinois Hematology Oncology Center Springfield, Illinois
Central Vermont Medical Center/National Life Cancer Treatment Berlin Corners, Vermont
Centralia Oncology Clinic Centralia, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Clackamas Radiation Oncology Center Clackamas, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Cleveland Clinic Foundation Cleveland, Ohio	Site Public Contact - (TaussigResearch@ccf.org)
Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center Wilmington, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Columbus Oncology and Hematology Associates Dublin, Ohio
Columbus Oncology and Hematology Associates Inc Columbus, Ohio
CommonSpirit Cancer Center Mercy Durango, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CommonSpirit Saint Anthony Hospital Cancer Center Lakewood, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CommonSpirit Saint Joseph Hospital - Bardstown Bardstown, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CommonSpirit Saint Joseph Hospital - Lexington Lexington, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CommonSpirit Saint Joseph Hospital London London, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CommonSpirit Saint Joseph Hospital Mount Sterling Mount Sterling, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
CommonSpirit Saint Joseph Medical Center - East Lexington Lexington, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Commonwealth Cancer Center-Corbin Corbin, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Community Medical Center Toms River, New Jersey	Site Public Contact - (mccinfo@mtcancer.org)
Community Medical Center Toms River, New Jersey
Comprehensive Cancer Centers of Nevada Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Central Valley Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Henderson Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Northwest Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Town Center Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada-Horizon Ridge Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada-Southeast Henderson Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada-Summerlin Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Condell Memorial Hospital Libertyville, Illinois	Site Public Contact - (advocateresearch@advocatehealth.com)
Corewell Health Dearborn Hospital Dearborn, Michigan
Corewell Health Grand Rapids Hospitals - Butterworth Hospital Grand Rapids, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital Grand Rapids, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center Saint Joseph, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Corewell Health Lakeland Hospitals - Niles Hospital Niles, Michigan
Corewell Health Lakeland Hospitals - Saint Joseph Hospital Saint Joseph, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Corewell Health Reed City Hospital Reed City, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Cox Cancer Center Branson Branson, Missouri
CoxHealth South Hospital Springfield, Missouri
Crossroads Cancer Center Effingham, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Dana-Farber Cancer Institute Boston, Massachusetts
Dartmouth Cancer Center - North Saint Johnsbury, Vermont	Site Public Contact - (cancer.research.nurse@hitchcock.org)
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon, New Hampshire	Site Public Contact - (cancer.research.nurse@dartmouth.edu)
Dayton Physician LLC - Englewood Dayton, Ohio
Dayton Physicians LLC - Troy Troy, Ohio
Dayton Physicians LLC-Atrium Franklin, Ohio
Dayton Physicians LLC-Miami Valley South Centerville, Ohio
Dayton Physicians LLC-Signal Point Middletown, Ohio
Dayton Physicians LLC-Wayne Greenville, Ohio
Dayton Physicians LLC-Wilson Sidney, Ohio
Decatur Memorial Hospital Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Delaware Health Center-Grady Cancer Center Delaware, Ohio
Delaware Radiation Oncology Delaware, Ohio
Dell Seton Medical Center at The University of Texas Austin, Texas
Desert West Surgery Las Vegas, Nevada
Doctors Hospital Columbus, Ohio
Duluth Clinic Ashland Ashland, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
East Carolina University Greenville, North Carolina
Eden Hospital Medical Center Castro Valley, California
Emory University Hospital Midtown Atlanta, Georgia
Emory University Hospital/Winship Cancer Institute Atlanta, Georgia
Essentia Health - Baxter Clinic Baxter, Minnesota
Essentia Health - Deer River Clinic Deer River, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - Ely Clinic Ely, Minnesota
Essentia Health - Fosston Fosston, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - International Falls Clinic International Falls, Minnesota
Essentia Health - Jamestown Clinic Jamestown, North Dakota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - Moose Lake Clinic Moose Lake, Minnesota
Essentia Health - Park Rapids Park Rapids, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - Saint Joseph's Crosslake Clinic Crosslake, Minnesota
Essentia Health - Saint Joseph's Pequot Lakes Clinic Pequot Lakes, Minnesota
Essentia Health - Saint Joseph's Pine River Clinic Pine River, Minnesota
Essentia Health - Saint Joseph's Staples Clinic Staples, Minnesota
Essentia Health Cancer Center Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center-South University Clinic Fargo, North Dakota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Hibbing Clinic Hibbing, Minnesota
Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Saint Mary's - Detroit Lakes Clinic Detroit Lakes, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Saint Mary's Medical Center Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Sandstone Sandstone, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Virginia Clinic Virginia, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Fairbanks Memorial Hospital Fairbanks, Alaska	Site Public Contact - (Veronica.Stevenson@foundationhealth.org)
Fairfield Medical Center Lancaster, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Fairview Clinics and Surgery Center Maple Grove Maple Grove, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Lakes Medical Center Wyoming, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Northland Medical Center Princeton, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Ridges Hospital Burnsville, Minnesota
Fairview Southdale Hospital Edina, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Farmington Health Center Farmington, Utah
First Dayton Cancer Care Kettering, Ohio
Franciscan Research Center-Northwest Medical Plaza Tacoma, Washington
Fred and Pamela Buffett Cancer Center - Kearney Kearney, Nebraska
Freeman Health System Joplin, Missouri	Site Public Contact - (LJCrockett@freemanhealth.com)
Geisinger Cancer Services-Pottsville Pottsville, Pennsylvania
Geisinger Medical Center Danville, Pennsylvania
Geisinger Medical Center-Cancer Center Hazleton Hazleton, Pennsylvania
Geisinger Medical Group State College, Pennsylvania
Geisinger Medical Oncology-Lewisburg Lewisburg, Pennsylvania
Geisinger Medical Oncology-Selinsgrove Selinsgrove, Pennsylvania
Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre, Pennsylvania
Genesee Hematology Oncology PC Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Genesis Healthcare System Cancer Care Center Zanesville, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Genesys Hurley Cancer Institute Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Gibbs Cancer Center-Gaffney Gaffney, South Carolina
Gibbs Cancer Center-Pelham Greer, South Carolina
Glens Falls Hospital Glens Falls, New York
Good Samaritan Hospital - Cincinnati Cincinnati, Ohio	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Good Samaritan Hospital - Dayton Dayton, Ohio
Grady Health System Atlanta, Georgia
Grady Memorial Hospital Delaware, Ohio
Grand Valley Oncology Grand Junction, Colorado
Grant Medical Center Columbus, Ohio
Greater Dayton Cancer Center Kettering, Ohio
Greater Regional Medical Center Creston, Iowa
Greenville Health System Cancer Institute-Andrews Greenville, South Carolina
Gundersen Lutheran Medical Center La Crosse, Wisconsin
HSHS Saint Elizabeth's Hospital O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Hackensack University Medical Center Hackensack, New Jersey
Harrison HealthPartners Hematology and Oncology-Poulsbo Poulsbo, Washington
Health Partners Inc Minneapolis, Minnesota
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills Las Vegas, Nevada
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway Las Vegas, Nevada
HealthCare Partners Medical Group Oncology/Hematology-San Martin Las Vegas, Nevada
HealthCare Partners Medical Group Oncology/Hematology-Tenaya Las Vegas, Nevada
Heartland Regional Medical Center Saint Joseph, Missouri	Site Public Contact - (Trisha.England2@mymlc.com)
Hematology Oncology Consultants-Clarkston Clarkston, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Hematology and Oncology Consultants PC Omaha, Nebraska
Hennepin County Medical Center Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Henry Ford Cancer Institute-Downriver Brownstown, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Health Saint John Hospital Detroit, Michigan	Site Public Contact - (Kkeenan1@hfhs.org)
Henry Ford Health Warren Hospital Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Hospital Detroit, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Macomb Health Center - Shelby Township Shelby, Michigan
Henry Ford Macomb Hospital-Clinton Township Clinton Township, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Madison Heights Hospital - Breast Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Medical Center-Columbus Novi, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Medical Center-Fairlane Dearborn, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford River District Hospital East China Township, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Rochester Hospital Rochester Hills, Michigan
Henry Ford Saint John Hospital - Academic Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Breast Grosse Pointe Woods, Michigan	Site Public Contact - (karen.forman@ascension.org)
Henry Ford Saint John Hospital - Macomb Medical Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Van Elslander Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Warren Hospital - Breast Macomb Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Warren Hospital - GLCMS Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford West Bloomfield Hospital West Bloomfield, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Wyandotte Hospital Wyandotte, Michigan	Site Public Contact - (nhay@hfhs.org)
Hi-Line Sletten Cancer Center Havre, Montana	Site Public Contact - (protocols@AllianceNCTN.org)
Highline Medical Center-Main Campus Burien, Washington
Holy Cross Hospital Silver Spring, Maryland	Site Public Contact - (eileen.georgi@holy-cross.com)
Hope Cancer Care of Nevada Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Hope Cancer Care of Nevada-Pahrump Pahrump, Nevada	Site Public Contact - (research@sncrf.org)
Hope Cancer Center Pontiac, Michigan
Hope Cancer Clinic Livonia, Michigan
Huntsman Cancer Institute/University of Utah Salt Lake City, Utah
Hurley Medical Center Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Huron Gastroenterology PC Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Idaho Urologic Institute-Meridian Meridian, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Illinois CancerCare - Washington Washington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Canton Canton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Carthage Carthage, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Dixon Dixon, Illinois
Illinois CancerCare-Eureka Eureka, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Galesburg Galesburg, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Kewanee Clinic Kewanee, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Macomb Macomb, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Ottawa Clinic Ottawa, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peru Peru, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Princeton Princeton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Indu and Raj Soin Medical Center Beavercreek, Ohio
Inova Fairfax Hospital Falls Church, Virginia
Inova Schar Cancer Institute Fairfax, Virginia	Site Public Contact - (Stephanie.VanBebber@inova.org)
Jersey Shore Medical Center Neptune City, New Jersey
Jewish Hospital Louisville, Kentucky
Jewish Hospital Medical Center South Shepherdsville, Kentucky
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland	Site Public Contact - (jhcccro@jhmi.edu)
Kadlec Clinic Hematology and Oncology Kennewick, Washington	Site Public Contact - (research@kadlecmed.org)
Kaiser Permanente Los Angeles Medical Center Los Angeles, California	Site Public Contact - (clinical.trials@kp.org)
Kaiser Permanente Medical Center - Santa Clara Santa Clara, California
Kaiser Permanente Medical Center-Vacaville Vacaville, California
Kaiser Permanente Moanalua Medical Center Honolulu, Hawaii
Kaiser Permanente Sacramento Medical Center Sacramento, California
Kaiser Permanente San Leandro San Leandro, California
Kaiser Permanente Washington Seattle, Washington
Kaiser Permanente-Deer Valley Medical Center Antioch, California
Kaiser Permanente-Fremont Fremont, California
Kaiser Permanente-Fresno Fresno, California
Kaiser Permanente-Modesto Modesto, California
Kaiser Permanente-Oakland Oakland, California
Kaiser Permanente-Redwood City Redwood City, California
Kaiser Permanente-Richmond Richmond, California
Kaiser Permanente-Roseville Roseville, California
Kaiser Permanente-San Francisco San Francisco, California
Kaiser Permanente-San Rafael San Rafael, California
Kaiser Permanente-Santa Rosa Santa Rosa, California
Kaiser Permanente-Santa Teresa-San Jose San Jose, California
Kaiser Permanente-South Sacramento Sacramento, California
Kaiser Permanente-South San Francisco South San Francisco, California
Kaiser Permanente-Stockton Stockton, California
Kaiser Permanente-Vallejo Vallejo, California
Kaiser Permanente-Walnut Creek Walnut Creek, California
Kaiser San Rafael-Gallinas San Rafael, California
Kansas Institute of Medicine Cancer and Blood Center Lenexa, Kansas
Katmai Oncology Group Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Keck Medical Center of USC Pasadena Pasadena, California
Kettering Medical Center Kettering, Ohio
Kingman Regional Medical Center Kingman, Arizona	Site Public Contact - (research@sncrf.org)
Knox Community Hospital Mount Vernon, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Clinic Cancer Services - Sandpoint Sandpoint, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Lake Huron Medical Center Port Huron, Michigan
Lake Region Healthcare Corporation-Cancer Care Fergus Falls, Minnesota
Lake Regional Hospital Osage Beach, Missouri	Site Public Contact - (clinicaltrials@lakeregional.com)
Lakeview Hospital Stillwater, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Las Vegas Cancer Center-Henderson Henderson, Nevada
Las Vegas Cancer Center-Medical Center Las Vegas, Nevada
Las Vegas Prostate Cancer Center Las Vegas, Nevada
Las Vegas Urology - Cathedral Rock Las Vegas, Nevada
Las Vegas Urology - Green Valley Henderson, Nevada
Las Vegas Urology - Pebble Henderson, Nevada
Las Vegas Urology - Pecos Las Vegas, Nevada
Las Vegas Urology - Smoke Ranch Las Vegas, Nevada
Las Vegas Urology - Sunset Las Vegas, Nevada
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York	Site Public Contact - (CancerTrials@nyulangone.org)
Lawrence Memorial Hospital Lawrence, Kansas
Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Cedar Crest Allentown, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Hazleton Hazleton, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lenox Hill Hospital New York, New York
Lewistown Hospital Lewistown, Pennsylvania
Liberty Hospital Liberty, Missouri
Licking Memorial Hospital Newark, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Logan Health Medical Center Kalispell, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Longmont United Hospital Longmont, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Los Angeles General Medical Center Los Angeles, California
Louisiana State University Health Science Center New Orleans, Louisiana
MU Health Care Goldschmidt Cancer Center Jefferson City, Missouri
Macomb Hematology Oncology PC Warren, Michigan
Marietta Memorial Hospital Marietta, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Marshfield Clinic Cancer Center at Sacred Heart Eau Claire, Wisconsin
Marshfield Clinic-Chippewa Center Chippewa Falls, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Clinic-Wausau Center Wausau, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Minocqua Minocqua, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Weston Weston, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-EC Cancer Center Eau Claire, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Marshfield Marshfield, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Rice Lake Rice Lake, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-River Region at Stevens Point Stevens Point, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Mary Greeley Medical Center Ames, Iowa
Massachusetts General Hospital Cancer Center Boston, Massachusetts
Mayo Clinic in Arizona Scottsdale, Arizona
Mayo Clinic in Florida Jacksonville, Florida
Mayo Clinic in Rochester Rochester, Minnesota
McFarland Clinic - Ames Ames, Iowa
McFarland Clinic - Boone Boone, Iowa
McFarland Clinic - Jefferson Jefferson, Iowa
McFarland Clinic - Marshalltown Marshalltown, Iowa
McFarland Clinic - Trinity Cancer Center Fort Dodge, Iowa
Medical College of Wisconsin Milwaukee, Wisconsin
Medical University of South Carolina Charleston, South Carolina
Memorial GYN Plus Ooltewah, Tennessee
Memorial Health University Medical Center Savannah, Georgia
Memorial Hermann Northeast Hospital Humble, Texas	Site Public Contact - (ctsucontact@westat.com)
Memorial Hermann Texas Medical Center Houston, Texas
Memorial Hermann The Woodlands Hospital The Woodlands, Texas	Site Public Contact - (ctsucontact@westat.com)
Memorial Hospital Carthage, Illinois	Site Public Contact - (Jeffh@columbusccop.org)
Memorial Hospital Carthage, Illinois
Memorial Hospital West Pembroke Pines, Florida
Memorial Hospital of Carbondale Carbondale, Illinois	Site Public Contact - (clinical.research@sih.net)
Memorial Hospital of Laramie County Cheyenne, Wyoming	Site Public Contact - (protocols@AllianceNCTN.org)
Memorial Hospital of South Bend South Bend, Indiana
Memorial Medical Center Modesto, California
Memorial Regional Cancer Center Day Road Mishawaka, Indiana
Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood, Florida	Site Public Contact - (OHR@mhs.net)
Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey
Memorial Sloan Kettering Bergen Montvale, New Jersey
Memorial Sloan Kettering Cancer Center New York, New York
Memorial Sloan Kettering Commack Commack, New York
Memorial Sloan Kettering Monmouth Middletown, New Jersey
Memorial Sloan Kettering Nassau Uniondale, New York
Memorial Sloan Kettering Westchester Harrison, New York
Menorah Medical Center Overland Park, Kansas
Mercy Cancer Center Merced, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Cape Girardeau Cape Girardeau, Missouri
Mercy Cancer Center - Carmichael Carmichael, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Elk Grove Elk Grove, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Rocklin Rocklin, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Sacramento Sacramento, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center-West Lakes Clive, Iowa
Mercy Clinic-Rolla-Cancer and Hematology Rolla, Missouri
Mercy Health - Perrysburg Hospital Perrysburg, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Health - Saint Anne Hospital Toledo, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Health - Saint Vincent Hospital Toledo, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Health Sylvania Radiation Oncology Center Toledo, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Hospital Cedar Rapids, Iowa	Site Public Contact - (mmcorc@healthpartners.com)
Mercy Hospital Fort Smith Fort Smith, Arkansas
Mercy Hospital Joplin Joplin, Missouri	Site Public Contact - (esmeralda.carrillo@mercy.net)
Mercy Hospital Oklahoma City Oklahoma City, Oklahoma
Mercy Hospital Pittsburg Pittsburg, Kansas
Mercy Hospital Saint Louis St Louis, Missouri
Mercy Hospital South St Louis, Missouri	Site Public Contact - (Danielle.Werle@mercy.net)
Mercy Hospital Springfield Springfield, Missouri
Mercy Hospital Washington Washington, Missouri
Mercy Infusion Center - Chippewa St Louis, Missouri
Mercy Medical Center Baltimore, Maryland	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Medical Center - Des Moines Des Moines, Iowa
Mercy Medical Center-West Lakes West Des Moines, Iowa
Mercy Oncology and Hematology - Clayton-Clarkson Ballwin, Missouri
Mercy San Juan Medical Center Carmichael, California	Site Public Contact - (ResearchInstituteInquiries@commonspirit.org)
Methodist Medical Center of Illinois Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Miami Valley Hospital Dayton, Ohio
Miami Valley Hospital North Dayton, Ohio
Miami Valley Hospital South Centerville, Ohio
Michigan Healthcare Professionals Pontiac Pontiac, Michigan	Site Public Contact - (Emily.Crofts@trinity-health.org)
Midlands Community Hospital Papillion, Nebraska
Miller-Dwan Hospital Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Mills Health Center San Mateo, California
Mills-Peninsula Medical Center Burlingame, California
Minimally Invasive Surgery Hospital Lenexa, Kansas
Minnesota Oncology - Burnsville Burnsville, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology - Coon Rapids Coon Rapids, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology - Edina Edina, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology - Maple Grove Maple Grove, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Chaska Chaska, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Maplewood Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Woodbury Woodbury, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Mission Hope Medical Oncology - Arroyo Grande Arroyo Grande, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mission Hope Medical Oncology - Santa Maria Santa Maria, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Missouri Baptist Medical Center St Louis, Missouri
Missouri Baptist Sullivan Hospital Sullivan, Missouri
Moffitt Cancer Center Tampa, Florida
Montefiore Medical Center - Moses Campus The Bronx, New York
Montefiore Medical Center-Einstein Campus The Bronx, New York
Montefiore Medical Center-Weiler Hospital The Bronx, New York
Monticello Cancer Center Monticello, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Mount Carmel East Hospital Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Carmel Grove City Hospital Grove City, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Carmel Health Center West Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Carmel New Albany Surgical Hospital New Albany, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Sinai Comprehensive Cancer Center at Aventura Aventura, Florida
Mount Sinai Hospital New York, New York
Mount Sinai Medical Center Miami Beach, Florida
Mountain Blue Cancer Care Center Golden, Colorado
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown Spokane, Washington
MultiCare Deaconess Cancer and Blood Specialty Center - North Spokane, Washington
MultiCare Deaconess Cancer and Blood Specialty Center - Valley Spokane Valley, Washington
Munson Medical Center Traverse City, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
MyMichigan Medical Center Alpena Alpena, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Gladwin Gladwin, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Gratiot Alma, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Midland Midland, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Mount Pleasant Mount Pleasant, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Saginaw Saginaw, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
MyMichigan Medical Center Tawas Tawas City, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, New York
NYP/Weill Cornell Medical Center New York, New York
Nebraska Cancer Specialists/Oncology Hematology West PC Grand Island, Nebraska
Nebraska Medicine-Bellevue Bellevue, Nebraska
Nebraska Medicine-Village Pointe Omaha, Nebraska
New Ulm Medical Center New Ulm, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Newark Radiation Oncology Newark, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Newland Medical Associates-Clarkston Clarkston, Michigan
Newland Medical Associates-Pontiac Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
North Memorial Medical Health Center Robbinsdale, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
North Shore University Hospital Manhasset, New York
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital Yakima, Washington	Site Public Contact - (Memorial-ClinicalTrials@yvmh.org)
Northwell Health/Center for Advanced Medicine Lake Success, New York
Northwest Medical Specialties PLLC Tacoma, Washington
Northwest Wisconsin Cancer Center Ashland, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Northwestern Medicine Cancer Center Delnor Geneva, Illinois
Northwestern Medicine Cancer Center Warrenville Warrenville, Illinois
Northwestern Medicine Orland Park Orland Park, Illinois
Northwestern University Chicago, Illinois
Norton Brownsboro Hospital and Medical Campus Louisville, Kentucky	Site Public Contact - (ctsucontact@westat.com)
OSF Saint Anthony's Health Center Alton, Illinois
OSF Saint Francis Medical Center Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
OSF Saint Francis Radiation Oncology at Pekin Pekin, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
OSF Saint Francis Radiation Oncology at Peoria Cancer Center Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
OSF Saint Joseph Medical Center Bloomington, Illinois
Ohio State University Comprehensive Cancer Center Columbus, Ohio
OhioHealth Mansfield Hospital Mansfield, Ohio
OhioHealth Marion General Hospital Marion, Ohio
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa, Oklahoma
Olympic Medical Cancer Care Center Sequim, Washington
Oncology Hematology Associates of Saginaw Valley PC Saginaw, Michigan
Oncology Hematology Care Inc-Anderson Cincinnati, Ohio
Oncology Hematology Care Inc-Blue Ash Cincinnati, Ohio
Oncology Hematology Care Inc-Crestview Crestview Hills, Kentucky
Oncology Hematology Care Inc-Eden Park Cincinnati, Ohio
Oncology Hematology Care Inc-Healthplex Fairfield, Ohio
Oncology Hematology Care Inc-Kenwood Cincinnati, Ohio
Oncology Hematology Care Inc-Mercy West Cincinnati, Ohio
Oncology Las Vegas - Henderson Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Oncology Las Vegas - Tenaya Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at Charleston Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at Fort Apache Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at MountainView Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Orion Cancer Care Findlay, Ohio
Overlake Medical Center Bellevue, Washington
Overlook Hospital Summit, New Jersey
PCR Oncology Arroyo Grande, California	Site Public Contact - (research@sncrf.org)
Pacific Central Coast Health Center-San Luis Obispo San Luis Obispo, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Pacific Gynecology Specialists Seattle, Washington
Palo Alto Medical Foundation Health Care Palo Alto, California
Palo Alto Medical Foundation-Camino Division Mountain View, California
Palo Alto Medical Foundation-Fremont Fremont, California
Palo Alto Medical Foundation-Gynecologic Oncology Mountain View, California
Palo Alto Medical Foundation-Santa Cruz Santa Cruz, California
Palo Alto Medical Foundation-Sunnyvale Sunnyvale, California
Park Nicollet Clinic - Saint Louis Park Saint Louis Park, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Parkland Health Center - Farmington Farmington, Missouri
Parkland Health Center-Bonne Terre Bonne Terre, Missouri
Parkland Memorial Hospital Dallas, Texas
PeaceHealth Saint John Medical Center Longview, Washington	Site Public Contact - (kmakin-bond@peacehealth.org)
PeaceHealth Saint Joseph Medical Center Bellingham, Washington	Site Public Contact - (achapman1@peacehealth.org)
PeaceHealth Southwest Medical Center Vancouver, Washington	Site Public Contact - (kmakin-bond@peacehealth.org)
PeaceHealth United General Medical Center Sedro-Woolley, Washington	Site Public Contact - (achapman1@peacehealth.org)
Peninsula Cancer Center Poulsbo, Washington
Penn State Milton S Hershey Medical Center Hershey, Pennsylvania	Site Public Contact - (CTO@hmc.psu.edu)
Penrose-Saint Francis Healthcare Colorado Springs, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Phelps Health Delbert Day Cancer Institute Rolla, Missouri	Site Public Contact - (research@phelpshealth.org)
Piedmont Hospital Atlanta, Georgia	Site Public Contact - (ORS@piedmont.org)
Pocono Medical Center East Stroudsburg, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Prisma Health Cancer Institute - Butternut Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Easley Easley, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Eastside Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Faris Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Greer Greer, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Seneca Seneca, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Spartanburg Boiling Springs, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Greenville Memorial Hospital Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
ProHealth D N Greenwald Center Mukwonago, Wisconsin
ProHealth Oconomowoc Memorial Hospital Oconomowoc, Wisconsin
ProHealth Waukesha Memorial Hospital Waukesha, Wisconsin
Providence Alaska Medical Center Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Providence Cancer Institute Clackamas Clinic Clackamas, Oregon
Providence Hood River Memorial Hospital Hood River, Oregon	Site Public Contact - (canrsrchstudies@provdience.org)
Providence Newberg Medical Center Newberg, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Portland Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Regional Cancer Partnership Everett, Washington	Site Public Contact - (marilyn.birchman@providence.org)
Providence Regional Cancer System-Aberdeen Aberdeen, Washington	Site Public Contact - (deidre.dillon@providence.org)
Providence Regional Cancer System-Centralia Centralia, Washington	Site Public Contact - (deidre.dillon@providence.org)
Providence Regional Cancer System-Lacey Lacey, Washington	Site Public Contact - (deidre.dillon@providence.org)
Providence Regional Cancer System-Shelton Shelton, Washington
Providence Regional Cancer System-Yelm Yelm, Washington
Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California	Site Public Contact - (Najee.Boucher@providence.org)
Providence Saint Mary Regional Cancer Center Walla Walla, Washington	Site Public Contact - (Cheryl.Dodd@providence.org)
Providence Saint Vincent Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Willamette Falls Medical Center Oregon City, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Pulmonary Medicine Center of Chattanooga-Hixson Hixson, Tennessee
Radiation Oncology Associates Reno, Nevada
Radiation Oncology Centers of Nevada Central Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Radiation Oncology Centers of Nevada Southeast Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Radiation Oncology of Northern Illinois Ottawa, Illinois
Regions Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Reid Health Richmond, Indiana
Renown Regional Medical Center Reno, Nevada	Site Public Contact - (Renown-CRD@renown.org)
Research Medical Center Kansas City, Missouri
Rhode Island Hospital Providence, Rhode Island
Rice Memorial Hospital Willmar, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Ridgeview Medical Center Waconia, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Riverside Methodist Hospital Columbus, Ohio
Riverwood Healthcare Center Aitkin, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Rocky Mountain Cancer Centers - Pueblo Pueblo, Colorado
Rocky Mountain Cancer Centers-Lakewood Lakewood, Colorado
Rocky Mountain Cancer Centers-Longmont Longmont, Colorado
Rocky Mountain Cancer Centers-Parker Parker, Colorado
Rocky Mountain Cancer Centers-Penrose Colorado Springs, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Rocky Mountain Cancer Centers-Thornton Thornton, Colorado
Rush MD Anderson Cancer Center Chicago, Illinois	Site Public Contact - (Cancer_Studies@rush.edu)
Rush MD Anderson Cancer Center at Rush Oak Park Oak Park, Illinois	Site Public Contact - (Cancer_Studies@rush.edu)
Rush-Copley Healthcare Center Yorkville, Illinois	Site Public Contact - (Cancer.Research@rushcopley.com)
Rush-Copley Medical Center Aurora, Illinois	Site Public Contact - (RCMC_Cancer_Research@rush.edu)
SIH Cancer Institute Carterville, Illinois	Site Public Contact - (clinical.research@sih.net)
SMC Center for Hematology Oncology Union Union, South Carolina
SSM Health Good Samaritan Mount Vernon, Illinois	Site Public Contact - (gayla.hall@ssmhealth.com)
Saint Alphonsus Cancer Care Center-Baker City Baker City, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Boise Boise, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Nampa Nampa, Idaho
Saint Alphonsus Cancer Care Center-Ontario Ontario, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Ann's Hospital Westerville, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Saint Anthony North Hospital Westminster, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Charles Health System Bend, Oregon	Site Public Contact - (nosall@stcharleshealthcare.org)
Saint Charles Health System-Redmond Redmond, Oregon
Saint Clare Hospital Lakewood, Washington
Saint Elizabeth Hospital Enumclaw, Washington
Saint Elizabeth Regional Medical Center Lincoln, Nebraska
Saint Francis Cancer Center Greenville, South Carolina	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Francis Hospital Federal Way, Washington
Saint Francis Medical Center Cape Girardeau, Missouri	Site Public Contact - (sfmc@sfmc.net)
Saint Francis Regional Medical Center Shakopee, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint James Community Hospital and Cancer Treatment Center Butte, Montana
Saint John's Hospital - Healtheast Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint Joseph Medical Center Hematology and Oncology - Silverdale Silverdale, Washington	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Joseph Radiation Oncology Resource Center Lexington, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Joseph Regional Cancer Center Bryan, Texas
Saint Joseph's Hospital and Medical Center Phoenix, Arizona
Saint Joseph's Medical Center Stockton, California
Saint Luke's Cancer Institute - Boise Boise, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Fruitland Fruitland, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Meridian Meridian, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Nampa Nampa, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Twin Falls Twin Falls, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's East - Lee's Summit Lee's Summit, Missouri
Saint Luke's Hospital of Kansas City Kansas City, Missouri
Saint Luke's South Hospital Overland Park, Kansas
Saint Mary Corwin Medical Center Pueblo, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Mary's Hospital Rhinelander, Wisconsin
Saint Mary's Oncology/Hematology Associates of Marlette Marlette, Michigan
Saint Mary's Oncology/Hematology Associates of West Branch West Branch, Michigan
Saint Mary's Regional Medical Center Reno, Nevada	Site Public Contact - (research@sncrf.org)
Saint Patrick Hospital - Community Hospital Missoula, Montana	Site Public Contact - (amy.hanneman@providence.org)
Saint Peter's Community Hospital Helena, Montana
Saint Rita's Medical Center Lima, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Saint Vincent Healthcare Billings, Montana
Sainte Genevieve County Memorial Hospital Sainte Genevieve, Missouri
Saints Mary and Elizabeth Hospital Louisville, Kentucky
Skagit Regional Health Cancer Care Center Mount Vernon, Washington	Site Public Contact - (rcccclinicalresearch@skagitvalleyhospital.org)
Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center-Trumbull Trumbull, Connecticut	Site Public Contact - (canceranswers@yale.edu)
South Jordan Health Center South Jordan, Utah
Southern Illinois University School of Medicine Springfield, Illinois
Southern Ohio Medical Center Portsmouth, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Southwest Illinois Health Services LLP Swansea, Illinois
Spartanburg Medical Center Spartanburg, South Carolina
Springfield Clinic Springfield, Illinois
Springfield Memorial Hospital Springfield, Illinois	Site Public Contact - (pallante.beth@mhsil.com)
Springfield Regional Cancer Center Springfield, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Springfield Regional Medical Center Springfield, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Strecker Cancer Center-Belpre Belpre, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Summerlin Hospital Medical Center Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Sunrise Hospital and Medical Center Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Sutter Auburn Faith Hospital Auburn, California
Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California
Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park, California
Sutter Cancer Centers Radiation Oncology Services-Roseville Roseville, California
Sutter Cancer Research Consortium Novato, California
Sutter Davis Hospital Davis, California
Sutter Medical Center Sacramento Sacramento, California
Sutter Pacific Medical Foundation Santa Rosa, California
Sutter Roseville Medical Center Roseville, California
Sutter Solano Medical Center/Cancer Center Vallejo, California
Swedish Cancer Institute-Edmonds Edmonds, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Cancer Institute-Issaquah Issaquah, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-Ballard Campus Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-Cherry Hill Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-First Hill Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Tamarack Health Hayward Medical Center Hayward, Wisconsin
Tampa General Hospital Tampa, Florida	Site Public Contact - (syapchanyk@tgh.org)
The Carle Foundation Hospital Urbana, Illinois	Site Public Contact - (Research@carle.com)
The Mark H Zangmeister Center Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Torrance Memorial Medical Center Torrance, California
Torrance Memorial Physician Network - Cancer Care Torrance, California	Site Public Contact - (courtney.steeneken@tmphysicians.com)
TriHealth Cancer Institute-Anderson Cincinnati, Ohio	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
TriHealth Cancer Institute-Westside Cincinnati, Ohio	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Trinity Health Grand Rapids Hospital Grand Rapids, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Trinity Health IHA Medical Group Hematology Oncology - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Muskegon Hospital Muskegon, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Oakland Hospital Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Mary Mercy Livonia Hospital Livonia, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Tufts Medical Center Boston, Massachusetts
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California
UC San Diego Medical Center - Hillcrest San Diego, California
UC San Diego Moores Cancer Center La Jolla, California	Site Public Contact - (cancercto@ucsd.edu)
UCHealth University of Colorado Hospital Aurora, Colorado
UCSF Medical Center-Mission Bay San Francisco, California
UCSF Medical Center-Parnassus San Francisco, California
UF Health Cancer Institute - Gainesville Gainesville, Florida
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny, Iowa
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Laurel Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic Clive, Iowa
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida
UM Sylvester Comprehensive Cancer Center at Plantation Plantation, Florida
UMass Memorial Medical Center - University Campus Worcester, Massachusetts
UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina
UPMC Cancer Center at UPMC McKeesport McKeesport, Pennsylvania
UPMC Cancer Center at UPMC Northwest Seneca, Pennsylvania
UPMC Cancer Centers - Arnold Palmer Pavilion Greensburg, Pennsylvania
UPMC Hillman Cancer Center Pittsburgh, Pennsylvania
UPMC Hillman Cancer Center in Coraopolis Moon Township, Pennsylvania
UPMC Jefferson Regional Radiation Oncology Pittsburgh, Pennsylvania
UPMC Uniontown Hospital Radiation Oncology Uniontown, Pennsylvania
UPMC Washington Hospital Radiation Oncology Washington, Pennsylvania
UPMC-Heritage Valley Health System Beaver Beaver, Pennsylvania
UPMC-Johnstown/John P. Murtha Regional Cancer Center Johnstown, Pennsylvania
UPMC-Magee Womens Hospital Pittsburgh, Pennsylvania
UPMC-Passavant Hospital Pittsburgh, Pennsylvania
UPMC-Presbyterian Hospital Pittsburgh, Pennsylvania
UPMC-Saint Clair Hospital Cancer Center Pittsburgh, Pennsylvania
UPMC-Saint Margaret Pittsburgh, Pennsylvania
UPMC-Shadyside Hospital Pittsburgh, Pennsylvania
USC / Norris Comprehensive Cancer Center Los Angeles, California
USC Norris Oncology/Hematology-Newport Beach Newport Beach, California
UT MD Anderson Cancer Center Houston, Texas
UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas
UW Cancer Center at ProHealth Care Waukesha, Wisconsin
United Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
United Hospital Center Bridgeport, West Virginia
Unity Hospital Fridley, Minnesota
University Cancer Center Las Vegas, Nevada
University Medical Center New Orleans New Orleans, Louisiana
University Medical Center of Southern Nevada Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
University of Alabama at Birmingham Cancer Center Birmingham, Alabama
University of California Davis Comprehensive Cancer Center Sacramento, California
University of Cincinnati Cancer Center-UC Medical Center Cincinnati, Ohio	Site Public Contact - (cancer@uchealth.com)
University of Cincinnati Cancer Center-West Chester West Chester, Ohio	Site Public Contact - (cancer@uchealth.com)
University of Illinois Chicago, Illinois
University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa
University of Kentucky/Markey Cancer Center Lexington, Kentucky
University of Maryland/Greenebaum Cancer Center Baltimore, Maryland
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida
University of Michigan Health - Sparrow Lansing Lansing, Michigan	Site Public Contact - (harsha.trivedi@umhsparrow.org)
University of Michigan Health - West Wyoming, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
University of Mississippi Medical Center Jackson, Mississippi
University of Nebraska Medical Center Omaha, Nebraska
University of New Mexico Cancer Center Albuquerque, New Mexico	Site Public Contact - (HSC-ClinicalTrialInfo@salud.unm.edu)
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma	Site Public Contact - (ou-clinical-trials@ouhsc.edu)
University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania	Site Public Contact - (PMCancerResearch@pennmedicine.upenn.edu)
University of Rochester Rochester, New York
University of Texas Health Science Center at San Antonio San Antonio, Texas
University of Vermont Medical Center Burlington, Vermont	Site Public Contact - (rpo@uvm.edu)
University of Vermont and State Agricultural College Burlington, Vermont	Site Public Contact - (rpo@uvm.edu)
University of Virginia Cancer Center Charlottesville, Virginia	Site Public Contact - (uvacancertrials@hscmail.mcc.virginia.edu)
University of Wisconsin Carbone Cancer Center - University Hospital Madison, Wisconsin
UofL Health Medical Center Northeast Louisville, Kentucky
Upper Valley Medical Center Troy, Ohio
Urology Specialists of Nevada - Central Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Urology Specialists of Nevada - Green Valley Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Urology Specialists of Nevada - Northwest Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Urology Specialists of Nevada - Southwest Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
VCU Massey Comprehensive Cancer Center Richmond, Virginia	Site Public Contact - (CTOclinops@vcu.edu)
Valley Medical Center Renton, Washington	Site Public Contact - (research@valleymed.org)
Valley Radiation Oncology Peru, Illinois
Vanderbilt Breast Center at One Hundred Oaks Nashville, Tennessee
Vanderbilt University/Ingram Cancer Center Nashville, Tennessee
Vanderbilt-Ingram Cancer Center Cool Springs Franklin, Tennessee
Vince Lombardi Cancer Clinic - Oshkosh Oshkosh, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Sheboygan Sheboygan, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Two Rivers Two Rivers, Wisconsin	Site Public Contact - (ncorp@aurora.org)
WVUH-Berkely Medical Center Martinsburg, West Virginia
Wake Forest University Health Sciences Winston-Salem, North Carolina
Walter Knox Memorial Hospital Emmett, Idaho
Washington University School of Medicine St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Wayne Hospital Greenville, Ohio
Welch Cancer Center Sheridan, Wyoming
West Jefferson Medical Center Marrero, Louisiana
West Michigan Cancer Center Kalamazoo, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
West Virginia University Healthcare Morgantown, West Virginia
Western Illinois Cancer Treatment Center Galesburg, Illinois
Woodland Memorial Hospital Woodland, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Yale University New Haven, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Zangmeister Center Grove City Grove City, Ohio	Site Public Contact - (Jeffh@columbusccop.org)

Research Participation With Transgender and Gender-Diverse Youth

Contact(s):

An Pham, MD - an.pham@vcuhealth.org

Principal Investigator:

System ID: NCT05927350

Show full eligibility criteria

Interventions: OTHER: Survey

Conditions: Transgender Persons

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	An Pham - (an.pham@vcuhealth.org)

National Liver Cancer Screening Trial (TRACER)

Contact(s):

Amit Singal, MD, MS - Amit.Singal@UTSouthwestern.edu

Principal Investigator:

System ID: NCT06084234

Show full eligibility criteria

Inclusion Criteria:

Patient must meet all of the following inclusion criteria:
• Adult patients ages 18-85 with cirrhosis from any etiology or with chronic hepatitis B with a PAGE-B score greater than 9 within 12 months of enrollment
• Patient is eligible for HCC surveillance according to treating physician or by the site investigator
• Able to provide informed consent
• Life expectancy \>6 months (after consent) as determined by the treating provider or site investigator

Exclusion Criteria:

Patient will be excluded for any of the following exclusion criteria:
• Child Pugh C cirrhosis
• History or clinical symptoms of hepatocellular carcinoma or cholangiocarcinoma
• History of solid nodule on baseline ultrasound (i.e., lesion 1cm or greater) within 9 months prior to consent without subsequent diagnostic CT/MRI demonstrating benign nature)
• AFP \>20 ng/mL within 6 months prior to consent, in the absence of a contrast-enhanced CT or MRI within 6 months of AFP (before or after) level demonstrating lack of suspicious liver lesions
• Newly diagnosed LR-3 greater than or equal to 1 cm within 6 months prior to consent
• History of LR-4, LR-5, or LR-M on multi-phase CT or contrast-enhanced MRI within 6 months prior to consent
• Presence of another active cancer besides non-melanomatous skin cancer or indolent cancer under active surveillance (e.g., prostate cancer or renal cell carcinoma) within the 2 years prior to consent
• Patient's provider is planning to use MRI- or CT- based surveillance moving forward
• History of a transjugular intrahepatic portosystemic shunt (TIPS)
• History of Fontan associated liver disease or cardiac cirrhosis
• History of solid organ transplantation
• Actively listed for liver transplantation
• Diagnosis of alcohol-associated hepatitis within 3 months prior to consent
• Documented current or continued signs and symptoms of acute Wilson disease (acute liver failure, acute neurological deficits, hemolysis)
• In patients with primary sclerosing cholangitis (PSC): Current active cholangitis within 90 days prior to consent
• Known or documented habitual non-adherence to previous research studies or medical procedures or unwillingness to adhere to protocol (e.g., unwilling to obtain consent or samples)
• In patients living with HIV: CD4+ T cell count less than 100 cells/mm3 within 60 days prior to consent
• Known pregnancy at consent
• Active warfarin use

Interventions: DIAGNOSTIC_TEST: GALAD, DIAGNOSTIC_TEST: Liver Ultrasound with or without AFP

Conditions: Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B

Keywords: Hepatocellular carcinoma surveillance, GALAD, Alpha Fetoprotein

I'm interested

Share via email

Show 19 locations

Study Locations

Hide all locations

Location	Contacts
Baylor College of Medicine Houston, Texas	Emad Sorial - (Emad.Sorial@bcm.edu) - (Sara.Fares@bcm.edu)
Case Western Reserve University Cleveland, Ohio	Pierre Gholam, MD - (pierre.gholam@case.edu) Paul Harris - (Paul.Harris2@UHhospitals.org)
Hennepin Healthcare Minneapolis, Minnesota	Jose Debes, MD - (debes003@umn.edu) Daniel Akah - (Dakah@bermancenter.org)
Henry Ford Health System Detroit, Michigan	Jessica Peruski - (jperusk1@hfhs.org)
Indiana University Indianapolis, Indiana	Sherri Cummins - (shcummin@iu.edu)
Kaiser Permanente Portland, Oregon	Sreepriya Balasubramanian, MD, MPH - (Sreepriya.Balasubramanian@kp.org) Quyen Chau - (Quyen.X.Chau@kp.org)
Massachusetts General Hospital Boston, Massachusetts	Megan Michta - (MMICHTA@mgh.harvard.edu)
Northwestern University Chicago, Illinois	Laura Kulik, MD - (laura.kulik@nm.org) Kimberly Sipich - (k-sipich@northwestern.edu)
Stanford University Palo Alto, California	Paul Kwo, MD - (pkwo@stanford.edu) Jennifer Smart - (Jsmart2@stanford.edu)
The Cleveland Clinic Cleveland, Ohio	Taebin Son - (Sont16@ccf.org)
The Feinstein Institutes, Northwell Health, Inc. Manhasset, New York	Dibnain Nanda - (dnanda1@northwell.edu)
UT Southwestern Medical Center and Parkland Hospital Dallas, Texas	Sneha Deodhar, MS - (TRACER@UTSouthwestern.edu)
University of California, San Francisco San Francisco, California	Rae Davis - (rayshawnda.davis@ucsf.edu)
University of Michigan Ann Arbor, Michigan	Shay Robison - (roshay@med.umich.edu)
University of Minnesota Minneapolis, Minnesota	Elizabeth Aby, MD - (abyxx002@umn.edu) Erin Wesley - (wesle091@umn.edu)
University of North Carolina Chapel Hill, North Carolina	Andrew Moon, MD - (Andrew.Moon@unchealth.unc.edu) Bhagyashree Behera - (BB_Behera@med.unc.edu)
University of Pennsylvania Philadelphia, Pennsylvania	Grace Kim - (gracekim.lee@pennmedicine.upenn.edu)
University of Southern California Los Angeles, California
Virginia Commonwealth University Richmond, Virginia	Hannah Lee, MD - (Hannah.Lee@vcuhealth.org) Hannah Cook - (Hannah.Cook1@vcuhealth.org)

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (CaMMouflage)

Contact(s):

Caribou Biosciences - clinicaltrials@cariboubio.com

Principal Investigator:

System ID: NCT05722418

Show full eligibility criteria

Interventions: BIOLOGICAL: CB-011

Conditions: Relapsed/Refractory Multiple Myeloma

Keywords: CaMMouflage, Allogeneic, Multiple Myeloma, Relapse Refractory Multiple Myeloma, CAR-T Cells, BCMA, Cell Therapy, Cellular Immuno-therapy, CB11A, CB-011, CB-011A, CAR-T, Anti BCMA, ALLO CAR T

I'm interested

Share via email

Show 16 locations

Study Locations

Hide all locations

Location	Contacts
CU Anschutz Medical Campus, Anshutz Cancer Pavillion Aurora, Colorado	Rona Wang - (deng.wang@cuanschutz.edu) Natalie Pfenning - (natalie.pfenning@cuanschutz.edu)
Cleveland Clinic Cleveland, Ohio	- (Canceranswer@ccf.org)
Duke University Health System (DUHS) Durham, North Carolina	Matthew Fisher - (Matthew.Fister@Duke.edu)
Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin	Danielle King - (daking@mcw.edu)
Hackensack Meridian John Theurer Cancer Center Hackensack, New Jersey	Oncology Clinical Research Referral Office - (oncologyresearchreferral@hmhn.org)
Huntsman Cancer Institute, University of Utah Salt Lake City, Utah	Collind Boyington - (collind.boyington@HCI.UTAH.EDU)
Icahn School of Medicine at Mount Sinai New York, New York	Adriana Rossi, MD - (adriana.rossi@mssm.edu)
Levine Cancer Institute Charlotte, North Carolina	Kelly Bumgarner - (Kelly.Bumgarner@atriumhealth.org)
Memorial Sloan Kettering Cancer Center New York, New York	Sham Mailankody, MBBS - (cart@mskcc.org)
Oncology Hematology Care, Inc Cincinnati, Ohio	Doug Hart - (douglas.hart@usoncology.com)
Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics Miami, Florida	Jay Spiegel, MD - (Spiegelj@med.miami.edu)
Tennessee Oncology Nashville, Tennessee	Jesus Berdeja, MD - (jberdeja@tnonc.com) Taylor Peach - (tpeach@tnonc.com)
University of Alabama at Birmingham Birmingham, Alabama	Luciano Costa, MD - (ljcosta@uabmc.edu)
University of Kentucky/ Markey Cancer Center Lexington, Kentucky	Ashley Walton-Robbins - (Ashley.robbins@uky.edu)
University of Texas Southwestern Medical Center Dallas, Texas	Marcella Aguilar - (Marcella.Aguilar@utsouthwestern.edu)
Virginia Commonwealth University Richmond, Virginia	Johanna Biamonte - (jbiamonte@vcu.edu)

Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia

Contact(s):

Ananna Zaman - Ananna.Zaman@vcuhealth.org

Principal Investigator:

System ID: NCT06771323

Show full eligibility criteria

Interventions: DRUG: Valbenazine, DRUG: Placebo

Conditions: Cervical Dystonia

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	Caileigh Dintino - (caileigh.dintino@vcuhealth.org) Brian Berman - (bermanbd2@vcu.edu)

Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

Contact(s):

Massey IIT Research Operations - masseyepd@vcu.edu

Principal Investigator:

System ID: NCT06731413

Show full eligibility criteria

Inclusion Criteria:

* Histologically or cytologically confirmed diagnosis of non-small cell lung cancer (NSCLC) (either squamous or non- squamous) * Stage IIIB, IIIC or IV disease OR have recurrent disease and not be candidates for curative treatment such as combined chemo-radiation * No previous line of treatment in the recurrent or metastatic setting. Neoadjuvant or adjuvant treatment more than 6 months before enrollment is acceptable. * Age 70 or meeting frailty definition or above at the date of signing informed consent * Absence of driver mutations that have first line Food and Drug Administration (FDA) approved targeted therapy (biomarker testing is optional for squamous cell) * PD-L1 tumor proportion score (TPS) of less than 50% * Eastern Cooperative Oncology Group (ECOG) PS of 0-3 * Have measurable disease based on RECIST 1.1 as determined by the local site investigator/radiology assessment * Absolute neutrophil count (ANC) ≥ 1,000/μL * Platelets ≥ 75,000/μL * Hemoglobin (Hgb) ≥ 8.0 g/dL (transfusion permitted) * Total bilirubin ≤ 2 x institutional upper limit of normal (ULN) * Aspartate amino transferase (AST)serum glutamic-oxaloacetic transaminase (SGOT) /alanine aminotransferase (ALT)serum glutamic-pyruvic transaminase (SGPT) ≤ 5.0 × institutional ULN * Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

* Participants with life expectancy of less than 3 months at the time of enrollment * Has active autoimmune disease that has required systemic treatment in past 2 years (ie, with use of disease modifying agents, or immunosuppressive drugs) * Diagnosis of interstitial lung disease * Creatinine clearance of \<30 mL/min * Symptomatic, untreated central nervous system (CNS) disease or leptomeningeal disease. Patients with asymptomatic or treated CNS disease are eligible * Required ongoing use of immunosuppressive medication, including steroids, with the following allowable exceptions: * Doses less than or equal to the equivalent of prednisone 10 mg daily * Short courses of steroids that are discontinued prior to enrollment * Inhaled, intranasal and/or topical steroids * Dexamethasone taper for treating vasogenic edema associated with CNS disease

Interventions: DRUG: Reduced Dose of Chemotherapy and Immunotherapy

Conditions: Non-small Cell Lung Cancer, NSCLC, Advanced Non-small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer

Keywords: Non-Small Cell Lung Cancer, NSCLC

I'm interested

Share via email

Show 2 locations

Study Locations

Hide all locations

Location	Contacts
VCU Health Tappahannock Hospital Tappahannock, Virginia	Massey CTO Lung Team - (masseylung@vcu.edu)
Virginia Commonwealth University Richmond, Virginia	Massey Lung Team - (masseylung@vcu.edu)

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma (HN001)

Contact(s):

Song W - UVARADONCClinicalTrials@uvahealth.org

Principal Investigator:

System ID: NCT05962242

Show full eligibility criteria

Inclusion Criteria:

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, ≥ 18 years of age
• Pathologically proven diagnosis of squamous cell carcinoma of the oropharynx of any AJCC 8th edition stage.
• Eligible for and planning to receive definitive treatment or adjuvant treatment with radiotherapy.
• Participants who are receiving concurrent systemic anticancer therapy (e.g. chemotherapy or immunotherapy) for oropharyngeal cancer are eligible.
• For participants with T1-2 and N0 disease, chemotherapy is not required for eligibility. Participants may or may not receive chemotherapy per physician discretion.
• For participants with T3-4 and/or N+ disease, chemotherapy is required for eligibility.
• Participants may receive investigational agents with prior approval from the Principal Investigator.
• ECOG Performance Status of 0-2.
• p16 positive HPV as determined by NavDx and immunohistochemistry
• For females of reproductive potential: agreement to use adequate contraception during radiation treatment and for 6 months (or more if applicable based on other medications) after the end of radiation treatment.

Exclusion Criteria:

• Evidence of distant metastatic disease
• Prior history of radiotherapy to the head and/or neck
• Had surgery for oropharyngeal cancer within 8 months of enrollment unless it was an incomplete oncologic surgery. Participant is eligible if the gross tumor was not completely removed.
• Diagnosis of T3-4 and/or N+ disease with no plans to receive concurrent chemotherapy.
• Diagnosis of a current or prior invasive malignancy (except non-melanoma skin cancer) unless the participant has been disease free for at least 3 years.
• Participant is a prisoner
• Known contraindications to head and neck radiation therapy such as ataxia telangiectasia or scleroderma.
• Pregnancy or lactation
• Active or severe co-morbidities as defined by the following:
• Unstable angina and/or congestive heart failure requiring hospitalization up to 180 days before registration
• Transmural myocardial infarction up to 180 days before registration
• Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
• Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration
• Hepatic insufficiency as determined by the treating clinician resulting in clinical jaundice and/or coagulation effects or severe liver dysfunction.
• Acquired immune deficiency syndrome (AIDS) based upon current CDC definition. The need to exclude patients with AIDS from this protocol is necessary because the treatments involved in this protocol may be slightly immunosuppressive. Protocol-specific requirements may also exclude immuno-compromised patients.
• Tobacco smoking history of 10 pack years or greater, or ≥ 20 pack years if smoking cessation occurred at least 1 year prior to enrollment
• Current use of antineoplastic drugs for other malignancies.

Interventions: RADIATION: Radiation Therapy

Conditions: Squamous Cell Carcinoma of the Oropharynx

Keywords: Radiation Therapy, Radiotherapy, Head Cancer, Neck Cancer, Low Dose Radiation, HPV

I'm interested

Share via email

Show 5 locations

Study Locations

Hide all locations

Location	Contacts
Bon Secours Richmond, Virginia
Eastern Virginia Medical School Norfolk, Virginia
Miami Cancer Institute Miami, Florida	Noah Kalman, M.D. - (noahk@baptisthealth.net)
University of Virginia Charlottesville, Virginia	Song W - (UVARADONCClinicalTrials@uvahealth.org)
Virginia Commonwealth University Richmond, Virginia	Shiyu Song, M.D. - (masseyhn@vcu.edu)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Contact(s):

Aishwarya Vijendran - aishwaryav@bsd.uchicago.edu

Principal Investigator:

System ID: NCT05677490

Show full eligibility criteria

Inclusion Criteria:

* Histologic documentation: HER2 negative adenocarcinoma as defined by American Society of Clinical Oncology (ASCO) College of American Pathologists (CAP) guidelines (Bartley et al., Journal of Clinical Oncology \[JCO\] 2017) with known PD-L1 CPS (Any CPS is allowed, but should be known prior to registration) * Stage: unresectable or metastatic * Tumor site: esophagus, gastroesophageal junction, or stomach * Measurable disease or non-measurable but evaluable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 * No prior treatment for unresectable or metastatic disease * Prior neoadjuvant or adjuvant cytotoxic chemotherapy or adjuvant immunotherapy is allowed as long as it was completed at least 1 year prior to registration * Age \>= 18 years * Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1 * Absolute neutrophil count (ANC) \>= 1,500/mm\^3 * Platelet count \>= 100,000/mm\^3 * Creatinine =\< 1.5 x upper limit of normal (ULN) OR calculated (calc.) creatinine clearance \>= 30 mL/min * Total bilirubin =\< 1.5 x ULN * Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =\< 3 x ULN (in patients with liver metastasis: =\< 5 x ULN if clearly attributable to liver metastases) * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * Patients positive for human immunodeficiency virus (HIV) are eligible only if they meet all of the following: * On effective anti-retroviral therapy * Undetectable HIV viral load by standard clinical assay =\< 6 months of registration * Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better * Patients who will receive nivolumab in addition to chemotherapy must not have any contraindications to immune checkpoint inhibitors * Patients must not have active autoimmune disease that has required systemic treatment within 6 months prior to registration. Patients are permitted to receive immunotherapy if they have vitiligo, type I diabetes, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger (precipitating event) * Patients must not have a condition requiring systemic treatment with either corticosteroids (\>10mg/day prednisone equivalents) or other immunosuppressive medications within 14 days prior to registration. Inhaled or topical steroids and adrenal replacement doses (=\< 10mg/day prednisone equivalent) are permitted * Patients must not have a history of noninfectious pneumonitis requiring steroids * Patients with prior immune mediated adverse events related to immunotherapy that resulted in permanent treatment discontinuation with these agents are ineligible * This study includes the use of the mandatory patient completed measure, PRO-CTCAE. For this study the PRO-CTCAE is available in English, Spanish, Korean, Chinese (Simplified), and Russian, hence patients must be able to speak, understand and read in these languages. Ad-hoc translation of patient-reported measures is not permitted

Exclusion Criteria:

* Not pregnant and not nursing, because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects \* Therefore, for women of childbearing potential only, a negative serum or urine pregnancy test done =\< 7 days prior to registration is required * No known Gilbert's syndrome or known homozygosity for UGAT1A1\*28 polymorphism * No baseline grade \>= 2 peripheral neuropathy, neurosensory toxicity, or neuromotor toxicity per CTCAE version (v) 5.0 regardless of causality * No medical condition such as uncontrolled infection or uncontrolled diabetes mellitus which, in the opinion of the treating physician, would make this protocol unreasonably hazardous for the patient * No untreated, symptomatic brain metastasis. Patients with treated brain metastases are eligible if the following criteria are met: 1) follow-up brain imaging done at least in 4 weeks after central nervous system (CNS)-directed therapy shows no evidence of progression and 2) the patient no longer requires steroids, or is on a stable steroid dose for more than four weeks * No allogeneic tissue/organ transplant

Interventions: DRUG: Fluorouracil, DRUG: Leucovorin Calcium, DRUG: Oxaliplatin, DRUG: Irinotecan, BIOLOGICAL: Nivolumab, PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Computed Tomography, PROCEDURE: Biospecimen Collection, OTHER: Questionnaire Administration

Conditions: Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Unresectable Esophageal Adenocarcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma

I'm interested

Share via email

Show 793 locations

Study Locations

Hide all locations

Location	Contacts
AMG Crystal Lake - Oncology Crystal Lake, Illinois	Site Public Contact - (advocateresearch@advocate.com)
AMG Libertyville - Oncology Libertyville, Illinois	Site Public Contact - (advocateresearch@advocatehealth.com)
Abbott-Northwestern Hospital Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Adena Regional Medical Center Chillicothe, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Advanced Breast Care Center PLLC Warren, Michigan
AdventHealth Littleton Littleton, Colorado
AdventHealth Parker Parker, Colorado
AdventHealth Porter Denver, Colorado
Advocate Christ Medical Center Oak Lawn, Illinois
Advocate Good Samaritan Hospital Downers Grove, Illinois	Site Public Contact - (Barbara.barhamand@advocatehealth.com)
Advocate Good Shepherd Hospital Barrington, Illinois
Advocate Illinois Masonic Medical Center Chicago, Illinois
Advocate Lutheran General Hospital Park Ridge, Illinois
Advocate Outpatient Center - Aurora Aurora, Illinois	Site Public Contact - (ncorp@aah.org)
Advocate Sherman Hospital Elgin, Illinois
Advocate South Suburban Hospital Hazel Crest, Illinois
Alaska Breast Care and Surgery LLC Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Alaska Oncology and Hematology LLC Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Alaska Women's Cancer Care Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Alegent Health Bergan Mercy Medical Center Omaha, Nebraska
Alegent Health Immanuel Medical Center Omaha, Nebraska
Alegent Health Lakeside Hospital Omaha, Nebraska
Alegent Health Mercy Hospital Council Bluffs, Iowa
Alliance for Childhood Diseases/Cure 4 the Kids Foundation Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Alta Bates Summit Medical Center-Herrick Campus Berkeley, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Anchorage Associates in Radiation Medicine Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Anchorage Oncology Centre Anchorage, Alaska
Anchorage Radiation Therapy Center Anchorage, Alaska
Ann M Wierman MD LTD Las Vegas, Nevada
Armes Family Cancer Center Findlay, Ohio
Aspirus Cancer Care - Stevens Point Stevens Point, Wisconsin	Site Public Contact - (Beth.Knetter@aspirus.org)
Aspirus Cancer Care - Wisconsin Rapids Wisconsin Rapids, Wisconsin
Aspirus Cancer Care-Antigo-Volm Cancer Center Antigo, Wisconsin	Site Public Contact - (Juli.Alford@aspirus.org)
Aspirus Cancer Care-Rhinelander-James Beck Cancer Center Rhinelander, Wisconsin	Site Public Contact - (Beth.Knetter@aspirus.org)
Aspirus Cancer Care-Wausau Wausau, Wisconsin
Aspirus Medford Hospital Medford, Wisconsin	Site Public Contact - (Beth.Knetter@aspirus.org)
Asplundh Cancer Pavilion Willow Grove, Pennsylvania	Site Public Contact - (ONCTrialNow@jefferson.edu)
Atrium Medical Center-Middletown Regional Hospital Franklin, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Aurora Bay Area Medical Group-Marinette Marinette, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora BayCare Medical Center Green Bay, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Grafton Grafton, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Kenosha South Kenosha, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee West Wauwatosa, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Racine Racine, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Southern Lakes VLCC Burlington, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Health Care Germantown Health Center Germantown, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Medical Center in Summit Summit, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Saint Luke's Medical Center Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Saint Luke's South Shore Cudahy, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Sinai Medical Center Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora West Allis Medical Center West Allis, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Avera Cancer Institute Sioux Falls, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute - Mitchell Mitchell, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute at Pierre Pierre, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute at Yankton Yankton, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute-Aberdeen Aberdeen, South Dakota	Site Public Contact - (oncregulatory@avera.org)
BASS Medical Group - Lennon Walnut Creek, California
Bay Area Hospital Coos Bay, Oregon	Site Public Contact - (cherie.cox@bayareahospital.org)
Beebe Health Campus Rehoboth Beach, Delaware	Site Public Contact - (research@beebehealthcare.org)
Beebe Medical Center Lewes, Delaware	Site Public Contact - (research@beebehealthcare.org)
Beebe South Coastal Health Campus Millville, Delaware	Site Public Contact - (research@beebehealthcare.org)
Benefis Helena Specialty Center Helena, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Benefis Sletten Cancer Institute Great Falls, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Bethesda North Hospital Cincinnati, Ohio
Bhadresh Nayak MD PC-Sterling Heights Sterling Heights, Michigan
Billings Clinic Cancer Center Billings, Montana	Site Public Contact - (research@billingsclinic.org)
Billings Clinic-Cody Cody, Wyoming	Site Public Contact - (research@billingsclinic.org)
Blanchard Valley Hospital Findlay, Ohio
Boston Medical Center Boston, Massachusetts
Boulder Community Foothills Hospital Boulder, Colorado
Bozeman Health Deaconess Hospital Bozeman, Montana	Site Public Contact - (mccinfo@mtcancer.org)
CARTI Cancer center Little Rock, Arkansas	Site Public Contact - (Research@CARTI.com)
CHI Health Good Samaritan Kearney, Nebraska
CHI Health Saint Francis Grand Island, Nebraska
California Pacific Medical Center-Pacific Campus San Francisco, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Cambridge Medical Center Cambridge, Minnesota
Cancer Care Associates PC Royal Oak, Michigan
Cancer Care Center of O'Fallon O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Care Northwest - Spokane South Spokane, Washington	Site Public Contact - (research@ccnw.net)
Cancer Care Northwest-North Spokane Spokane, Washington	Site Public Contact - (research@ccnw.net)
Cancer Care Northwest-Valley Spokane, Washington	Site Public Contact - (research@ccnw.net)
Cancer Care Specialists of Illinois - Decatur Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Care and Hematology-Fort Collins Fort Collins, Colorado	Site Public Contact - (protocols@AllianceNCTN.org)
Cancer Center at Saint Joseph's Phoenix, Arizona
Cancer Center of Colorado at Sloan's Lake Denver, Colorado
Cancer Center of Western Wisconsin New Richmond, Wisconsin	Site Public Contact - (mmcorc@healthpartners.com)
Cancer Center-Metro Medical Center Bayamon Bayamón,
Cancer Hematology Centers - Flint Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Cancer and Blood Specialists-Henderson Henderson, Nevada
Carle Cancer Center Urbana, Illinois	Site Public Contact - (Research@carle.com)
Carle Cancer Institute Normal Normal, Illinois	Site Public Contact - (Research@Carle.com)
Carle Physician Group-Effingham Effingham, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Mattoon/Charleston Mattoon, Illinois	Site Public Contact - (Research@carle.com)
Carle at The Riverfront Danville, Illinois	Site Public Contact - (Research@Carle.com)
Caro Cancer Center Caro, Michigan
Carson Tahoe Regional Medical Center Carson City, Nevada	Site Public Contact - (research@sncrf.org)
Castle Medical Center Kailua, Hawaii
Centra Alan B Pearson Regional Cancer Center Lynchburg, Virginia	Site Public Contact - (Kevin.Patel@centrahealth.com)
Central Care Cancer Center - Bolivar Bolivar, Missouri	Site Public Contact - (aroland@kccop.org)
Central Care Cancer Center - Garden City Garden City, Kansas	Site Public Contact - (aroland@kccop.org)
Central Care Cancer Center - Great Bend Great Bend, Kansas	Site Public Contact - (aroland@kccop.org)
Central Ohio Breast and Endocrine Surgery Gahanna, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Central Vermont Medical Center/National Life Cancer Treatment Berlin Corners, Vermont
Centralia Oncology Clinic Centralia, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Centro Comprensivo de Cancer de UPR San Juan,	Site Public Contact - (ctsucontact@westat.com)
Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Cheyenne Regional Medical Center-West Cheyenne, Wyoming
Christiana Care - Union Hospital Elkton, Maryland	Site Public Contact - (frank.crum@christianacare.org)
Christiana Care Health System-Christiana Hospital Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Christiana Care Health System-Concord Health Center Chadds Ford, Pennsylvania	Site Public Contact - (lbarone@christianacare.org)
Christiana Care Health System-Wilmington Hospital Wilmington, Delaware	Site Public Contact - (lbarone@christianacare.org)
Clackamas Radiation Oncology Center Clackamas, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Cleveland Clinic Mercy Hospital Canton, Ohio
Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center Wilmington, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Coborn Cancer Center at Saint Cloud Hospital Saint Cloud, Minnesota	Site Public Contact - (coborncancercenter@centracare.com)
Colorado Blood Cancer Institute Denver, Colorado
Columbus Oncology and Hematology Associates Dublin, Ohio
Columbus Oncology and Hematology Associates Inc Columbus, Ohio
CommonSpirit Cancer Center Mercy Durango, Colorado
CommonSpirit Saint Anthony Hospital Cancer Center Lakewood, Colorado
CommonSpirit Saint Joseph Hospital - Bardstown Bardstown, Kentucky
CommonSpirit Saint Joseph Hospital - Lexington Lexington, Kentucky
CommonSpirit Saint Joseph Hospital London London, Kentucky
CommonSpirit Saint Joseph Hospital Mount Sterling Mount Sterling, Kentucky
CommonSpirit Saint Joseph Medical Center - East Lexington Lexington, Kentucky
Commonwealth Cancer Center-Corbin Corbin, Kentucky
Community Hospital of Anaconda Anaconda, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Community Medical Center Toms River, New Jersey	Site Public Contact - (mccinfo@mtcancer.org)
Community Medical Center Toms River, New Jersey	Site Public Contact - (HemonCCTrials@geisinger.edu)
Comprehensive Cancer Centers of Nevada Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Central Valley Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Henderson Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Northwest Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Town Center Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada-Horizon Ridge Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada-Southeast Henderson Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada-Summerlin Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Comprehensive Medical Center PLLC Royal Oak, Michigan
Condell Memorial Hospital Libertyville, Illinois	Site Public Contact - (advocateresearch@advocatehealth.com)
Contra Costa Regional Medical Center Martinez, California
Corewell Health Beaumont Troy Hospital Troy, Michigan
Corewell Health Dearborn Hospital Dearborn, Michigan
Corewell Health Farmington Hills Hospital Farmington Hills, Michigan
Corewell Health William Beaumont University Hospital Royal Oak, Michigan
Cox Cancer Center Branson Branson, Missouri
CoxHealth South Hospital Springfield, Missouri
Crossroads Cancer Center Effingham, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Dana Farber-Merrimack Valley Methuen, Massachusetts
Dana-Farber Cancer Institute Boston, Massachusetts
Dana-Farber Cancer Institute at Boston Medical Center - Brighton Brighton, Massachusetts
Dana-Farber Cancer Institute at Foxborough Foxborough, Massachusetts
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Milford, Massachusetts
Dana-Farber/Brigham and Women's Cancer Center at South Shore South Weymouth, Massachusetts
Dayton Physician LLC - Englewood Dayton, Ohio
Dayton Physicians LLC - Troy Troy, Ohio
Dayton Physicians LLC-Atrium Franklin, Ohio
Dayton Physicians LLC-Miami Valley South Centerville, Ohio
Dayton Physicians LLC-Wayne Greenville, Ohio
Decatur Memorial Hospital Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Delaware Clinical and Laboratory Physicians PA Newark, Delaware
Delaware Health Center-Grady Cancer Center Delaware, Ohio
Doctors Cancer Center Manati,
Doctors Hospital Columbus, Ohio
Dublin Methodist Hospital Dublin, Ohio
Duluth Clinic Ashland Ashland, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
East Carolina University Greenville, North Carolina	Site Public Contact - (eubankss@ecu.edu)
Eden Hospital Medical Center Castro Valley, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Einstein Medical Center Philadelphia Philadelphia, Pennsylvania
Eisenhower Medical Center Rancho Mirage, California
Essentia Health - Baxter Clinic Baxter, Minnesota
Essentia Health - Deer River Clinic Deer River, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - Ely Clinic Ely, Minnesota
Essentia Health - Fosston Fosston, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - International Falls Clinic International Falls, Minnesota
Essentia Health - Jamestown Clinic Jamestown, North Dakota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - Moose Lake Clinic Moose Lake, Minnesota
Essentia Health - Park Rapids Park Rapids, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health - Saint Joseph's Crosslake Clinic Crosslake, Minnesota
Essentia Health - Saint Joseph's Pequot Lakes Clinic Pequot Lakes, Minnesota
Essentia Health - Saint Joseph's Pine River Clinic Pine River, Minnesota
Essentia Health - Saint Joseph's Staples Clinic Staples, Minnesota
Essentia Health Cancer Center Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center-South University Clinic Fargo, North Dakota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Hibbing Clinic Hibbing, Minnesota
Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Saint Mary's - Detroit Lakes Clinic Detroit Lakes, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Saint Mary's Hospital - Superior Superior, Wisconsin
Essentia Health Saint Mary's Medical Center Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Sandstone Sandstone, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Virginia Clinic Virginia, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health-Hayward Clinic Hayward, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health-Spooner Clinic Spooner, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Fairbanks Memorial Hospital Fairbanks, Alaska	Site Public Contact - (Veronica.Stevenson@foundationhealth.org)
Fairfield Medical Center Lancaster, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Fairview Clinics and Surgery Center Maple Grove Maple Grove, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Lakes Medical Center Wyoming, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Northland Medical Center Princeton, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Ridges Hospital Burnsville, Minnesota
Fairview Southdale Hospital Edina, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Farmington Health Center Farmington, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
FirstHealth of the Carolinas-Moore Regional Hospital Pinehurst, North Carolina	Site Public Contact - (jcwilliams@firsthealth.org)
Freeman Health System Joplin, Missouri	Site Public Contact - (LJCrockett@freemanhealth.com)
Freeman Physician Group of Pittsburg Pittsburg, Kansas	Site Public Contact - (BNMathew@freemanhealth.com)
Fresno Cancer Center Fresno, California	Site Public Contact - (Kpoct@kp.org)
Geisinger Cancer Center Dickson City Dickson City, Pennsylvania	Site Public Contact - (hemoncctrials@geisinger.edu)
Geisinger Cancer Services-Pottsville Pottsville, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Geisinger Medical Center Danville, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Geisinger Medical Center-Cancer Center Hazleton Hazleton, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Geisinger Medical Oncology-Lewisburg Lewisburg, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Genesee Hematology Oncology PC Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Genesis Healthcare System Cancer Care Center Zanesville, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Genesys Hurley Cancer Institute Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
George Washington University Medical Center Washington D.C., District of Columbia
Glens Falls Hospital Glens Falls, New York
Good Samaritan Hospital - Cancer Centers of Colorado Lafayette, Colorado	Site Public Contact - (peaksresearch@imail.org)
Good Samaritan Hospital - Cincinnati Cincinnati, Ohio
Grady Memorial Hospital Delaware, Ohio
Grant Medical Center Columbus, Ohio
Great Falls Clinic Great Falls, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Greater Dayton Cancer Center Kettering, Ohio
Gundersen Lutheran Medical Center La Crosse, Wisconsin	Site Public Contact - (cancerctr@gundersenhealth.org)
HSHS Saint Elizabeth's Hospital O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Hartford HealthCare - Avon Avon, Connecticut
Hartford HealthCare - Manchester Manchester, Connecticut
Hartford Hospital Hartford, Connecticut
Hawaii Cancer Care - Westridge ‘Aiea, Hawaii	Site Public Contact - (info@hawaiicancercare.com)
Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii	Site Public Contact - (i.webster@hawaiicancercare.com)
Hawaii Diagnostic Radiology Services LLC Honolulu, Hawaii	Site Public Contact - (mmiyoshi@hawaiidrs.com)
HaysMed Hays, Kansas
Health Partners Inc Minneapolis, Minnesota
Heartland Oncology and Hematology LLP Council Bluffs, Iowa
Heartland Regional Medical Center Saint Joseph, Missouri	Site Public Contact - (Trisha.England2@mymlc.com)
Helen F Graham Cancer Center Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Hematology Oncology Consultants PC-Royal Oak Royal Oak, Michigan
Hematology Oncology Consultants PC-Troy Troy, Michigan
Hematology Oncology Consultants-Clarkston Clarkston, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Hennepin County Medical Center Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Henry Ford Health Saint John Hospital Detroit, Michigan	Site Public Contact - (Kkeenan1@hfhs.org)
Henry Ford Health Warren Hospital Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Madison Heights Hospital - Breast Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford River District Hospital East China Township, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Academic Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Breast Grosse Pointe Woods, Michigan	Site Public Contact - (karen.forman@ascension.org)
Henry Ford Saint John Hospital - Macomb Medical Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Van Elslander Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Warren Hospital - Breast Macomb Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Warren Hospital - GLCMS Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Hi-Line Sletten Cancer Center Havre, Montana	Site Public Contact - (protocols@AllianceNCTN.org)
Hickman Cancer Center Adrian, Michigan
Holy Cross Hospital Silver Spring, Maryland	Site Public Contact - (eileen.georgi@holy-cross.com)
Hope Cancer Care of Nevada Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Hope Cancer Care of Nevada-Pahrump Pahrump, Nevada	Site Public Contact - (research@sncrf.org)
Hope Cancer Center Pontiac, Michigan
Huntsman Cancer Institute/University of Utah Salt Lake City, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
Hurley Medical Center Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Huron Gastroenterology PC Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Idaho Urologic Institute-Meridian Meridian, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Illinois CancerCare - Washington Washington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Canton Canton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Carthage Carthage, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Dixon Dixon, Illinois
Illinois CancerCare-Eureka Eureka, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Galesburg Galesburg, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Kewanee Clinic Kewanee, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Macomb Macomb, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Ottawa Clinic Ottawa, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peru Peru, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Princeton Princeton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Indu and Raj Soin Medical Center Beavercreek, Ohio
Ingalls Memorial Hospital Harvey, Illinois	Site Public Contact - (clinicaltrials@ingalls.org)
Inova Fair Oaks Hospital Fairfax, Virginia	Site Public Contact - (Stephanie.VanBebber@inova.org)
Inova Fairfax Hospital Falls Church, Virginia	Site Public Contact - (Stephanie.VanBebber@inova.org)
Inova Schar Cancer Institute Fairfax, Virginia	Site Public Contact - (Stephanie.VanBebber@inova.org)
Intermountain Health Lutheran Hospital Wheat Ridge, Colorado	Site Public Contact - (peaksresearch@imail.org)
Intermountain Health Platte Valley Hospital Brighton, Colorado	Site Public Contact - (peaksresearch@imail.org)
Intermountain Health West End Clinic Billings, Montana
Iowa Methodist Medical Center Des Moines, Iowa
Jefferson Cherry Hill Hospital Cherry Hill, New Jersey	Site Public Contact - (ONCTrialNow@jefferson.edu)
Jefferson Healthcare Port Townsend, Washington
John H Stroger Jr Hospital of Cook County Chicago, Illinois
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland	Site Public Contact - (jhcccro@jhmi.edu)
Jupiter Medical Center Jupiter, Florida	Site Public Contact - (clinicaltrials@jupitermed.com)
Kadlec Clinic Hematology and Oncology Kennewick, Washington	Site Public Contact - (research@kadlecmed.org)
Kaiser Permanente Cancer Treatment Center South San Francisco, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente Downtown Commons Sacramento, California	Site Public Contact - (kpoct@kp.org)
Kaiser Permanente Dublin Dublin, California
Kaiser Permanente Fresno Orchard Plaza Fresno, California
Kaiser Permanente Medical Center - Santa Clara Santa Clara, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente Medical Center-Vacaville Vacaville, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente Moanalua Medical Center Honolulu, Hawaii	Site Public Contact - (shelley.a.clark@kp.org)
Kaiser Permanente Oakland-Broadway Oakland, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente San Leandro San Leandro, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente- Marshall Medical Offices Redwood City, California
Kaiser Permanente- Modesto MOB II Modesto, California
Kaiser Permanente-Deer Valley Medical Center Antioch, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Fremont Fremont, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Fresno Fresno, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Modesto Modesto, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Oakland Oakland, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Rancho Cordova Cancer Center Rancho Cordova, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Richmond Richmond, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Roseville Roseville, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-San Francisco San Francisco, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Santa Rosa Santa Rosa, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Santa Teresa-San Jose San Jose, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-South Sacramento Sacramento, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-South San Francisco South San Francisco, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Stockton Stockton, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Vallejo Vallejo, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Walnut Creek Walnut Creek, California	Site Public Contact - (Kpoct@kp.org)
Kaiser San Rafael-Gallinas San Rafael, California	Site Public Contact - (Kpoct@kp.org)
Kapiolani Medical Center for Women and Children Honolulu, Hawaii
Karmanos Cancer Institute at McLaren Greater Lansing Lansing, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
Katmai Oncology Group Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Keck Medicine of USC Koreatown Los Angeles, California
Kettering Medical Center Kettering, Ohio
Kingman Regional Medical Center Kingman, Arizona	Site Public Contact - (research@sncrf.org)
Knox Community Hospital Mount Vernon, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Clinic Cancer Services - Sandpoint Sandpoint, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kuakini Medical Center Honolulu, Hawaii
Lake Regional Hospital Osage Beach, Missouri	Site Public Contact - (clinicaltrials@lakeregional.com)
Lakeview Hospital Stillwater, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Las Vegas Cancer Center-Henderson Henderson, Nevada
Las Vegas Cancer Center-Medical Center Las Vegas, Nevada
Las Vegas Prostate Cancer Center Las Vegas, Nevada
Las Vegas Urology - Cathedral Rock Las Vegas, Nevada
Las Vegas Urology - Green Valley Henderson, Nevada
Las Vegas Urology - Pebble Henderson, Nevada
Las Vegas Urology - Pecos Las Vegas, Nevada
Las Vegas Urology - Smoke Ranch Las Vegas, Nevada
Las Vegas Urology - Sunset Las Vegas, Nevada
Lawrence Memorial Hospital Lawrence, Kansas	Site Public Contact - (Stephanie.Norris@LMH.ORG)
Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Cedar Crest Allentown, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Hazleton Hazleton, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lenox Hill Hospital New York, New York
Lewistown Hospital Lewistown, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Licking Memorial Hospital Newark, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Logan Health Medical Center Kalispell, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Longmont United Hospital Longmont, Colorado
Los Angeles General Medical Center Los Angeles, California	Site Public Contact - (uscnorrisinfo@med.usc.edu)
Lutheran Hospital - Cancer Centers of Colorado Golden, Colorado	Site Public Contact - (peaksresearch@imail.org)
MU Health Care Goldschmidt Cancer Center Jefferson City, Missouri
Macomb Hematology Oncology PC Warren, Michigan
Manhattan Eye Ear and Throat Hospital New York, New York
Margaret R Pardee Memorial Hospital Hendersonville, North Carolina	Site Public Contact - (pardeecancerresearch@unchealth.unc.edu)
Marietta Memorial Hospital Marietta, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Marshfield Clinic - Wisconsin Rapids Center Wisconsin Rapids, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Clinic-Chippewa Center Chippewa Falls, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Clinic-Wausau Center Wausau, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Ladysmith Ladysmith, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Minocqua Minocqua, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Neillsville Neillsville, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Weston Weston, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-EC Cancer Center Eau Claire, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Marshfield Marshfield, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Rice Lake Rice Lake, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-River Region at Stevens Point Stevens Point, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Mary Greeley Medical Center Ames, Iowa
McFarland Clinic - Ames Ames, Iowa	Site Public Contact - (ksoder@mcfarlandclinic.com)
McFarland Clinic - Boone Boone, Iowa
McFarland Clinic - Jefferson Jefferson, Iowa
McFarland Clinic - Marshalltown Marshalltown, Iowa
McFarland Clinic - Trinity Cancer Center Fort Dodge, Iowa
McLaren Cancer Institute-Bay City Bay City, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Clarkston Clarkston, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Flint Flint, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Lapeer Region Lapeer, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Macomb Mount Clemens, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Northern Michigan Petoskey, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren-Port Huron Port Huron, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
MedStar Georgetown University Hospital Washington D.C., District of Columbia
Medical Center of the Rockies Loveland, Colorado
Medical Oncology Hematology Consultants PA Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Medical University of South Carolina Charleston, South Carolina	Site Public Contact - (hcc-clinical-trials@musc.edu)
Medstar Washington Hospital Center Washington D.C., District of Columbia
Memorial Hospital Carthage, Illinois	Site Public Contact - (Jeffh@columbusccop.org)
Memorial Hospital North Colorado Springs, Colorado
Memorial Hospital West Pembroke Pines, Florida
Memorial Hospital of Carbondale Carbondale, Illinois	Site Public Contact - (clinical.research@sih.net)
Memorial Hospital of Laramie County Cheyenne, Wyoming	Site Public Contact - (protocols@AllianceNCTN.org)
Memorial Medical Center Modesto, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood, Florida	Site Public Contact - (OHR@mhs.net)
Mercy Cancer Center Merced, California
Mercy Cancer Center - Cape Girardeau Cape Girardeau, Missouri
Mercy Cancer Center - Carmichael Carmichael, California
Mercy Cancer Center - Elk Grove Elk Grove, California
Mercy Cancer Center - Rocklin Rocklin, California
Mercy Cancer Center - Sacramento Sacramento, California
Mercy Clinic-Rolla-Cancer and Hematology Rolla, Missouri
Mercy Health - Paducah Cancer Center Paducah, Kentucky
Mercy Health - Perrysburg Hospital Perrysburg, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Health - Saint Anne Hospital Toledo, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Health - Saint Vincent Hospital Toledo, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Health Sylvania Radiation Oncology Center Toledo, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Hospital Cedar Rapids, Iowa
Mercy Hospital Cedar Rapids, Iowa	Site Public Contact - (mmcorc@healthpartners.com)
Mercy Hospital Fort Smith Fort Smith, Arkansas
Mercy Hospital Joplin Joplin, Missouri	Site Public Contact - (esmeralda.carrillo@mercy.net)
Mercy Hospital Oklahoma City Oklahoma City, Oklahoma
Mercy Hospital Pittsburg Pittsburg, Kansas
Mercy Hospital Saint Louis St Louis, Missouri
Mercy Hospital South St Louis, Missouri	Site Public Contact - (Danielle.Werle@mercy.net)
Mercy Hospital Springfield Springfield, Missouri
Mercy Hospital Washington Washington, Missouri
Mercy Infusion Center - Chippewa St Louis, Missouri
Mercy Medical Center Baltimore, Maryland
Mercy Oncology and Hematology - Clayton-Clarkson Ballwin, Missouri
Mercy San Juan Medical Center Carmichael, California
Methodist Jennie Edmundson Hospital Council Bluffs, Iowa	Site Public Contact - (kathryn.bartz@nmhs.org)
Methodist Medical Center of Illinois Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Miami Valley Cancer Care and Infusion Greenville, Ohio
Miami Valley Hospital Dayton, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Miami Valley Hospital North Dayton, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Miami Valley Hospital South Centerville, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Michigan Healthcare Professionals Pontiac Pontiac, Michigan	Site Public Contact - (Emily.Crofts@trinity-health.org)
Michigan Institute of Urology-Town Center Troy, Michigan
Midlands Community Hospital Papillion, Nebraska
Midstate Medical Center Meriden, Connecticut
Miller-Dwan Hospital Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Mills Health Center San Mateo, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Mills-Peninsula Medical Center Burlingame, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Minnesota Oncology - Burnsville Burnsville, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology - Coon Rapids Coon Rapids, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology - Edina Edina, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology - Maple Grove Maple Grove, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Chaska Chaska, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Maplewood Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Woodbury Woodbury, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Mission Hope Medical Oncology - Arroyo Grande Arroyo Grande, California
Mission Hope Medical Oncology - Santa Maria Santa Maria, California
Missouri Baptist Medical Center St Louis, Missouri
Missouri Baptist Sullivan Hospital Sullivan, Missouri
Montefiore Medical Center-Einstein Campus The Bronx, New York	Site Public Contact - (eskwak@montefiore.org)
Montefiore Medical Center-Weiler Hospital The Bronx, New York	Site Public Contact - (eskwak@montefiore.org)
Monticello Cancer Center Monticello, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Mount Carmel East Hospital Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Carmel Grove City Hospital Grove City, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Carmel Health Center West Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Carmel New Albany Surgical Hospital New Albany, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Sinai Comprehensive Cancer Center at Aventura Aventura, Florida	Site Public Contact - (yenrique@msmc.com)
Mount Sinai Hospital Medical Center Chicago, Illinois	Site Public Contact - (suhi@sinai.org)
Mount Sinai Medical Center Miami Beach, Florida	Site Public Contact - (Yvonne.Enriquez@msmc.com)
Mountain Blue Cancer Care Center - Swedish Englewood, Colorado
MyMichigan Medical Center Alpena Alpena, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Gladwin Gladwin, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Gratiot Alma, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Midland Midland, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Mount Pleasant Mount Pleasant, Michigan	Site Public Contact - (CVResearch@mymichigan.org)
MyMichigan Medical Center Saginaw Saginaw, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
MyMichigan Medical Center Tawas Tawas City, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, New York
NYP/Weill Cornell Medical Center New York, New York
National Jewish Health-Main Campus Denver, Colorado	Site Public Contact - (glicht@co-cancerresearch.org)
National Jewish Health-Northern Hematology Oncology Thornton, Colorado	Site Public Contact - (glicht@co-cancerresearch.org)
National Jewish Health-Western Hematology Oncology Golden, Colorado	Site Public Contact - (glicht@co-cancerresearch.org)
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC Omaha, Nebraska
Nebraska Medicine-Bellevue Bellevue, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
Nebraska Medicine-Village Pointe Omaha, Nebraska
Nebraska Methodist Hospital Omaha, Nebraska
New Ulm Medical Center New Ulm, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
New York-Presbyterian/Brooklyn Methodist Hospital Brooklyn, New York	Site Public Contact - (Adg9003@nyp.org)
Newark Radiation Oncology Newark, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Newland Medical Associates-Clarkston Clarkston, Michigan
Newland Medical Associates-Pontiac Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
North Memorial Medical Health Center Robbinsdale, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital Yakima, Washington	Site Public Contact - (Memorial-ClinicalTrials@yvmh.org)
Northern Westchester Hospital Mount Kisco, New York	Site Public Contact - (AMellor@northwell.edu)
Northwell Health Cancer Institute at Huntington Greenlawn, New York
Northwell Health/Center for Advanced Medicine Lake Success, New York
Northwest Cancer Center - Crown Point Crown Point, Indiana	Site Public Contact - (CancerResearch@powershealth.org)
Northwest Cancer Center - Hobart Hobart, Indiana
Northwest Cancer Center - Valparaiso Valparaiso, Indiana	Site Public Contact - (CancerResearch@COMHS.org)
Northwest Oncology LLC Dyer, Indiana
Northwest Wisconsin Cancer Center Ashland, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
OSF Saint Anthony Medical Center Rockford, Illinois
OSF Saint Anthony's Health Center Alton, Illinois
OSF Saint Francis Hospital and Medical Group Escanaba, Michigan	Site Public Contact - (WI_research_admin@hshs.org)
Oakland Colon Rectal Associates Royal Oak, Michigan
Oakland Medical Group Royal Oak, Michigan
Ohio State University Comprehensive Cancer Center Columbus, Ohio	Site Public Contact - (Jamesline@osumc.edu)
OhioHealth Mansfield Hospital Mansfield, Ohio
OhioHealth Marion General Hospital Marion, Ohio
Oncology Associates PC Omaha, Nebraska
Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa
Oncology Hematology Associates of Saginaw Valley PC Saginaw, Michigan
Oncology Hematology Care Inc-Kenwood Cincinnati, Ohio
Oncology Las Vegas - Henderson Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Oncology Las Vegas - Tenaya Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at Charleston Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at Fort Apache Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at MountainView Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Orion Cancer Care Findlay, Ohio
Overlake Medical Center Bellevue, Washington
PCR Oncology Arroyo Grande, California	Site Public Contact - (research@sncrf.org)
PROncology San Juan,	Site Public Contact - (info@PRoncology.com)
Pacific Central Coast Health Center-San Luis Obispo San Luis Obispo, California
Pali Momi Medical Center ‘Aiea, Hawaii
Palo Alto Medical Foundation Health Care Palo Alto, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Palo Alto Medical Foundation-Camino Division Mountain View, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Palo Alto Medical Foundation-Fremont Fremont, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Palo Alto Medical Foundation-Gynecologic Oncology Mountain View, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Palo Alto Medical Foundation-Santa Cruz Santa Cruz, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Palo Alto Medical Foundation-Sunnyvale Sunnyvale, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Park Nicollet Clinic - Saint Louis Park Saint Louis Park, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Parkland Health Center - Farmington Farmington, Missouri
Parkland Memorial Hospital Dallas, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
PeaceHealth Saint John Medical Center Longview, Washington	Site Public Contact - (kmakin-bond@peacehealth.org)
PeaceHealth Saint Joseph Medical Center Bellingham, Washington	Site Public Contact - (achapman1@peacehealth.org)
PeaceHealth Southwest Medical Center Vancouver, Washington	Site Public Contact - (kmakin-bond@peacehealth.org)
PeaceHealth United General Medical Center Sedro-Woolley, Washington	Site Public Contact - (achapman1@peacehealth.org)
Penrose-Saint Francis Healthcare Colorado Springs, Colorado
Phelps Health Delbert Day Cancer Institute Rolla, Missouri	Site Public Contact - (research@phelpshealth.org)
Phelps Memorial Hospital Center Sleepy Hollow, New York
Pocono Medical Center East Stroudsburg, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Poudre Valley Hospital Fort Collins, Colorado
Premier Blood and Cancer Center Dayton, Ohio
Premier Hematology Oncology Care Sterling Heights, Michigan
Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado
ProHealth D N Greenwald Center Mukwonago, Wisconsin	Site Public Contact - (research.institute@phci.org)
ProHealth Oconomowoc Memorial Hospital Oconomowoc, Wisconsin
ProHealth Waukesha Memorial Hospital Waukesha, Wisconsin
Providence Alaska Medical Center Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Providence Cancer Institute Clackamas Clinic Clackamas, Oregon
Providence Hood River Memorial Hospital Hood River, Oregon	Site Public Contact - (canrsrchstudies@provdience.org)
Providence Medical Foundation - Santa Rosa Santa Rosa, California
Providence Newberg Medical Center Newberg, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Portland Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Queen of The Valley Napa, California
Providence Regional Cancer Partnership Everett, Washington	Site Public Contact - (marilyn.birchman@providence.org)
Providence Regional Cancer System-Aberdeen Aberdeen, Washington	Site Public Contact - (deidre.dillon@providence.org)
Providence Regional Cancer System-Centralia Centralia, Washington	Site Public Contact - (deidre.dillon@providence.org)
Providence Regional Cancer System-Lacey Lacey, Washington	Site Public Contact - (deidre.dillon@providence.org)
Providence Regional Cancer System-Shelton Shelton, Washington
Providence Regional Cancer System-Yelm Yelm, Washington
Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California	Site Public Contact - (Najee.Boucher@providence.org)
Providence Saint Mary Regional Cancer Center Walla Walla, Washington	Site Public Contact - (Cheryl.Dodd@providence.org)
Providence Saint Vincent Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Santa Rosa Memorial Hospital Santa Rosa, California
Providence Willamette Falls Medical Center Oregon City, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Puerto Rico Hematology Oncology Group Bayamón,
Queen's Cancer Cenrer - POB I Honolulu, Hawaii
Queen's Cancer Center - Kuakini Honolulu, Hawaii
Queen's Cancer Center - Pearlridge ‘Aiea, Hawaii
Queen's Medical Center Honolulu, Hawaii
Queens Cancer Center Rego Park, New York
Radiation Oncology Associates Reno, Nevada
Radiation Oncology Centers of Nevada Central Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Radiation Oncology Centers of Nevada Southeast Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Rapid City Regional Hospital Rapid City, South Dakota	Site Public Contact - (research@monument.health)
Reading Hospital West Reading, Pennsylvania
Regional Cancer Center-Lee Memorial Health System Fort Myers, Florida	Site Public Contact - (protocols@AllianceNCTN.org)
Regions Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Reid Health Richmond, Indiana
Renown Regional Medical Center Reno, Nevada	Site Public Contact - (Renown-CRD@renown.org)
Rice Memorial Hospital Willmar, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Ridgeview Medical Center Waconia, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Ridley-Tree Cancer Center Santa Barbara, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Riverside Methodist Hospital Columbus, Ohio
Riverwood Healthcare Center Aitkin, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Rocky Mountain Cancer Centers - Centennial Centennial, Colorado
Rocky Mountain Cancer Centers - Swedish Englewood, Colorado
Rocky Mountain Cancer Centers-Aurora Aurora, Colorado
Rocky Mountain Cancer Centers-Boulder Boulder, Colorado
Rocky Mountain Cancer Centers-Lakewood Lakewood, Colorado
Rocky Mountain Cancer Centers-Littleton Littleton, Colorado
Rocky Mountain Cancer Centers-Longmont Longmont, Colorado
Rocky Mountain Cancer Centers-Midtown Denver, Colorado
Rocky Mountain Cancer Centers-Penrose Colorado Springs, Colorado
Rocky Mountain Cancer Centers-Rose Denver, Colorado
Rocky Mountain Cancer Centers-Sky Ridge Lone Tree, Colorado
Rocky Mountain Cancer Centers-Thornton Thornton, Colorado
Rohnert Park Cancer Center Rohnert Park, California	Site Public Contact - (Kpoct@kp.org)
Rose Medical Center Denver, Colorado
Rush-Copley Healthcare Center Yorkville, Illinois	Site Public Contact - (Cancer.Research@rushcopley.com)
Rush-Copley Medical Center Aurora, Illinois	Site Public Contact - (RCMC_Cancer_Research@rush.edu)
SIH Cancer Institute Carterville, Illinois	Site Public Contact - (clinical.research@sih.net)
SSM Health Good Samaritan Mount Vernon, Illinois	Site Public Contact - (gayla.hall@ssmhealth.com)
Saint Alphonsus Cancer Care Center-Baker City Baker City, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Boise Boise, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Nampa Nampa, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Ontario Ontario, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Ann's Hospital Westerville, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Saint Anthony North Hospital Westminster, Colorado
Saint Catherine Hospital Garden City, Kansas	Site Public Contact - (protocols@AllianceNCTN.org)
Saint Charles Health System Bend, Oregon	Site Public Contact - (nosall@stcharleshealthcare.org)
Saint Charles Health System-Redmond Redmond, Oregon
Saint Elizabeth Boardman Hospital Boardman, Ohio
Saint Elizabeth Regional Medical Center Lincoln, Nebraska
Saint Elizabeth Youngstown Hospital Youngstown, Ohio
Saint Francis Cancer Center Greenville, South Carolina
Saint Francis Medical Center Cape Girardeau, Missouri	Site Public Contact - (sfmc@sfmc.net)
Saint Francis Regional Medical Center Shakopee, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint James Community Hospital and Cancer Treatment Center Butte, Montana
Saint John's Hospital - Healtheast Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint Joseph Hospital - Cancer Centers of Colorado Denver, Colorado
Saint Joseph Medical Center Hematology and Oncology - Silverdale Silverdale, Washington
Saint Joseph Radiation Oncology Resource Center Lexington, Kentucky
Saint Joseph Warren Hospital Warren, Ohio
Saint Luke's Cancer Institute - Boise Boise, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Fruitland Fruitland, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Meridian Meridian, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Nampa Nampa, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Twin Falls Twin Falls, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Mary Corwin Medical Center Pueblo, Colorado
Saint Mary Medical Center Hobart, Indiana	Site Public Contact - (CancerResearch@COMHS.org)
Saint Mary's Hospital Rhinelander, Wisconsin
Saint Mary's Hospital and Regional Medical Center Grand Junction, Colorado	Site Public Contact - (ccrp@co-cancerresearch.org)
Saint Mary's Oncology/Hematology Associates of Marlette Marlette, Michigan
Saint Mary's Oncology/Hematology Associates of West Branch West Branch, Michigan
Saint Mary's Regional Medical Center Reno, Nevada	Site Public Contact - (research@sncrf.org)
Saint Patrick Hospital - Community Hospital Missoula, Montana	Site Public Contact - (amy.hanneman@providence.org)
Saint Rita's Medical Center Lima, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Saint Vincent Frontier Cancer Center Billings, Montana
Saint Vincent Healthcare Billings, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Saint Vincent Hospital Cancer Center Green Bay Green Bay, Wisconsin	Site Public Contact - (WI_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Oconto Falls Oconto Falls, Wisconsin	Site Public Contact - (WI_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Saint Mary's Green Bay, Wisconsin	Site Public Contact - (wi_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Sheboygan Sheboygan, Wisconsin	Site Public Contact - (wi_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Sturgeon Bay Sturgeon Bay, Wisconsin	Site Public Contact - (wi_research_admin@hshs.org)
Sainte Genevieve County Memorial Hospital Sainte Genevieve, Missouri
Salina Regional Health Center Salina, Kansas	Site Public Contact - (mleepers@srhc.com)
San Juan City Hospital San Juan,
San Juan Community Oncology Group San Juan,
Sanford Bismarck Medical Center Bismarck, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Broadway Medical Center Fargo, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Cancer Center Oncology Clinic Sioux Falls, South Dakota	Site Public Contact - (OncologyClinicTrialsSF@sanfordhealth.org)
Sanford Cancer Center Worthington Worthington, Minnesota
Sanford Joe Lueken Cancer Center Bemidji, Minnesota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Medical Center Fargo Fargo, North Dakota
Sanford Roger Maris Cancer Center Fargo, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford South University Medical Center Fargo, North Dakota
Sanford Thief River Falls Medical Center Thief River Falls, Minnesota
Sanford USD Medical Center - Sioux Falls Sioux Falls, South Dakota	Site Public Contact - (OncologyClinicalTrialsSF@SanfordHealth.org)
Santa Cruz Radiation Oncology Medical Group Santa Cruz, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Schulze Family Foundation Cancer Clinic - Bonita Health Center Bonita Springs, Florida	Site Public Contact - (RCCR@leehealth.org)
Sheboygan Physicians Group Sheboygan, Wisconsin	Site Public Contact - (wi_research_admin@hshs.org)
Sibley Memorial Hospital Washington D.C., District of Columbia	Site Public Contact - (jquiver1@jhmi.edu)
Sidney Kimmel Cancer Center Washington Township Sewell, New Jersey	Site Public Contact - (ONCTrialNow@jefferson.edu)
Siouxland Regional Cancer Center Sioux City, Iowa
Skagit Regional Health Cancer Care Center Mount Vernon, Washington	Site Public Contact - (rcccclinicalresearch@skagitvalleyhospital.org)
South Sacramento Cancer Center Sacramento, California	Site Public Contact - (Kpoct@kp.org)
Southeastern Medical Oncology Center-Clinton Clinton, North Carolina	Site Public Contact - (jfields@cancersmoc.com)
Southeastern Medical Oncology Center-Goldsboro Goldsboro, North Carolina	Site Public Contact - (jfields@cancersmoc.com)
Southeastern Medical Oncology Center-Jacksonville Jacksonville, North Carolina	Site Public Contact - (jfields@cancersmoc.com)
Southern Illinois University School of Medicine Springfield, Illinois
Southern Ohio Medical Center Portsmouth, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Southpointe-Sanford Medical Center Fargo Fargo, North Dakota
Springfield Clinic Springfield, Illinois
Springfield Memorial Hospital Springfield, Illinois	Site Public Contact - (pallante.beth@mhsil.com)
Springfield Regional Cancer Center Springfield, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Springfield Regional Medical Center Springfield, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Stony Brook University Medical Center Stony Brook, New York
Straub Clinic and Hospital Honolulu, Hawaii
Straub Medical Center - Kahului Clinic Kahului, Hawaii	Site Public Contact - (lori.kam@hawaiipacifichealth.org)
Strecker Cancer Center-Belpre Belpre, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Summerlin Hospital Medical Center Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Sunrise Hospital and Medical Center Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Sutter Auburn Faith Hospital Auburn, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Cancer Centers Radiation Oncology Services-Roseville Roseville, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Cancer Research Consortium Novato, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Davis Hospital Davis, California	Site Public Contact - (NCIclinicaltrials@sutterhealth.org)
Sutter Medical Center Sacramento Sacramento, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Pacific Medical Foundation Santa Rosa, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Roseville Medical Center Roseville, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Sutter Solano Medical Center/Cancer Center Vallejo, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Swedish Cancer Institute-Edmonds Edmonds, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Cancer Institute-Issaquah Issaquah, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center Englewood, Colorado
Swedish Medical Center-Ballard Campus Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-Cherry Hill Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-First Hill Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Tamarack Health Hayward Medical Center Hayward, Wisconsin
Tarrant County Hospital District/JPS Health Network Fort Worth, Texas	Site Public Contact - (macosta02@jpshealth.org)
The Cancer Center of Hawaii-Liliha Honolulu, Hawaii
The Cancer Center of Hawaii-Pali Momi ‘Aiea, Hawaii
The Community Hospital Munster, Indiana
The Dana-Farber Cancer Institute at Londonderry Londonderry, New Hampshire	Site Public Contact - (protocols@AllianceNCTN.org)
The Hospital of Central Connecticut New Britain, Connecticut
The James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky
The Mark H Zangmeister Center Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
The Melanoma and Skin Cancer Institute Englewood, Colorado
The New York Hospital Medical Center of Queens Flushing, New York	Site Public Contact - (ctsucontact@westat.com)
The Permanente Medical Group-Roseville Radiation Oncology Roseville, California	Site Public Contact - (Kpoct@kp.org)
The Queen's Medical Center - West Oahu ‘Ewa Beach, Hawaii	Site Public Contact - (rohta@queens.org)
The University of Kansas Cancer Center - Olathe Olathe, Kansas	Site Public Contact - (OlatheCCResearch@kumc.edu)
The Watson Clinic Lakeland, Florida
The Women's Imaging Center Denver, Colorado
Thomas Jefferson University Hospital Philadelphia, Pennsylvania	Site Public Contact - (ONCTrialNow@jefferson.edu)
Tift Regional Medical Center Tifton, Georgia
Toledo Clinic Cancer Centers-Maumee Maumee, Ohio
Toledo Clinic Cancer Centers-Monroe Monroe, Michigan
Toledo Clinic Cancer Centers-Toledo Toledo, Ohio
TriHealth Cancer Institute-Anderson Cincinnati, Ohio
TriHealth Cancer Institute-Westside Cincinnati, Ohio
Trinity Health IHA Medical Group Hematology Oncology - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Oakland Hospital Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Mary Mercy Livonia Hospital Livonia, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Medical Center Moline, Illinois
UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
UC Irvine Health Cancer Center-Newport Costa Mesa, California
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California	Site Public Contact - (ucstudy@uci.edu)
UCHealth Greeley Hospital Greeley, Colorado	Site Public Contact - (protocols@AllianceNCTN.org)
UCHealth Memorial Hospital Central Colorado Springs, Colorado
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California	Site Public Contact - (ucstudy@uci.edu)
UChicago Medicine Northwest Indiana Crown Point, Indiana	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
UF Health Cancer Institute - Gainesville Gainesville, Florida
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny, Iowa
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Laurel Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic Clive, Iowa
UI Healthcare Mission Cancer and Blood - Pella Pella, Iowa	Site Public Contact - (trials@missioncancer.com)
UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina	Site Public Contact - (cancerclinicaltrials@med.unc.edu)
USC / Norris Comprehensive Cancer Center Los Angeles, California
USC Norris Oncology/Hematology-Newport Beach Newport Beach, California
UT Southwestern Clinical Center at Richardson/Plano Richardson, Texas	Site Public Contact - (Suzanne.cole@utsouthwestern.edu)
UT Southwestern Simmons Cancer Center - RedBird Dallas, Texas	Site Public Contact - (canceranswerline@utsouthwestern.edu)
UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
UT Southwestern/Simmons Cancer Center-Fort Worth Fort Worth, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
UW Cancer Center at ProHealth Care Waukesha, Wisconsin	Site Public Contact - (Chanda.miller@phci.org)
UW Health Carbone Cancer Center Rockford Rockford, Illinois	Site Public Contact - (lkline@uwhealth.org)
United Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Unity Hospital Fridley, Minnesota
University Cancer Center Las Vegas, Nevada
University Health Truman Medical Center Kansas City, Missouri
University Medical Center New Orleans New Orleans, Louisiana	Site Public Contact - (emede1@lsuhsc.edu)
University Medical Center of Southern Nevada Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
University of Alabama at Birmingham Cancer Center Birmingham, Alabama
University of Chicago Comprehensive Cancer Center Chicago, Illinois	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
University of Chicago Medicine-Orland Park Orland Park, Illinois	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
University of Hawaii Cancer Center Honolulu, Hawaii
University of Illinois Chicago, Illinois
University of Iowa Healthcare Cancer Services Quad Cities Bettendorf, Iowa	Site Public Contact - (katherine-daprile@uiowa.edu)
University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa
University of Kansas Health System Saint Francis Campus Topeka, Kansas
University of Kentucky/Markey Cancer Center Lexington, Kentucky
University of Michigan Health - Sparrow Lansing Lansing, Michigan	Site Public Contact - (harsha.trivedi@umhsparrow.org)
University of Nebraska Medical Center Omaha, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
University of New Mexico Cancer Center Albuquerque, New Mexico
University of North Carolina-Hillsborough Campus Hillsborough, North Carolina	Site Public Contact - (cancerclinicaltrials@med.unc.edu)
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma	Site Public Contact - (ou-clinical-trials@ouhsc.edu)
University of Rochester Rochester, New York
University of Utah Sugarhouse Health Center Salt Lake City, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
University of Vermont Medical Center Burlington, Vermont	Site Public Contact - (rpo@uvm.edu)
University of Vermont and State Agricultural College Burlington, Vermont	Site Public Contact - (rpo@uvm.edu)
University of Virginia Cancer Center Charlottesville, Virginia	Site Public Contact - (uvacancertrials@hscmail.mcc.virginia.edu)
UofL Health Medical Center Northeast Louisville, Kentucky	Site Public Contact - (ctoinfo@louisville.edu)
Upper Valley Medical Center Troy, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Urology Specialists of Nevada - Central Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Urology Specialists of Nevada - Green Valley Henderson, Nevada	Site Public Contact - (research@sncrf.org)
Urology Specialists of Nevada - Northwest Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Urology Specialists of Nevada - Southwest Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
VCU Community Memorial Health Center South Hill, Virginia	Site Public Contact - (nemer.elmouallem@vcuhealth.org)
VCU Massey Cancer Center at Stony Point Richmond, Virginia	Site Public Contact - (ctoclinops@vcu.edu)
VCU Massey Comprehensive Cancer Center Richmond, Virginia	Site Public Contact - (CTOclinops@vcu.edu)
Valley Medical Center Renton, Washington	Site Public Contact - (research@valleymed.org)
Valley Radiation Oncology Peru, Illinois
Vince Lombardi Cancer Clinic - Oshkosh Oshkosh, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Sheboygan Sheboygan, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Two Rivers Two Rivers, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Virginia Cancer Institute Richmond, Virginia	Site Public Contact - (smoore@vacancer.com)
Wake Forest Baptist Health - Wilkes Medical Center Wilkesboro, North Carolina
Wake Forest University Health Sciences Winston-Salem, North Carolina
Wake Forest University at Clemmons Clemmons, North Carolina
Walter Knox Memorial Hospital Emmett, Idaho
Wayne Hospital Greenville, Ohio
Wayne State University/Karmanos Cancer Institute Detroit, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
Weisberg Cancer Treatment Center Farmington Hills, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
Welch Cancer Center Sheridan, Wyoming
West Virginia University Charleston Division Charleston, West Virginia
Western Illinois Cancer Treatment Center Galesburg, Illinois
Wilcox Memorial Hospital and Kauai Medical Clinic Lihue, Hawaii
Wilmot Cancer Institute at Webster Webster, New York	Site Public Contact - (WCICTOresearch@urmc.rochester.edu)
Women's Diagnostic Center - Munster Munster, Indiana	Site Public Contact - (mnicholson@comhs.org)
Woodland Memorial Hospital Woodland, California
Zangmeister Center Grove City Grove City, Ohio	Site Public Contact - (Jeffh@columbusccop.org)

Behavioral Exercise Training to Reduce Cardiovascular Disease Risk (EXTRA-PC)

Contact(s):

Alexander R Lucas, PhD - Alexander.Lucas@vcuhealth.org

Principal Investigator:

System ID: NCT06237179

Show full eligibility criteria

Interventions: BEHAVIORAL: Exercise Training Intervention, BEHAVIORAL: Healthy Living Education

Conditions: Prostate Cancer, Supportive Care

Keywords: Prostate Cancer, Supportive Care, Exercise

I'm interested

Share via email

Show 2 locations

Study Locations

Hide all locations

Location	Contacts
Richmond Veterans Affairs Medical Center Richmond, Virginia	Alexander R Lucas, PhD - (Alexander.Lucas2@va.gov) Alexandra L Marshall, MS - (lara.marshall@vcuhealth.org)
Virginia Commonwealth University Massey Cancer Center Richmond, Virginia	Alexandra Marshall - (marshallla@vcu.edu) Alexander Lucas, PhD - (Alexander.Lucas@vcuhealth.org)

Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation

Contact(s):

Brooke Dexheimer, PhD, OTD, OTR/L - dexheimerb@vcu.edu

Principal Investigator:

System ID: NCT05947279

Show full eligibility criteria

Interventions: BEHAVIORAL: Comparing motor adaptation reaching performance

Conditions: Motor Adaptation and Generalization, Posterior Parietal Cortex, Cerebellum

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Medical Center Richmond, Virginia	Brooke Dexheimer - (dexheimerb@vcu.edu)

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Contact(s):

Anne Beaven, MD - anne_beaven@med.unc.edu

Principal Investigator:

System ID: NCT05976763

Show full eligibility criteria

Inclusion Criteria:

* • Histologically confirmed mantle cell lymphoma with cyclin D1 (BCL1) expression by immunohistochemical stains and/or evidence of CCND1 rearrangement or t(11;14)(q13;q32) as confirmed by the enrolling center (such as by fluorescence in situ hybridization \[FISH\], polymerase chain reaction \[PCR\]/sequencing, karyotype). Patients with cyclin D1 and/or t(11;14) negative mantle cell lymphoma with an expression profile suggesting a diagnosis of mantle cell lymphoma \[MCL\] such as SOX11 expression are also eligible * Any stage allowed (stage I-IV) * Patient must have at least one objective measurable disease parameter by PET or CT. Measurable disease in the liver is required if the liver is the only site of lymphoma OR bone marrow involvement by MCL * Steroids for management of mantle cell lymphoma are allowed up to a dose of prednisone 100mg/day (or equivalent) for up to 7 days prior to registration * No prior systemic treatment for mantle cell lymphoma * No prior radiation treatment for stage I MCL * No prior exposure to a BTK inhibitor or anti-CD20 monoclonal antibody * No prior stem cell transplant * Age \>= 70 years OR age \>= 60 to \< 70 years with comorbidities precluding autologous stem cell transplantation (autoSCT) including at least one of the following: a) cardiac ejection fraction (EF) \<= 45%, b) diffusing capacity for carbon monoxide \<= 60% predicted; c) creatinine clearance \< 70 but \>= 30ml/minute (min); d) Eastern Cooperative Oncology Group (ECOG) performance status of 2, which poses an unacceptable risk of toxicity for high-dose therapy and stem cell transplantation; or e) Cumulative Illness Rating Scales (CIRS) total score \> 6 * ECOG Performance Status 0-2 * Absolute neutrophil count (ANC) \>= 750/mm\^3 (without growth factor support within 7 days) * Platelet count \>= 75,000/mm\^3 (or \>= 50,000/mm\^3 if thrombocytopenia is due to lymphoma) without growth factor support or transfusion within 7 days * Creatinine clearance \>= 30 mL/ min determined by either: a) Estimation using the Cockcroft-Gault equation or b) Measurement by nuclear medicine scan or 24 hour urine collection * Total bilirubin =\< 1.5 x upper limit of normal (ULN) (unless documented Gilbert's syndrome) * Aspartate transferase (AST) / alanine transaminase (ALT) =\< 3 x ULN * Patients should not be considered candidates for stem cell transplant or must have declined a stem cell transplant strategy * No clinically significant cardiovascular disease including the following * Unstable angina within 3 months before registration * New York Heart Association class III or IV congestive heart failure * History of clinically significant arrhythmias (eg, sustained ventricular tachycardia, ventricular fibrillation, torsades de pointes) * Known QT correction formula (QTcF) \> 480 msecs based on Fredericia's formula (unless pacemaker in place) * History of Mobitz II second-degree or third-degree heart block without a permanent pacemaker in place * Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial * No active Hepatitis B or Hepatitis C infection. Patients with prior hepatitis B virus (HBV) exposure (positive HBV core antibody and/or surface antigen) are eligible if they have no detectable viral load, and are taking appropriate prophylactic antiviral therapy to prevent reactivation. Patients with history of hepatitis C virus (HCV) are eligible if they have an undetectable HCV viral load * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * No history of severe bleeding disorder such as hemophilia A, hemophilia B, von Willebrand disease, or history of spontaneous bleeding requiring blood transfusion or other medical intervention * No history of stroke or intracranial hemorrhage within 6 months prior to registration * No disease significantly affecting gastrointestinal function such as malabsorption syndrome, resection of the stomach or small bowel, bariatric surgery procedures, symptomatic inflammatory bowel disease, or partial or complete bowel obstruction. Patient must be able to swallow pills * Potential trial participants should have recovered from major surgery * No vaccination with a live vaccine within 35 days prior to registration * No hypersensitivity to zanubrutinib or rituximab or any of the other ingredients of the study drugs * Patients on strong CYP3A4 inhibitors must discontinue the drug for 14 days prior to registration on the study. * Patients on strong CYP3A4 inducers must discontinue the drug 14 days prior to registration.

Interventions: DRUG: Zanubrutinib, BIOLOGICAL: Rituximab, OTHER: Patient Observation, PROCEDURE: Bone Marrow Biopsy, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Computed Tomography, PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Esophagogastroduodenoscopy, PROCEDURE: Colonoscopy, PROCEDURE: Biospecimen Collection, OTHER: Questionnaire Administration

Conditions: Mantle Cell Lymphoma

I'm interested

Share via email

Show 238 locations

Study Locations

Hide all locations

Location	Contacts
Abbott-Northwestern Hospital Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Alliance for Clinical Trials in Oncology Chicago, Illinois	Anne W. Beaven - (beaven@med.unc.edu)
Augusta University Medical Center Augusta, Georgia	Site Public Contact - (ga_cares@augusta.edu)
Benefis Sletten Cancer Institute Great Falls, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Billings Clinic Cancer Center Billings, Montana	Site Public Contact - (research@billingsclinic.org)
Bozeman Health Deaconess Hospital Bozeman, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Broadlawns Medical Center Des Moines, Iowa
Cancer Care Center of O'Fallon O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Care Specialists of Illinois - Decatur Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Centers of Southwest Oklahoma Research Lawton, Oklahoma
Cancer Hematology Centers - Flint Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Carle Cancer Center Urbana, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Effingham Effingham, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Mattoon/Charleston Mattoon, Illinois	Site Public Contact - (Research@carle.com)
Carle at The Riverfront Danville, Illinois	Site Public Contact - (Research@Carle.com)
Cedars-Sinai Medical Center Los Angeles, California	Site Public Contact - (Cancer.trial.info@cshs.org)
Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
City of Hope Comprehensive Cancer Center Duarte, California
City of Hope at Irvine Lennar Irvine, California
Coborn Cancer Center at Saint Cloud Hospital Saint Cloud, Minnesota	Site Public Contact - (coborncancercenter@centracare.com)
Community Hospital of Anaconda Anaconda, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Community Medical Center Toms River, New Jersey	Site Public Contact - (mccinfo@mtcancer.org)
Corewell Health Beaumont Troy Hospital Troy, Michigan
Corewell Health Farmington Hills Hospital Farmington Hills, Michigan
Corewell Health William Beaumont University Hospital Royal Oak, Michigan
CoxHealth South Hospital Springfield, Missouri
Crossroads Cancer Center Effingham, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Dartmouth Cancer Center - North Saint Johnsbury, Vermont	Site Public Contact - (cancer.research.nurse@hitchcock.org)
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon, New Hampshire	Site Public Contact - (cancer.research.nurse@dartmouth.edu)
Decatur Memorial Hospital Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Duke University Medical Center Durham, North Carolina
Duluth Clinic Ashland Ashland, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Emory Johns Creek Hospital Johns Creek, Georgia	Site Public Contact - (m.lisa.hwang@emory.edu)
Emory Saint Joseph's Hospital Atlanta, Georgia
Emory University Hospital Midtown Atlanta, Georgia
Emory University Hospital/Winship Cancer Institute Atlanta, Georgia
Essentia Health - Deer River Clinic Deer River, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center-South University Clinic Fargo, North Dakota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Hibbing Clinic Hibbing, Minnesota
Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Sandstone Sandstone, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Virginia Clinic Virginia, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Fred and Pamela Buffett Cancer Center - Kearney Kearney, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
Freeman Physician Group of Pittsburg Pittsburg, Kansas	Site Public Contact - (BNMathew@freemanhealth.com)
Froedtert and MCW Moorland Reserve Health Center New Berlin, Wisconsin
Genesee Hematology Oncology PC Flint, Michigan
Genesys Hurley Cancer Institute Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Grady Health System Atlanta, Georgia
Gundersen Lutheran Medical Center La Crosse, Wisconsin	Site Public Contact - (cancerctr@gundersenhealth.org)
HaysMed Hays, Kansas
Helen F Graham Cancer Center Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Hematology Oncology Associates of CNY at Camillus Camillus, New York
Hematology Oncology Associates of Central New York-East Syracuse East Syracuse, New York
Hennepin County Medical Center Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Henry Ford Saint John Hospital - Macomb Medical Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Huntsman Cancer Institute/University of Utah Salt Lake City, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
Hurley Medical Center Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Huron Gastroenterology PC Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Illinois CancerCare - Washington Washington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Canton Canton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Carthage Carthage, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Dixon Dixon, Illinois
Illinois CancerCare-Eureka Eureka, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Galesburg Galesburg, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Kewanee Clinic Kewanee, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Macomb Macomb, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Ottawa Clinic Ottawa, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peru Peru, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Princeton Princeton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Iowa Methodist Medical Center Des Moines, Iowa
Kansas City Veterans Affairs Medical Center Kansas City, Missouri
Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Clinic Cancer Services - Sandpoint Sandpoint, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York	Site Public Contact - (CancerTrials@nyulangone.org)
Lawrence Memorial Hospital Lawrence, Kansas	Site Public Contact - (Stephanie.Norris@LMH.ORG)
Logan Health Medical Center Kalispell, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Marshfield Medical Center - Minocqua Minocqua, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Weston Weston, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-EC Cancer Center Eau Claire, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Marshfield Marshfield, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Rice Lake Rice Lake, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-River Region at Stevens Point Stevens Point, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Mary Greeley Medical Center Ames, Iowa
McFarland Clinic - Ames Ames, Iowa	Site Public Contact - (ksoder@mcfarlandclinic.com)
McFarland Clinic - Boone Boone, Iowa
McFarland Clinic - Jefferson Jefferson, Iowa
McFarland Clinic - Marshalltown Marshalltown, Iowa
McFarland Clinic - Trinity Cancer Center Fort Dodge, Iowa
McLaren Cancer Institute-Bay City Bay City, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Central Michigan Mount Pleasant, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Clarkston Clarkston, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Flint Flint, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Lapeer Region Lapeer, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
McLaren Cancer Institute-Northern Michigan Petoskey, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
Medical College of Wisconsin Milwaukee, Wisconsin
Medical Oncology Hematology Consultants PA Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Medical University of South Carolina Charleston, South Carolina	Site Public Contact - (hcc-clinical-trials@musc.edu)
Memorial Hospital East Shiloh, Illinois	Site Public Contact - (dschwab@wustl.edu)
Mercy Hospital Cedar Rapids, Iowa	Site Public Contact - (mmcorc@healthpartners.com)
Mercy Hospital South St Louis, Missouri	Site Public Contact - (Danielle.Werle@mercy.net)
Mercy Hospital Springfield Springfield, Missouri
Mercy Medical Center - Des Moines Des Moines, Iowa
Minnesota Oncology Hematology PA-Woodbury Woodbury, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
MyMichigan Medical Center Saginaw Saginaw, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
MyMichigan Medical Center Tawas Tawas City, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
NYP/Weill Cornell Medical Center New York, New York
NYU Langone Hospital - Long Island Mineola, New York	Site Public Contact - (cancertrials@nyulangone.org)
Nebraska Medicine-Bellevue Bellevue, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
Nebraska Medicine-Village Pointe Omaha, Nebraska
Northwest Cancer Center - Crown Point Crown Point, Indiana	Site Public Contact - (CancerResearch@powershealth.org)
Northwest Cancer Center - Hobart Hobart, Indiana
Northwest Cancer Center - Valparaiso Valparaiso, Indiana	Site Public Contact - (CancerResearch@COMHS.org)
Northwest Oncology LLC Dyer, Indiana
Ohio State University Comprehensive Cancer Center Columbus, Ohio	Site Public Contact - (Jamesline@osumc.edu)
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa, Oklahoma
Oncology Hematology Associates of Saginaw Valley PC Saginaw, Michigan
Park Nicollet Clinic - Saint Louis Park Saint Louis Park, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Phoebe Putney Memorial Hospital Albany, Georgia	Site Public Contact - (ga_cares@augusta.edu)
Prisma Health Cancer Institute - Butternut Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Easley Easley, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Eastside Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Faris Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Greer Greer, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Seneca Seneca, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Spartanburg Boiling Springs, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
ProHealth D N Greenwald Center Mukwonago, Wisconsin	Site Public Contact - (research.institute@phci.org)
ProHealth Oconomowoc Memorial Hospital Oconomowoc, Wisconsin
Providence Newberg Medical Center Newberg, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Portland Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Saint Vincent Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Willamette Falls Medical Center Oregon City, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Regions Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Rhode Island Hospital Providence, Rhode Island
Roswell Park Cancer Institute Buffalo, New York	Site Public Contact - (askroswell@roswellpark.org)
SSM Health Good Samaritan Mount Vernon, Illinois	Site Public Contact - (gayla.hall@ssmhealth.com)
Saint Alphonsus Cancer Care Center-Boise Boise, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Nampa Nampa, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Ontario Ontario, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Anthony Regional Hospital Carroll, Iowa	Site Public Contact - (sbenson@iora.org)
Saint Catherine Hospital Garden City, Kansas	Site Public Contact - (protocols@AllianceNCTN.org)
Saint Francis Medical Center Cape Girardeau, Missouri	Site Public Contact - (sfmc@sfmc.net)
Saint John's Hospital - Healtheast Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint Luke's Cancer Institute - Boise Boise, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Fruitland Fruitland, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Meridian Meridian, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Nampa Nampa, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Hospital Maumee, Ohio
Saint Mary Medical Center Hobart, Indiana	Site Public Contact - (CancerResearch@COMHS.org)
Saint Mary's Oncology/Hematology Associates of West Branch West Branch, Michigan
Salina Regional Health Center Salina, Kansas	Site Public Contact - (mleepers@srhc.com)
Sanford Bismarck Medical Center Bismarck, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Broadway Medical Center Fargo, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Cancer Center Oncology Clinic Sioux Falls, South Dakota	Site Public Contact - (OncologyClinicTrialsSF@sanfordhealth.org)
Sanford Joe Lueken Cancer Center Bemidji, Minnesota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Roger Maris Cancer Center Fargo, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford USD Medical Center - Sioux Falls Sioux Falls, South Dakota	Site Public Contact - (OncologyClinicalTrialsSF@SanfordHealth.org)
Siteman Cancer Center at Christian Hospital St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center at West County Hospital Creve Coeur, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center-South County St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Smilow Cancer Hospital Care Center - Guilford Guilford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center - Waterford Waterford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center - Westerly Westerly, Rhode Island	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Glastonbury Glastonbury, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Greenwich Greenwich, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Long Ridge Stamford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center-Fairfield Fairfield, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center-Trumbull Trumbull, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital-Derby Care Center Derby, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital-Torrington Care Center Torrington, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital-Waterbury Care Center Waterbury, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Southern Illinois University School of Medicine Springfield, Illinois
Springfield Clinic Springfield, Illinois
Springfield Memorial Hospital Springfield, Illinois	Site Public Contact - (pallante.beth@mhsil.com)
Swedish Cancer Institute-Edmonds Edmonds, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Cancer Institute-Issaquah Issaquah, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-First Hill Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
The Community Hospital Munster, Indiana
The James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky
The University of Kansas Cancer Center - Olathe Olathe, Kansas	Site Public Contact - (OlatheCCResearch@kumc.edu)
ThedaCare Regional Cancer Center Appleton, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
ThedaCare Regional Medical Center - Appleton Appleton, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
Tower Cancer Research Foundation Beverly Hills, California	Site Public Contact - (towercancerresearch@toweroncology.com)
Trinity Health IHA Medical Group Hematology Oncology - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Oakland Hospital Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Mary Mercy Livonia Hospital Livonia, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny, Iowa
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Laurel Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic Clive, Iowa
UI Healthcare Mission Cancer and Blood - Fort Dodge Fort Dodge, Iowa	Site Public Contact - (trials@missioncancer.com)
UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina	Site Public Contact - (cancerclinicaltrials@med.unc.edu)
UW Cancer Center at ProHealth Care Waukesha, Wisconsin	Site Public Contact - (Chanda.miller@phci.org)
United Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
University Health Truman Medical Center Kansas City, Missouri
University of Arkansas for Medical Sciences Little Rock, Arkansas
University of Illinois Chicago, Illinois
University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa
University of Kansas Cancer Center Kansas City, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center - Briarcliff Kansas City, Missouri
University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center - North Kansas City, Missouri	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center at North Kansas City Hospital North Kansas City, Missouri
University of Kansas Cancer Center-Overland Park Overland Park, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Health System Saint Francis Campus Topeka, Kansas
University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Michigan Health - Sparrow Lansing Lansing, Michigan	Site Public Contact - (harsha.trivedi@umhsparrow.org)
University of Nebraska Medical Center Omaha, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma	Site Public Contact - (ou-clinical-trials@ouhsc.edu)
University of Rochester Rochester, New York
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center Madison, Wisconsin	Site Public Contact - (clinicaltrials@cancer.wisc.edu)
University of Wisconsin Carbone Cancer Center - Johnson Creek Johnson Creek, Wisconsin	Site Public Contact - (clinicaltrials@cancer.wisc.edu)
University of Wisconsin Carbone Cancer Center - University Hospital Madison, Wisconsin	Site Public Contact - (clinicaltrials@cancer.wisc.edu)
UofL Health Medical Center Northeast Louisville, Kentucky	Site Public Contact - (ctoinfo@louisville.edu)
VCU Massey Cancer Center at Stony Point Richmond, Virginia	Site Public Contact - (ctoclinops@vcu.edu)
VCU Massey Comprehensive Cancer Center Richmond, Virginia	Site Public Contact - (CTOclinops@vcu.edu)
Veteran Administration Eastern Kansas Healthcare Leavenworth, Kansas	Site Public Contact - (ctsucontact@westat.com)
Washington University School of Medicine St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Wayne State University/Karmanos Cancer Institute Detroit, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
Weisberg Cancer Treatment Center Farmington Hills, Michigan	Site Public Contact - (ctoadmin@karmanos.org)
Wilmot Cancer Institute at Webster Webster, New York	Site Public Contact - (WCICTOresearch@urmc.rochester.edu)
Women's Diagnostic Center - Munster Munster, Indiana	Site Public Contact - (mnicholson@comhs.org)
Yale University New Haven, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Yale-New Haven Hospital North Haven Medical Center North Haven, Connecticut	Site Public Contact - (canceranswers@yale.edu)

Health Education Approach to Lung Screening (HEALS)

Contact(s):

Massey IIT Research Operations - masseyepd@vcu.edu

Principal Investigator:

System ID: NCT06070870

Show full eligibility criteria

Interventions: BEHAVIORAL: Patient Navigation

Conditions: Lung Cancer

Keywords: Lung cancer, Screening

I'm interested

Share via email

Show 3 locations

Study Locations

Hide all locations

Location	Contacts
Medical University of South Carolina Charleston, South Carolina	Megan Ellison, Ed.D - (ellisome@musc.edu)
University of North Carolina-Chapel Hill Carrboro, North Carolina	Christopher Lyu, MPA - (Christopher_Lyu@med.unc.edu)
Virginia Commonwealth University Richmond, Virginia	Massey CPC Team - (MasseyCPC@vcu.edu)

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality (REMAIN1)

Contact(s):

Massey IIT Research Operations - masseyepd@vcu.edu

Principal Investigator:

System ID: NCT06370000

Show full eligibility criteria

Inclusion Criteria:

* Patients must have histologically or cytologically confirmed non-Acute Promyelocytic (APL) FLT3 negative AML and have completed induction and consolidation as defined by the treating physician and must be in complete response (CR), Complete response with partial hematologic recovery (CRh), or Complete response with incomplete count recovery (CRi) at time of study enrollment * For patients in CR1, AML disease phenotype must be one that is considered for allo HCT in CR1 (intermediate or high risk by European Leukemia Net (ELN), MRD+ CR, slow clearance of MRD) or any AML phenotype (aside from FLT3+ and APL) in CR2 and beyond * Medically eligible for allogeneic hematopoietic cell transplant (allo HCT) as defined by either: treating physician discretion, transplant physician discretion, or hematopoietic cell transplantation-specific Comorbidity index (HCT-CI) index of 5 or less * Age ≥ 18 years * Enrollment must occur within 4 months of completion of therapy * A patient or staff identified health disparity in 1 of the 5 Centers for Disease Control (CDC) defined social determinants of health (SDOH). This may include financial difficulties, lack of caregiver support, difficulties with medical literacy, rurality, appropriate access to health care, lack of an appropriate allogeneic hematopoietic cell transplant (allo HCT) donor, substance abuse * Patient must have adequate organ function defined as: Creatinine clearance (by Cockroft-Gault formula) greater than or equal to 29 mL/min, total bilirubin and aspartate aminotransferase/ alanine transaminase (AST/ALT) ≤ to institutional 2x upper limit of normal (except Gilbert's syndrome, which may enroll if \< 2x patient's baseline total bilirubin) * Eastern Cooperative Oncology Group (ECOG) 0,1,2,3 * Ability to take oral medications * No history of malabsorption syndrome which, in the investigator's opinion, may inhibit absorption of oral medications * Women of childbearing potential must consent to effective contraception during study treatment and at least 6 months following the last dose. Women who are breastfeeding are also excluded * Male patients must consent to effective contraception during study and at least 3 months after last dose * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria A patient who meets any of the following exclusion criteria is ineligible to participate in the study. * FMS-like tyrosine kinase 3 (FLT3 ITD) or tyrosine kinase domain (TKD) mutation * Uncontrolled central nervous system (CNS) involvement * History of hypersensitivity or allergic reaction to azacitidine or its components * Stem cell transplant within previous 3 months prior to initiation of study therapy * Uncontrolled intercurrent illness or infection * History of prior therapy with oral azacitidine * Female patients who are pregnant or intend to donate eggs during the study or for 6 months after receiving their last dose of study drug * Male patients who intend to donate sperm during the course of this study or for 3 months after last dose * Other malignancy for which the patient is currently receiving therapy (except excisable skin cancer) * Medical, psychological, or social condition that, in the opinion of the investigator, may increase the participant's risk or limit the participant's adherence with study requirements

Interventions: DRUG: Oral Azacitidine

Conditions: Acute Myeloid Leukemia

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	Massey CTO Heme Team - (MasseyHemMlg@vcu.edu)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (PREDICT)

Contact(s):

Rana McKay, MD - rmckay@health.ucsd.edu

Principal Investigator:

System ID: NCT06632977

Show full eligibility criteria

Inclusion Criteria:

* PRE-REGISTRATION: Histological or cytological evidence of prostate cancer. Patients with variant histologies including neuroendocrine, small cell and sarcomatoid prostate cancer are allowed to enroll and these will not be used as selection criteria for individual arms. Central pathology review is not required. * PRE-REGISTRATION: Measurable disease and/or non-measurable metastatic disease per RECIST version 1.1. * PRE-REGISTRATION: Tissue procured within 12 months of pre-registration (metastatic disease preferred over primary tissue, though both are acceptable) available for submission per Section 6.2. For patients who have progressed on A032102 and are pre-registering again, repeat tissue procurement will not be mandated. * PRE-REGISTRATION: Molecular report available performed as part of standard of care testing via any Clinical Laboratory Improvement Act (CLIA)-certified next generation sequencing (NGS) assay. Patients may be assigned based on pre-determined qualifying molecular/DNA alterations as stated in Section 4.8 after receipt of local molecular testing by the A032102 molecular tumor board (MTB). Final determination of arm assignment will be determined by the MTB. For qualifying DNA alteration determined by the MTB, testing may be from tumor tissue collected at any time or circulating tumor DNA (ctDNA) within 12 months of pre-registration. If no qualifying DNA alteration is identified based on the CLIA-certified next generation sequencing assay and MTB review, Caris testing, should be performed for both DNA/RNA profiling. Arm assignment based RNA requires testing of tumor tissue collected within 12 months of pre-registration and MTB review. * PRE-REGISTRATION: Age ≥ 18 years. * REGISTRATION: Progressive mCRPC as defined: 1) castrate levels of serum testosterone \< 50 ng/dL AND one or more of the following criteria (choose all the apply): * PSA progression, defined by at least 2 consecutive rising PSA values at a minimum of 1-week intervals with the most recent PSA value being 2.0 ng/mL or higher, if confirmed PSA rise is the only indication of progression. Patients who received an anti-androgen must have PSA progression after withdrawal of anti-androgen therapy. * Radiographic progression per RECIST 1.1 criteria for soft tissue lesions * Bone metastasis progression per Prostate Cancer Working Group 3 (PCWG3) criteria. * REGISTRATION: Patients selected to receive lutetium Lu 177 vipivotide tetraxetan treatment are required to have prostate-specific membrane antigen (PSMA) positive mCRPC as determined by investigator assessment. For reference, in the VISION trial this was defined as at least 1 PSMA+ metastatic lesion (defined as uptake greater than that of liver parenchyma in lesions of any size in any organ system) and no PSMA- lesions (defined as uptake equal to or lower than that of liver parenchyma in any lymph node with a short axis of at least 2.5 cm, in any solid organ lesion with a short axis of at least 1.0 cm, or in any bone lesion with a soft-tissue component of at least 1.0 cm in the short axis). * REGISTRATION: Prior treatment with androgen receptor signaling inhibitor (ARSI) in either the metastatic hormone sensitive setting or mCRPC is required. Prior taxane therapy in either metastatic hormone sensitive setting or mCRPC is mandated unless patient is taxane ineligible or the patient refuses taxane therapy. Prior lutetium LU177 vipivotide tetraxetan treatment is permitted but not mandated. Patients with known germline or somatic deleterious BRCA 1/2 mutations must have received a prior PARPi. * REGISTRATION: Resolved toxicities from previous anticancer therapy, defined as toxicities (other than alopecia) resolved to Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, grade ≤ 1 or baseline. Note: Subjects may be enrolled with chronic, stable grade 2 toxicities (defined as no worsening to \> grade 2 for at least 3 months prior to registration and managed with standard of care treatment) that the investigator deems related to previous anticancer therapy, comprised of: * Chemotherapy-induced neuropathy * Fatigue * Residual toxicities from prior treatment: Grade 1 or grade 2 endocrinopathies which may include: Hypothyroidism/hyperthyroidism. type I diabetes, hyperglycemia, adrenal insufficiency, adrenalitis, skin hypopigmentation (vitiligo) * REGISTRATION: No cytotoxic, biologic, radiopharmaceutical or other non-kinase inhibitor investigational agent within 4 weeks of registration. Treatment with any type of small molecular kinase inhibitor (including investigational kinase inhibitor) within 2 weeks of registration. Treatment with abiraterone acetate, apalutamide, or darolutamide within 2 weeks of registration. Treatment with enzalutamide within 4 weeks of registration. No treatment with radiation therapy within 2 weeks of registration. * REGISTRATION: No major surgery within 4 weeks of registration. * REGISTRATION: No prior treatment with EZH inhibitors. * REGISTRATION: Prior treatment with cabazitaxel + carboplatin. * REGISTRATION: None of the following conditions: * Current use of moderate or strong cytochrome P450 (CYP)3A inducers. * Known or suspected hypersensitivity to valemetostat tosylate (DS-3201b) or any of the excipients. * For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated. Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load. \* HIV-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial. * Imminent or established spinal cord compression based on clinical and/or imaging findings. * Known brain metastases or cranial epidural disease unless adequately treated with radiotherapy and/or surgery (including radiosurgery) and stable for at least 4 weeks prior to registration after radiotherapy or at least 4 weeks prior to registration after major surgery (e.g., removal or biopsy of brain metastasis). Patients must have complete wound healing from major surgery or minor surgery before registration. * Significant cardiovascular defined as: * Myocardial infarction within 6 months prior to enrollment. * Uncontrolled angina pectoris within 6 months prior to enrollment. * New York Heart Association Class 3 or 4 congestive heart failure. * Corrected QT interval calculated by the Fridericia\'s formula (QTcF) ≥ 470 ms per electrocardiogram (ECG) within 42 days before randomization in any individual with any history of any cardiac disease or medication which can impact QTcF. Patients with known history or current symptoms of cardiac disease, history of treatment with cardiotoxic agents, or agents/conditions known to impact QTcF should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification and ECG. * Uncontrolled hypertension (resting systolic blood pressure \>160 mmHg or diastolic blood pressure \> 100 mmHg). * Clinically significant acute infection requiring systemic antibacterial, antifungal or antiviral therapy. * Moderate to severe hepatic impairment (Child-Pugh Class C) * REGISTRATION: No freezing or donating sperm ≤ 14 days prior to registration. * REGISTRATION: Eastern Cooperative Oncology Group (ECOG) performance status 0-2. * REGISTRATION: No granulocyte colony-stimulating factor (GCSF) within 2 weeks of registration. * REGISTRATION: No red blood cell (RBC) transfusions within 2 weeks of registration. * REGISTRATION: No platelet transfusions within 2 weeks of registration. * REGISTRATION: No bleeding diathesis. * REGISTRATION: White blood cell count (WBC) ≥ 2,500/mcL. * REGISTRATION: Absolute neutrophil count (ANC) ≥ 1,500/mcL. * REGISTRATION: Hemoglobin ≥ 9 g/dL. * REGISTRATION: Platelet count ≥ 100,000/mcL. * REGISTRATION: Creatinine clearance ≥ 30 mL/min as defined by Cockcroft-Gault equation. * REGISTRATION: Total bilirubin ≤ 1.5 x ULN (≤ 3 x upper limit of normal \[ULN\] for subjects with documented Gilbert\'s disease). * REGISTRATION: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x ULN. * REGISTRATION: Albumin ≥ 2.8 g/dL. * REGISTRATION: The A032102 molecular tumor board will review the local pathology report and molecular sequencing report, and the Alliance registration/randomization office will relay the assignment to the submitting site. Once the site receives this assignment, they can register the patient to A032102. Any questions about the molecular board treatment assignments can be directed to A032102@alliancenctn.org. * RE-REGISTRATION: Progressive mCRPC (after receiving the tumor board assigned therapy) as defined: 1) castrate levels of serum testosterone \< 50 ng/dL AND 2) progressive disease defined by radiographic progression on conventional imaging (CT/MRI chest, abdomen and pelvis and bone scan within 42 days of re-registration). * RE-REGISTRATION: Resolved toxicities from previous anticancer therapy, defined as toxicities (other than alopecia) resolved to CTCAE version 5.0, grade ≤ 1 or baseline. Note: Subjects may be enrolled with chronic, stable grade 2 toxicities (defined as no worsening to \> grade 2 for at least 3 months prior to registration and managed with standard of care treatment) that the investigator deems related to previous anticancer therapy, comprised of: * Chemotherapy-induced neuropathy * Fatigue * Residual toxicities from prior treatment: Grade 1 or grade 2 endocrinopathies which may include: Hypothyroidism/hyperthyroidism. type I diabetes, hyperglycemia, adrenal insufficiency, adrenalitis, skin hypopigmentation (vitiligo). * RE-REGISTRATION: None of the following conditions: * Imminent or established spinal cord compression based on clinical and/or imaging findings. * Known brain metastases or cranial epidural disease unless adequately treated with radiotherapy and/or surgery (including radiosurgery) and stable for at least 4 weeks prior to registration after radiotherapy or at least 4 weeks prior to re-registration after major surgery (e.g., removal or biopsy of brain metastasis). Patients must have complete wound healing from major surgery or minor surgery before re-registration. * Corrected QT interval calculated by the Fridericia\'s formula (QTcF) \< 470 ms per ECG within 42 days before randomization in any individual with any history of any cardiac disease or medication which can impact QTcF. * Significant cardiovascular defined as: * Myocardial infarction within 6 months prior to enrollment. * Uncontrolled angina pectoris within 6 months prior to enrollment. * New York Heart Association Class 3 or 4 congestive heart failure. * Uncontrolled hypertension (resting systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 100 mmHg). * RE-REGISTRATION: ECOG Performance Status 0-2. * RE-REGISTRATION: No GCSF within 2 weeks of registration. * RE-REGISTRATION: No RBC transfusions within 2 weeks of registration. * RE-REGISTRATION: No platelet transfusions within 2 weeks of registration. * RE-REGISTRATION: WBC ≥ 2,500/mcL. * RE-REGISTRATION: ANC ≥ 1,500/mcL. * RE-REGISTRATION: Hemoglobin ≥ 9 g/dL (transfusions permitted). * RE-REGISTRATION: Platelet count ≥ 100,000/mcL. * RE-REGISTRATION: Creatinine clearance ≥ 30 mL/min as defined by Cockcroft-Gault equation. * RE-REGISTRATION: Total bilirubin ≤ 1.5 x ULN (≤ 3 x ULN for subjects with documented Gilbert\'s disease). * RE-REGISTRATION: AST and ALT ≤ 3 x ULN. * RE-REGISTRATION: Albumin ≥ 2.8 g/dL. * RE-REGISTRATION: QT Interval (QTcF) \< 470 ms (in individuals with any cardiac history of any medication or condition known to impact QTcF). * RE-REGISTRATION: The A032102 molecular tumor board will review the CARIS molecular sequencing report, the Alliance registration/randomization office will relay the assignment to the site. Any questions about the molecular board treatment assignments can be directed to A032102@alliancenctn.org.

Exclusion Criteria:

Interventions: OTHER: Genetic testing, DRUG: Valemetostat Tosylate, PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Computed Tomography, PROCEDURE: Bone scan, PROCEDURE: FDG-Positron Emission Tomography, PROCEDURE: PSMA PET Scan, PROCEDURE: Biospecimen Collection, DRUG: Carboplatin, DRUG: Cabazitaxel, DRUG: Abiraterone Acetate, DRUG: Enzalutamide, DRUG: Lutetium Lu 177 Vipivotide Tetraxetan

Conditions: Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8

I'm interested

Share via email

Show 108 locations

Study Locations

Hide all locations

Location	Contacts
Banner University Medical Center - Tucson Tucson, Arizona	Site Public Contact - (UACC-IIT@uacc.arizona.edu)
Baystate Medical Center Springfield, Massachusetts	Site Public Contact - (tamara.wrenn@baystatehealth.org)
Beebe Health Campus Rehoboth Beach, Delaware	Site Public Contact - (research@beebehealthcare.org)
Beebe South Coastal Health Campus Millville, Delaware	Site Public Contact - (research@beebehealthcare.org)
Billings Clinic Cancer Center Billings, Montana	Site Public Contact - (research@billingsclinic.org)
Bon Secours Cancer Institute at Reynolds Crossing Richmond, Virginia	Site Public Contact - (Anne_caramella@bshsi.org)
Bon Secours Memorial Regional Medical Center Mechanicsville, Virginia	Site Public Contact - (anne_carmellat@bshsi.org)
Bon Secours Richmond Community Hospital Richmond, Virginia	Site Public Contact - (anne_carmellat@bshsi.org)
Bon Secours Saint Francis Medical Center Midlothian, Virginia	Site Public Contact - (anne_carmellat@bshsi.org)
Bon Secours Saint Mary's Hospital Richmond, Virginia	Site Public Contact - (anne_carmellat@bshsi.org)
Cancer Care Center of O'Fallon O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Care and Hematology-Fort Collins Fort Collins, Colorado	Site Public Contact - (protocols@AllianceNCTN.org)
Carle Cancer Center Urbana, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Effingham Effingham, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Mattoon/Charleston Mattoon, Illinois	Site Public Contact - (Research@carle.com)
Carle at The Riverfront Danville, Illinois	Site Public Contact - (Research@Carle.com)
Coborn Cancer Center at Saint Cloud Hospital Saint Cloud, Minnesota	Site Public Contact - (coborncancercenter@centracare.com)
Dana Farber-Merrimack Valley Methuen, Massachusetts
Dana-Farber Cancer Institute Boston, Massachusetts
Dana-Farber Cancer Institute at Foxborough Foxborough, Massachusetts
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Milford, Massachusetts
Dana-Farber/Brigham and Women's Cancer Center at South Shore South Weymouth, Massachusetts
Drexel Town Square Health Center Oak Creek, Wisconsin
Edwards Comprehensive Cancer Center Huntington, West Virginia	Site Public Contact - (Christina.Cole@chhi.org)
Enloe Medical Center Chico, California
Essentia Health Cancer Center Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center-South University Clinic Fargo, North Dakota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Froedtert Menomonee Falls Hospital Menomonee Falls, Wisconsin
Froedtert West Bend Hospital/Kraemer Cancer Center West Bend, Wisconsin
Gibbs Cancer Center-Gaffney Gaffney, South Carolina	Site Public Contact - (kmertz-rivera@gibbscc.org)
Gibbs Cancer Center-Pelham Greer, South Carolina	Site Public Contact - (kmertz-rivera@gibbscc.org)
Guthrie Medical Group PC-Robert Packer Hospital Sayre, Pennsylvania
Hackensack University Medical Center Hackensack, New Jersey
Helen F Graham Cancer Center Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Illinois CancerCare - Washington Washington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Canton Canton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Eureka Eureka, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Ottawa Clinic Ottawa, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peru Peru, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Jupiter Medical Center Jupiter, Florida	Site Public Contact - (clinicaltrials@jupitermed.com)
Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho
MU Health - University Hospital/Ellis Fischel Cancer Center Columbia, Missouri
Marshfield Medical Center-Marshfield Marshfield, Wisconsin
McFarland Clinic - Ames Ames, Iowa	Site Public Contact - (ksoder@mcfarlandclinic.com)
Medical Center of the Rockies Loveland, Colorado
Medical College of Wisconsin Milwaukee, Wisconsin
Medical Oncology Hematology Consultants PA Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Memorial Hospital East Shiloh, Illinois	Site Public Contact - (dschwab@wustl.edu)
Memorial Hospital North Colorado Springs, Colorado
MetroHealth Medical Center Cleveland, Ohio	Site Public Contact - (ababal@metrohealth.org)
Mount Sinai Hospital New York, New York	Site Public Contact - (CCTO@mssm.edu)
Ohio State University Comprehensive Cancer Center Columbus, Ohio	Site Public Contact - (Jamesline@osumc.edu)
Oregon Health and Science University Portland, Oregon	Site Public Contact - (trials@ohsu.edu)
Parkland Memorial Hospital Dallas, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
Poudre Valley Hospital Fort Collins, Colorado
Providence Portland Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Saint Vincent Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Roswell Park Cancer Institute Buffalo, New York	Site Public Contact - (askroswell@roswellpark.org)
SMC Center for Hematology Oncology Union Union, South Carolina	Site Public Contact - (kmertz-rivera@gibbscc.org)
Saint Elizabeth Healthcare Edgewood Edgewood, Kentucky	Site Public Contact - (Kristi.Curtsinger@stelizabeth.com)
Saint Elizabeth Healthcare Fort Thomas Fort Thomas, Kentucky
Siteman Cancer Center at Christian Hospital St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center at West County Hospital Creve Coeur, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center-South County St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Spartanburg Medical Center Spartanburg, South Carolina	Site Public Contact - (kmertz-rivera@gibbscc.org)
Stamford Hospital/Bennett Cancer Center Stamford, Connecticut
Swedish Cancer Institute-Edmonds Edmonds, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-First Hill Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
The University of Kansas Cancer Center - Olathe Olathe, Kansas	Site Public Contact - (OlatheCCResearch@kumc.edu)
Trinity Health IHA Medical Group Hematology Oncology - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Mary Mercy Livonia Hospital Livonia, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Tripler Army Medical Center Honolulu, Hawaii
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California	Site Public Contact - (ucstudy@uci.edu)
UC San Diego Health System - Encinitas Encinitas, California
UC San Diego Medical Center - Hillcrest San Diego, California	Site Public Contact - (rhabbaba@health.ucsd.edu)
UC San Diego Moores Cancer Center La Jolla, California	Site Public Contact - (cancercto@ucsd.edu)
UCHealth Greeley Hospital Greeley, Colorado	Site Public Contact - (protocols@AllianceNCTN.org)
UCHealth Memorial Hospital Central Colorado Springs, Colorado
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California	Site Public Contact - (ucstudy@uci.edu)
UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina	Site Public Contact - (cancerclinicaltrials@med.unc.edu)
UT Southwestern Clinical Center at Richardson/Plano Richardson, Texas	Site Public Contact - (Suzanne.cole@utsouthwestern.edu)
UT Southwestern Simmons Cancer Center - RedBird Dallas, Texas	Site Public Contact - (canceranswerline@utsouthwestern.edu)
UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
UT Southwestern/Simmons Cancer Center-Fort Worth Fort Worth, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
University of Alabama at Birmingham Cancer Center Birmingham, Alabama	Site Public Contact - (gingerreeves@uabmc.edu)
University of Arizona Cancer Center-North Campus Tucson, Arizona	Site Public Contact - (UACC-IIT@uacc.arizona.edu)
University of California Davis Comprehensive Cancer Center Sacramento, California
University of Iowa Healthcare Cancer Services Quad Cities Bettendorf, Iowa	Site Public Contact - (katherine-daprile@uiowa.edu)
University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa
University of Kansas Cancer Center Kansas City, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Health System Saint Francis Campus Topeka, Kansas
University of Kansas Hospital-Indian Creek Campus Overland Park, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Michigan Health - Sparrow Lansing Lansing, Michigan	Site Public Contact - (harsha.trivedi@umhsparrow.org)
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma	Site Public Contact - (ou-clinical-trials@ouhsc.edu)
VCU Massey Cancer Center at Stony Point Richmond, Virginia	Site Public Contact - (ctoclinops@vcu.edu)
VCU Massey Comprehensive Cancer Center Richmond, Virginia	Site Public Contact - (CTOclinops@vcu.edu)
Vanderbilt University/Ingram Cancer Center Nashville, Tennessee
Washington University School of Medicine St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
West Virginia University Charleston Division Charleston, West Virginia

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck (HERCULES)

Contact(s):

Suzanne Holewijn, PhD - herculestrial@rijnstate.nl

Principal Investigator:

System ID: NCT05484115

Show full eligibility criteria

Interventions: DEVICE: endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system, DEVICE: endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system

Conditions: Aortic Aneurysm, Abdominal

Keywords: AAA, Endovascular treatment, Wide proximal neck, EndoAnchors, Infrarenal, EVAR (Endovascular aneurysm repair), ESAR (Endosuture aneurysm repair), Endurant II/IIs stent graft system, Heli-FX EndoAnchor system

I'm interested

Share via email

Show 36 locations

Study Locations

Hide all locations

Location	Contacts
Alina Health Minneapolis, Minnesota
Asklepios Klinik Langen Langen, Hesse	Prof. Dr. med. Konstantinos Donas, MD PhD - (k.donas@asklepios.com) Anja Bukvarevic - (a.bukvarevic@asklepios.com)
Ballad Health/Holston Valley Kingsport, Tennessee
Barnes-Jewish Hospital St Louis, Missouri
Beaumont University Hospital Royal Oak, Michigan
Catharina Ziekenhuis Eindhoven, North Brabant
EHC-Hôpital de Morges Morges,
HCL Lyon Lyon,
Henry Ford Hospital Detroit, Michigan
Hospital Clinic de Barcelona Barcelona,
Hospital Clinico Universitario Lozano Blesa Zaragoza,
Hospital Universitario Miguel Servet Zaragoza,
IRCCS Ospedale Policlinico San Martino Genova, Other
Leeds General Infirmary West Yorkshire,
Les Franciscaines Nîmes,
Loyola Maywood, Illinois
Mt Sinai Med Ctr Miami Beach, Florida
NC Heart& Vascular Raleigh, North Carolina
Noordwest ziekenhuis Alkmaar, North Holland
Osp. S.Orsola Malpighi - Bologna Bologna,
Penn State Health Milton S. Hershey Medical Center Hershey, Pennsylvania	Dr. Faisal Aziz, MD - (faziz@pennstatehealth.psu.edu)
Promedica Toledo Hospital Toledo, Ohio
Queen Elizabeth University Hospital, Glasgow Glasgow,
Rijnstate hospital Arnhem,	Suzanne Holewijn, PhD - (herculestrial@rijnstate.nl) Daphne van der Veen, MSc - (herculestrial@rijnstate.nl)
Robert Wood Johnson University Medical Center New Brunswick, New Jersey
Saint Joseph Marseille Marseille,
Sisters of Charity hospital Buffalo, New York
Spaarne Gasthuis Haarlem,
St. George's Hospital London,
St. Mary's Hospital Manchester,
Stony Brook University Medical Center Stony Brook, New York
University Hospital Leipzig Leipzig,	Dr. Schmidt, MD PhD - (Andrej.Schmidt@medizin.uni-leipzig.de) Steffi Anding - (Steffi.Anding@medizin.uni-leipzig.de)
University of Missouri Columbia, Missouri
Universitätsklinikum Frankfurt Frankfurt,	Prof. Dr. med. Kyriakos Oikonomou, Prof. MD - (kyriakos.oikonomou@unimedizin-ffm.de) Tanja Dietrich - (tanja.dietrich@unimedizin-ffm.de)
Virginia Commonwealth University (VCU) Richmond, Virginia
Washington Regional Medical Center Washington, Arkansas

GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

Contact(s):

Massey IIT Research Operations - masseyepd@vcu.edu

Principal Investigator:

System ID: NCT06636123

Show full eligibility criteria

Inclusion Criteria:

* Patients diagnosed with prostate cancer and treated with androgen deprivation therapy (ADT) and at least one androgen receptor pathway inhibitor (ARPI) (eg, abiraterone, enzalutamide, apalutamide or darolutamide). Previous prostate-specific membrane antigen (PSMA)-targeted therapy or cytotoxic chemotherapy is allowed but not required. * Androgen levels ≤50 ng/dL (≤1.73 nmol/L). * Disease progression following ADT and ARPI treatment described * PSA progression over 2 assessments, defined as rising PSA values from 2 consecutive assessments with an interval of at least 7 days between assessments. PSA levels prior to study enrollment are considered and appropriate for inclusion. * Measurable disease by RECIST v1.1 on chest/abdomen/pelvis CT or evaluable disease observed on bone scan. * Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 * Appropriate hepatic function defined by a total bilirubin (TBL) ≤1.5 × the upper limit of normal (ULN), alanine aminotransferase (ALT) AND aspartate aminotransferase (AST) ≤3 × ULN at screening. * Appropriate kidney function defined by calculated or actual creatinine clearance ≥30 mL/min * Absolute neutrophil count (ANC) ≥ 1,500 cells/mm3. * Platelets ≥100,000 cells/mm3. * Serum hemoglobin level ≥8 g/dL. * Agree to not donate blood or sperm during the study and for 90 days after the last dose of study treatment. * Patients with sexual partners of childbearing potential must agree to use highly effective methods of contraception throughout the study * Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

* Any investigational agent: within 4 weeks OR within a time interval less than at least 5 half-lives of the investigational agent, whichever is shorter, before initiating study treatment. * Low PSA (≤10 ng/mL) at initial presentation (before ADT or at symptomatic progression in the castrate setting) plus high volume (≥20) bone metastases. * Simultaneous enrollment in any other cancer treatment interventional clinical trial. * Active, uncontrolled diarrhea leading to dehydration or electrolyte disturbances not controlled with oral repletion. * Grade ≥3 uncontrolled infection. * Major surgery (in the opinion of the treating investigator) ≤3 weeks before initiating study treatment. * Not having fully recovered to a grade of 1 or lower from any surgery-related adverse effects within the 3 weeks preceding the start of the study treatment. * Small cell, anaplastic, or neuroendocrine component. * Known active brain metastasis. * Known active leptomeningeal disease. * Planned ongoing treatment with other drugs thought to potentially have adverse interactions with either of the medications included in the study treatment must be discontinued ≥2 weeks prior to initiating study treatment unless otherwise noted: * Monoamine oxidase inhibitors (MAOI) use; must discontinue use 10 days prior to initiating study therapy. * Strong or moderate CYP1A2, CYP3A4 and CYP2C19 inhibitors. * Rucaparib, Olaparib and Talazoparib, due to their common findings of liver enzyme elevation. * Inability to swallow medication. * Known hypersensitivity to GZ17-6.02 components (curcumin, harmine, and isovanillin) or excipients. * Known or suspected malabsorption condition or obstruction. * Active untreated hepatitis B or C" and "Known liver cirrhosis of any cause, active nonalcoholic steatohepatitis, or nonalcoholic fatty liver disease. Note: no additional testing necessary to confirm * Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements

Interventions: DRUG: Investigational Agent Administration

Conditions: Castration-resistant Prostate Cancer

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	Massey CTO GU Team - (masseygu@vcu.edu)

Study of ATX-01 in Participants With DM1 (ArthemiR)

Contact(s):

Project Manager - clinical@arthexbiotech.com

Principal Investigator:

System ID: NCT06300307

Show full eligibility criteria

Interventions: DRUG: ATX-01, DRUG: Placebo

Conditions: Myotonic Dystrophy 1

I'm interested

Share via email

Show 12 locations

Study Locations

Hide all locations

Location	Contacts
Centre Intégré Universitaire de Santé et Services Sociaux du Saguenay-Lac-St-Jean Chicoutimi, Quebec	Sabrina Côté - (sabrina.cote.inf@ssss.gouv.qc.ca)
Fondazione Policlinico A. Gemelli- IRCCS Rome,	Professor - (marika.pane@policlinicogemelli.it)
Hospital Universitario Donostia San Sebastián,	Ioana Croitoru - (IOANA.CROITORU@bio-gipuzkoa.eus)
Institute of Myology Paris,	Study Co-ordinator - (essais-adultes@institut-myologie.org)
Radboudumc Nijmegen,	Spierziekten Research Team Radboudumc - (spierziektenresearchteam@radboudumc.nl)
St. George's University Hospital London,	Joana Teixeira - (Joana.Teixeira@stgeorges.nhs.uk)
The NeMO Clinical Center in Milan, Neurorehabilitation Unit, University of Milan Milan,	Clinical Research Co-ordinator - (crc_rsu@centrocliniconemo.it)
UCLA Santa Monica, California	Michael Yan - (MYan@mednet.ucla.edu)
University of Florida Gainesville, Florida	Brandy Donahue-Quails - (Brandy.Donahue-Quails@neurology.ufl.edu)
University of Iowa Health Care - Department of Neurology Iowa City, Iowa	Heena Olalde - (heena-olalde@uiowa.edu)
University of Kansas Medical Center, Department of Neurology Fairway, Kansas	Cassidy Nelson - (cnelson15@kumc.edu)
Virginia Commonwealth University Richmond, Virginia	Jodie Howell - (jodie.howell@vcuhealth.org)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Contact(s):

Sara Tolaney, MD - Sara_Tolaney@dfci.harvard.edu

Principal Investigator:

System ID: NCT05812807

Show full eligibility criteria

Inclusion Criteria:

* Age \>= 18 years * Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 * Triple Negative Breast Cancer: * Patients with a history of clinical stage T1cN1-2 or T2-4N0-2 (clinical stage II or III prior to preoperative therapy) breast cancer at time of diagnosis according to the primary tumor-regional lymph node anatomic staging criteria of the American Joint Committee on Cancer (AJCC), 8th edition as determined by the investigator in radiologic assessment, clinical assessment or both * Patients must have no residual invasive disease in the breast or lymph nodes after the completion of neoadjuvant therapy. Residual ductal carcinoma in situ (DCIS) is allowed. Isolated tumor cells are considered node-negative * Estrogen receptor (ER) and progesterone receptor (PR) =\< 10%; HER2-negative by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines (immunohistochemistry \[IHC\] and fluorescence in situ hybridization \[FISH\]) * If invasive disease was present in both breasts, participation in the study is permitted as long as the eligibility criteria are met for both tumors/breasts * Patients must have received neoadjuvant chemotherapy in combination with pembrolizumab for a minimum of 6 cycles. All systemic chemotherapy must have been completed preoperatively * An interval of no more than 12 weeks between the completion date of the final surgery and the date of randomization \* Note: Adjuvant radiation can be given on study, however, it is recommended to complete adjuvant radiation prior to registration. If radiation is given on study, it is encouraged to be given concurrently with pembrolizumab if the patient is on the pembrolizumab arm, per investigator discretion. Treatment with adjuvant pembrolizumab is strongly discouraged prior to participation in this trial, but if administered (e.g., if patients are awaiting pathology results), pembrolizumab may be administered for up to 6 weeks (i.e., up to 2 q3week doses or up to one q6week dose) post-surgery and must be completed prior to registration post-surgery and must be completed prior to registration * Use of investigational anti-cancer agents must be discontinued at time of registration * Adequate excision: Surgical removal of all clinically evident disease in the breast and lymph nodes as follows: * Breast surgery: Total mastectomy or breast-conserving surgery with histologically negative margins, including no ink on tumor for DCIS, at the time of excision \*\* For patients who undergo breast-conserving surgery, the margins of the resected specimen must be histologically free of ductal carcinoma in-situ (DCIS) as determined by the local pathologist. If pathologic examination demonstrates DCIS at the line of resection, additional operative procedures may be performed to obtain clear margins. If DCIS is still present at the resected margin after re-excision(s), the patient must undergo total mastectomy to be eligible. Patients with margins positive for classic lobular carcinoma in situ (LCIS) are eligible without additional resection * Lymph node surgery: * For a patient with clinically N0 disease, a sentinel lymph node biopsy should have been performed at time of surgical evaluation, and if pathologically node positive, the patient is no longer eligible. Isolated tumor cells are considered node-negative * For a patient with clinically N1 disease at diagnosis (with positive results from a fine-needle aspiration, core biopsy, or sentinel node biopsy performed prior to preoperative therapy) additional surgical evaluation of the axilla following preoperative therapy is required \*\*\* If they become cN0 (no palpable adenopathy), then a sentinel lymph node biopsy could have been performed at time of surgery (axillary dissection would also be permitted); if the sentinel lymph node biopsy is positive, the patient is no longer eligible * If sentinel node biopsy performed before preoperative therapy was negative, no additional surgical evaluation of the axilla is required after preoperative therapy. If sentinel node biopsy performed before preoperative therapy was positive, an ALND is required after preoperative therapy * If the only sentinel node identified by isotope scan is in the internal mammary chain, surgical evaluation of the axilla is still required * If sentinel node evaluation after preoperative therapy is negative, no further additional surgical evaluation of the axilla is required * Axillary dissection without sentinel node evaluation is permitted as the initial or sole axillary evaluation after preoperative therapy * If breast-conserving surgery was performed but patient will not be receiving breast radiation, the patient is not eligible * Not pregnant and not nursing, because this study involves an agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown. Therefore, for women of childbearing potential only, a negative serum or urine pregnancy test done =\< 7 days prior to randomization is required * Absolute neutrophil count (ANC) \>= 1,000/mm\^3 * Platelet Count \>= 100,000/mm\^3 * Estimated glomerular filtration rate (eGFR) \>= 15 mL/min/1.73m\^2 * Total Bilirubin =\<1.5 x upper limit of normal (ULN) \* Patients with Gilbert's disease with a total bilirubin =\< 2.5 x ULN and direct bilirubin within normal limits are permitted * Aspartate aminotransferase (AST) serum aspartate aminotransferase \[SGOT\] / alanine aminotransferase (ALT) serum glutamic pyruvic transaminase \[SGPT\] =\< 3 x institutional ULN * Patients must be willing to provide tumor tissue from the diagnostic core biopsy. If inadequate tumor tissue is available, patients are still eligible to participate in the trial * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better * Patients with known HIV infection who are on effective anti-retroviral therapy with undetectable viral load within 6 months prior to registration are eligible for this trial

Exclusion Criteria:

* No stage IV (metastatic) breast cancer * No history of any prior (ipsi- or contralateral) invasive breast cancer. Prior DCIS is allowed * No evidence of recurrent disease following preoperative therapy and surgery * No known active liver disease, e.g. due to hepatitis B virus (HBV), hepatitis C virus (HCV), autoimmune hepatic disorders, or sclerosing cholangitis * No history of intolerance, including Grade 3 or 4 infusion reaction or hypersensitivity to pembrolizumab or murine proteins or any components of the product \* Note: Prior immune-related adverse events (irAEs) are allowed if they resolved to ≤ grade 1 and the patient tolerated subsequent therapy without requiring chronic steroids for the irAE. The following are exceptions to this criterion: Grade 2 or lower immune mediated endocrinopathies due to neoadjuvant checkpoint inhibition but patients are stable on endocrine therapy and were able to continue checkpoint inhibition. * No medical conditions that require chronic systemic steroids (\>10 mg prednisone daily or equivalent) or any other form of immunosuppressive medications and has required such therapy in the last two years. Replacement therapy (e.g. thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic therapy * Patients who are unable or unwilling to comply with the requirements of the protocol per investigator assessment are not eligible

Interventions: BIOLOGICAL: Pembrolizumab, OTHER: Patient Observation, PROCEDURE: Biopsy, PROCEDURE: Biospecimen Collection, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment

Conditions: Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

I'm interested

Share via email

Show 846 locations

Study Locations

Hide all locations

Location	Contacts
AMG Crystal Lake - Oncology Crystal Lake, Illinois	Site Public Contact - (advocateresearch@advocate.com)
AMG Libertyville - Oncology Libertyville, Illinois	Site Public Contact - (advocateresearch@advocatehealth.com)
Abbott-Northwestern Hospital Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Adams Cancer Center Gettysburg, Pennsylvania
Adena Regional Medical Center Chillicothe, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
AdventHealth Altamonte Altamonte Springs, Florida
AdventHealth Littleton Littleton, Colorado	Site Public Contact - (research.institute@adventhealth.com)
AdventHealth Orlando Orlando, Florida
AdventHealth Parker Parker, Colorado	Site Public Contact - (research.institute@adventhealth.com)
AdventHealth Porter Denver, Colorado	Site Public Contact - (research.institute@adventhealth.com)
Advocate Christ Medical Center Oak Lawn, Illinois
Advocate Good Samaritan Hospital Downers Grove, Illinois	Site Public Contact - (Barbara.barhamand@advocatehealth.com)
Advocate Good Shepherd Hospital Barrington, Illinois
Advocate Illinois Masonic Medical Center Chicago, Illinois
Advocate Lutheran General Hospital Park Ridge, Illinois
Advocate Outpatient Center - Aurora Aurora, Illinois	Site Public Contact - (ncorp@aah.org)
Advocate Sherman Hospital Elgin, Illinois
Advocate South Suburban Hospital Hazel Crest, Illinois
Allan Blair Cancer Centre Regina, Saskatchewan
Allegheny General Hospital Pittsburgh, Pennsylvania
Allegiance Health Jackson, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Alta Bates Summit Medical Center-Herrick Campus Berkeley, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Annie Penn Memorial Hospital Reidsville, North Carolina	Site Public Contact - (stacey.phelps@conehealth.com)
Asante Rogue Regional Medical Center Medford, Oregon	Site Public Contact - (research@asante.org)
Ascension All Saints Hospital-Spring Street-Racine Racine, Wisconsin	Site Public Contact - (AWRI.Inquiry@Ascension.org)
Ascension Calumet Hospital-Chilton Chilton, Wisconsin	Site Public Contact - (AWRI.inquiry@ascension.org)
Ascension Columbia Saint Mary's Hospital-Milwaukee Campus Milwaukee, Wisconsin	Site Public Contact - (AWRI.Inquiry@Ascension.org)
Ascension Columbia Saint Mary's Hospital-Ozaukee Campus-Mequon Mequon, Wisconsin	Site Public Contact - (AWRI.Inquiry@Ascension.org)
Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh Oshkosh, Wisconsin	Site Public Contact - (AWRI.inquiry@ascension.org)
Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton Appleton, Wisconsin	Site Public Contact - (AWRI.inquiry@ascension.org)
Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield Brookfield, Wisconsin	Site Public Contact - (AWRI.Inquiry@Ascension.org)
Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa Wauwatosa, Wisconsin	Site Public Contact - (AWRI.Inquiry@Ascension.org)
Ascension Via Christi Hospitals Wichita Wichita, Kansas	Site Public Contact - (research@viachristi.org)
Aspirus Cancer Care - Stevens Point Stevens Point, Wisconsin	Site Public Contact - (Beth.Knetter@aspirus.org)
Aspirus Cancer Care - Wisconsin Rapids Wisconsin Rapids, Wisconsin
Aspirus Cancer Care-Antigo-Volm Cancer Center Antigo, Wisconsin	Site Public Contact - (Juli.Alford@aspirus.org)
Aspirus Cancer Care-Rhinelander-James Beck Cancer Center Rhinelander, Wisconsin	Site Public Contact - (Beth.Knetter@aspirus.org)
Aspirus Cancer Care-Wausau Wausau, Wisconsin
Aspirus Medford Hospital Medford, Wisconsin	Site Public Contact - (Beth.Knetter@aspirus.org)
Asplundh Cancer Pavilion Willow Grove, Pennsylvania	Site Public Contact - (ONCTrialNow@jefferson.edu)
Atlantic Health Sciences Corporation-Saint John Regional Hospital Saint John, New Brunswick
Atrium Health Cabarrus/LCI-Concord Concord, North Carolina
Atrium Health Cleveland/LCI-Cleveland Shelby, North Carolina
Atrium Health Lincoln/LCI-Lincolnton Lincolnton, North Carolina
Atrium Health Pineville/LCI-Pineville Charlotte, North Carolina
Atrium Health Stanly/LCI-Albemarle Albemarle, North Carolina
Atrium Health Union/LCI-Union Monroe, North Carolina
Atrium Health University City/LCI-University Charlotte, North Carolina
Atrium Medical Center-Middletown Regional Hospital Franklin, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Augusta Health Center for Cancer and Blood Disorders Fishersville, Virginia
Augusta Oncology Associates PC-D'Antignac Augusta, Georgia
Augusta Oncology Associates PC-Wheeler Augusta, Georgia
Aurora Bay Area Medical Group-Marinette Marinette, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora BayCare Medical Center Green Bay, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Grafton Grafton, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Kenosha South Kenosha, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee West Wauwatosa, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Racine Racine, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Cancer Care-Southern Lakes VLCC Burlington, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Health Care Germantown Health Center Germantown, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Medical Center in Summit Summit, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Saint Luke's Medical Center Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora Sinai Medical Center Milwaukee, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Aurora West Allis Medical Center West Allis, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Avera Cancer Institute Sioux Falls, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute - Mitchell Mitchell, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute at Pierre Pierre, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute at Yankton Yankton, South Dakota	Site Public Contact - (OncRegulatory@avera.org)
Avera Cancer Institute-Aberdeen Aberdeen, South Dakota	Site Public Contact - (oncregulatory@avera.org)
BCCA-Cancer Centre for the Southern Interior Kelowna, British Columbia
BCCA-Vancouver Cancer Centre Vancouver, British Columbia
Baptist Cancer Center-Grenada Grenada, Mississippi	Site Public Contact - (BCCclintrials@bmhcc.org)
Baptist Health Corbin Corbin, Kentucky
Baptist Health Floyd New Albany, Indiana	Site Public Contact - (ctsucontact@westat.com)
Baptist Health Hamburg Lexington, Kentucky
Baptist Health Hardin Elizabethtown, Kentucky
Baptist Health Lexington Lexington, Kentucky
Baptist Health Louisville Louisville, Kentucky	Site Public Contact - (Cbcresearch@bhsi.com)
Baptist MD Anderson Cancer Center Jacksonville, Florida
Baptist Memorial Hospital and Cancer Center-Collierville Collierville, Tennessee	Site Public Contact - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Desoto Southhaven, Mississippi	Site Public Contact - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Golden Triangle Columbus, Mississippi	Site Public Contact - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Memphis Memphis, Tennessee	Site Public Contact - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Oxford Oxford, Mississippi
Baptist Memorial Hospital and Cancer Center-Union County New Albany, Mississippi	Site Public Contact - (BCCclintrials@bmhcc.org)
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston, Texas	Site Public Contact - (burton@bcm.edu)
Baystate Medical Center Springfield, Massachusetts	Site Public Contact - (tamara.wrenn@baystatehealth.org)
Beacon Kalamazoo Cancer Center Kalamazoo, Michigan
Beebe Health Campus Rehoboth Beach, Delaware	Site Public Contact - (research@beebehealthcare.org)
Beebe South Coastal Health Campus Millville, Delaware	Site Public Contact - (research@beebehealthcare.org)
Ben Taub General Hospital Houston, Texas
Benefis Sletten Cancer Institute Great Falls, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Beth Israel Deaconess Medical Center Boston, Massachusetts
Billings Clinic Cancer Center Billings, Montana	Site Public Contact - (research@billingsclinic.org)
Bon Secours Memorial Regional Medical Center Mechanicsville, Virginia	Site Public Contact - (anne_carmellat@bshsi.org)
Bon Secours Saint Francis Medical Center Midlothian, Virginia	Site Public Contact - (anne_carmellat@bshsi.org)
Bon Secours Saint Mary's Hospital Richmond, Virginia	Site Public Contact - (anne_carmellat@bshsi.org)
Boston Medical Center Boston, Massachusetts
Bozeman Health Deaconess Hospital Bozeman, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Broadlawns Medical Center Des Moines, Iowa
Bronson Battle Creek Battle Creek, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Bronson Methodist Hospital Kalamazoo, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Broward Health Medical Center Fort Lauderdale, Florida	Site Public Contact - (Allison.bruce@nemours.org)
CHRISTUS Highland Medical Center Shreveport, Louisiana	Site Public Contact - (Nancy.hassan@christushealth.org)
CHU de Quebec-Hopital du Saint-Sacrement (HSS) Québec, Quebec	Site Public Contact - (jbegin@uresp.ulaval.ca)
CTCA at Western Regional Medical Center Goodyear, Arizona
Cambridge Memorial Hospital Cambridge, Ontario
Camden Clark Medical Center Parkersburg, West Virginia	Site Public Contact - (cancertrialsinfo@hsc.wvu.edu)
Cancer Care Associates of York York, Pennsylvania
Cancer Care Center of O'Fallon O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Care Specialists of Illinois - Decatur Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Center at Saint Joseph's Phoenix, Arizona	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Cancer Center of Kansas - Chanute Chanute, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Dodge City Dodge City, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - El Dorado El Dorado, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - McPherson McPherson, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Newton Newton, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Parsons Parsons, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Pratt Pratt, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Salina Salina, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Wellington Wellington, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Wichita Wichita, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas - Winfield Winfield, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas-Independence Independence, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas-Kingman Kingman, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas-Liberal Liberal, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Center of Kansas-Wichita Medical Arts Tower Wichita, Kansas	Site Public Contact - (research@viachristi.org)
Cancer Hematology Centers - Flint Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Cancer and Hematology Centers of Western Michigan - Norton Shores Norton Shores, Michigan
Carle BroMenn Medical Center Normal, Illinois	Site Public Contact - (Research@Carle.com)
Carle Cancer Center Urbana, Illinois	Site Public Contact - (Research@carle.com)
Carle Cancer Institute Normal Normal, Illinois	Site Public Contact - (Research@Carle.com)
Carle Physician Group-Effingham Effingham, Illinois	Site Public Contact - (Research@carle.com)
Carle Physician Group-Mattoon/Charleston Mattoon, Illinois	Site Public Contact - (Research@carle.com)
Carle at The Riverfront Danville, Illinois	Site Public Contact - (Research@Carle.com)
Carolinas Medical Center/Levine Cancer Institute Charlotte, North Carolina
Case Western Reserve University Cleveland, Ohio	Site Public Contact - (CTUReferral@UHhospitals.org)
Cedars-Sinai Cancer - Tarzana Tarzana, California
Cedars-Sinai Medical Center Los Angeles, California	Site Public Contact - (Cancer.trial.info@cshs.org)
Centerpoint Medical Center LLC Independence, Missouri	Site Public Contact - (aroland@kccop.org)
Centra Alan B Pearson Regional Cancer Center Lynchburg, Virginia	Site Public Contact - (Kevin.Patel@centrahealth.com)
Central Vermont Medical Center/National Life Cancer Treatment Berlin Corners, Vermont
Centralia Oncology Clinic Centralia, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Centre Hospitalier Regional de Trois-Rivieres Trois-Rivières, Quebec
Centro Comprensivo de Cancer de UPR San Juan,	Site Public Contact - (ctsucontact@westat.com)
Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Clackamas Radiation Oncology Center Clackamas, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Coborn Cancer Center at Saint Cloud Hospital Saint Cloud, Minnesota	Site Public Contact - (coborncancercenter@centracare.com)
Columbus Oncology and Hematology Associates Dublin, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Columbus Oncology and Hematology Associates Inc Columbus, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
CommonSpirit Saint Joseph Medical Center - East Lexington Lexington, Kentucky	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Community Hospital of Anaconda Anaconda, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Community Medical Center Toms River, New Jersey	Site Public Contact - (mccinfo@mtcancer.org)
Community Medical Center Toms River, New Jersey	Site Public Contact - (HemonCCTrials@geisinger.edu)
Condell Memorial Hospital Libertyville, Illinois	Site Public Contact - (advocateresearch@advocatehealth.com)
Cone Health Cancer Center Greensboro, North Carolina	Site Public Contact - (stacey.phelps@conehealth.com)
Cone Health Cancer Center at Alamance Regional Burlington, North Carolina	Site Public Contact - (stacey.phelps@conehealth.com)
Cone Health Cancer Center at Asheboro Asheboro, North Carolina
Cone Health Cancer Center at Drawbridge Parkway Greensboro, North Carolina	Site Public Contact - (stacey.phelps@conehealth.com)
Cone Health MedCenter Asheboro Asheboro, North Carolina	Site Public Contact - (stacey.phelps@conehealth.com)
Cooper Hospital University Medical Center Camden, New Jersey
Cooperman Barnabas Medical Center Livingston, New Jersey
Corewell Health Grand Rapids Hospitals - Butterworth Hospital Grand Rapids, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center Saint Joseph, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Corewell Health Lakeland Hospitals - Niles Hospital Niles, Michigan
Corewell Health Lakeland Hospitals - Saint Joseph Hospital Saint Joseph, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
Corewell Health Reed City Hospital Reed City, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
CoxHealth South Hospital Springfield, Missouri
Crossroads Cancer Center Effingham, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Dana Farber-Merrimack Valley Methuen, Massachusetts
Dana-Farber Cancer Institute Boston, Massachusetts
Dana-Farber Cancer Institute at Foxborough Foxborough, Massachusetts
Dana-Farber/Brigham and Women's Cancer Center at South Shore South Weymouth, Massachusetts
Danbury Hospital Danbury, Connecticut
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon, New Hampshire	Site Public Contact - (cancer.research.nurse@dartmouth.edu)
Dayton Physician LLC - Englewood Dayton, Ohio
Decatur Memorial Hospital Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Delaware Health Center-Grady Cancer Center Delaware, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Desert Regional Medical Center Palm Springs, California
Doctors Cancer Center Manati,
Doctors Hospital Columbus, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Drexel Town Square Health Center Oak Creek, Wisconsin
Dublin Methodist Hospital Dublin, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Duke Cancer Center Cary Cary, North Carolina	Site Public Contact - (NCTNStudyTeam@dm.duke.edu)
Duke University Medical Center Durham, North Carolina
Duke Women's Cancer Care Raleigh Raleigh, North Carolina
Duluth Clinic Ashland Ashland, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
East Carolina University Greenville, North Carolina	Site Public Contact - (eubankss@ecu.edu)
Edwards Comprehensive Cancer Center Huntington, West Virginia	Site Public Contact - (Christina.Cole@chhi.org)
Eisenhower Medical Center Rancho Mirage, California
Emory Decatur Hospital Decatur, Georgia	Site Public Contact - (clinicaltrialsoncology@dekalbmedical.org)
Emory Johns Creek Hospital Johns Creek, Georgia	Site Public Contact - (m.lisa.hwang@emory.edu)
Emory Saint Joseph's Hospital Atlanta, Georgia
Emory University Hospital Midtown Atlanta, Georgia
Emory University Hospital/Winship Cancer Institute Atlanta, Georgia
Englewood Hospital and Medical Center Englewood, New Jersey
Enloe Medical Center Chico, California
Ephrata Cancer Center Ephrata, Pennsylvania
Essentia Health - Deer River Clinic Deer River, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center Duluth, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center-South University Clinic Fargo, North Dakota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Hibbing Clinic Hibbing, Minnesota
Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Sandstone Sandstone, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health Virginia Clinic Virginia, Minnesota	Site Public Contact - (CancerTrials@EssentiaHealth.org)
Essentia Health-Spooner Clinic Spooner, Wisconsin	Site Public Contact - (CancerTrials@EssentiaHealth.org)
FHCC Overlake Bellevue, Washington
FHCC at EvergreenHealth Kirkland, Washington
FHCC at Northwest Hospital Seattle, Washington
FMH James M Stockman Cancer Institute Frederick, Maryland
Fairfield Medical Center Lancaster, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Fairview Southdale Hospital Edina, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Farmington Health Center Farmington, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
FirstHealth of the Carolinas-Moore Regional Hospital Pinehurst, North Carolina	Site Public Contact - (jcwilliams@firsthealth.org)
Forbes Hospital Monroeville, Pennsylvania
Fred Hutchinson Cancer Center Seattle, Washington
Fred and Pamela Buffett Cancer Center - Kearney Kearney, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
Fremont - Rideout Cancer Center Marysville, California
Froedtert Menomonee Falls Hospital Menomonee Falls, Wisconsin
Froedtert West Bend Hospital/Kraemer Cancer Center West Bend, Wisconsin
Geisinger Cancer Center Dickson City Dickson City, Pennsylvania	Site Public Contact - (hemoncctrials@geisinger.edu)
Geisinger Medical Center Danville, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Geisinger Medical Oncology-Lewisburg Lewisburg, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre, Pennsylvania	Site Public Contact - (HemonCCTrials@geisinger.edu)
Gene Upshaw Memorial Tahoe Forest Cancer Center Truckee, California
Genesee Hematology Oncology PC Flint, Michigan
Genesis Healthcare System Cancer Care Center Zanesville, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Genesys Hurley Cancer Institute Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Good Samaritan Hospital - Cincinnati Cincinnati, Ohio	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Good Samaritan University Hospital West Islip, New York
Grady Health System Atlanta, Georgia
Grady Memorial Hospital Delaware, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Grant Medical Center Columbus, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Greater Baltimore Medical Center Baltimore, Maryland
Gundersen Lutheran Medical Center La Crosse, Wisconsin	Site Public Contact - (cancerctr@gundersenhealth.org)
Guthrie Cortland Memorial Hospital Cortland, New York
Guthrie Medical Group PC-Robert Packer Hospital Sayre, Pennsylvania
Hackensack University Medical Center Hackensack, New Jersey
Hartford HealthCare - Saint Vincent's Medical Center Bridgeport, Connecticut
Hartford Hospital Hartford, Connecticut
Hawaii Cancer Care - Westridge ‘Aiea, Hawaii	Site Public Contact - (info@hawaiicancercare.com)
Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii	Site Public Contact - (i.webster@hawaiicancercare.com)
HaysMed Hays, Kansas
Health Central Ocoee, Florida	Site Public Contact - (ctsucontact@westat.com)
Heartland Oncology and Hematology LLP Council Bluffs, Iowa
Heartland Regional Medical Center Saint Joseph, Missouri	Site Public Contact - (Trisha.England2@mymlc.com)
Helen F Graham Cancer Center Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Hematology Oncology Associates of CNY at Camillus Camillus, New York
Hematology Oncology Associates of Central New York-East Syracuse East Syracuse, New York
Hennepin County Medical Center Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Henry Ford Cancer Institute-Downriver Brownstown, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Health Providence Novi Hospital Novi, Michigan	Site Public Contact - (kfife3@hfhs.org)
Henry Ford Health Providence Southfield Hospital Southfield, Michigan	Site Public Contact - (kfife3@hfhs.org)
Henry Ford Health Saint John Hospital Detroit, Michigan	Site Public Contact - (Kkeenan1@hfhs.org)
Henry Ford Health Warren Hospital Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Hospital Detroit, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Macomb Hospital-Clinton Township Clinton Township, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Madison Heights Hospital - Breast Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Medical Center-Columbus Novi, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Medical Center-Fairlane Dearborn, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford River District Hospital East China Township, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Academic Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Breast Grosse Pointe Woods, Michigan	Site Public Contact - (karen.forman@ascension.org)
Henry Ford Saint John Hospital - Macomb Medical Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Van Elslander Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Warren Hospital - Breast Macomb Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Warren Hospital - GLCMS Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford West Bloomfield Hospital West Bloomfield, Michigan	Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Wyandotte Hospital Wyandotte, Michigan	Site Public Contact - (nhay@hfhs.org)
Highlands Oncology Group Springdale, Arkansas	Site Public Contact - (research@hogonc.com)
Highlands Oncology Group - Fayetteville Fayetteville, Arkansas	Site Public Contact - (research@hogonc.com)
Highlands Oncology Group - Rogers Rogers, Arkansas	Site Public Contact - (research@hogonc.com)
Houston Methodist Cypress Hospital Cypress, Texas	Site Public Contact - (irb@houstonmethodist.org)
Houston Methodist Hospital Houston, Texas
Houston Methodist Saint John Hospital Nassau Bay, Texas	Site Public Contact - (protocols@AllianceNCTN.org)
Houston Methodist San Jacinto Hospital Baytown, Texas	Site Public Contact - (protocols@AllianceNCTN.org)
Houston Methodist Sugar Land Hospital Sugar Land, Texas
Houston Methodist The Woodlands Hospital The Woodlands, Texas	Site Public Contact - (hmthewoodlands@houstonmethodist.org)
Houston Methodist West Hospital Houston, Texas
Huntington Memorial Hospital Pasadena, California
Huntsman Cancer Institute/University of Utah Salt Lake City, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
Hurley Medical Center Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Huron Gastroenterology PC Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
IU Health North Hospital Carmel, Indiana
IU Health West Hospital Avon, Indiana
Illinois CancerCare - Washington Washington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Canton Canton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Carthage Carthage, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Dixon Dixon, Illinois
Illinois CancerCare-Eureka Eureka, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Galesburg Galesburg, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Kewanee Clinic Kewanee, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Macomb Macomb, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Ottawa Clinic Ottawa, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peru Peru, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Princeton Princeton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana	Site Public Contact - (iutrials@iu.edu)
Ingalls Memorial Hospital Harvey, Illinois	Site Public Contact - (clinicaltrials@ingalls.org)
Inova Fair Oaks Hospital Fairfax, Virginia	Site Public Contact - (Stephanie.VanBebber@inova.org)
Inova Fairfax Hospital Falls Church, Virginia	Site Public Contact - (Stephanie.VanBebber@inova.org)
Inova Schar Cancer Institute Fairfax, Virginia	Site Public Contact - (Stephanie.VanBebber@inova.org)
Inspira Medical Center Mullica Hill Mullica Hill, New Jersey
Iowa Methodist Medical Center Des Moines, Iowa
Jefferson Cherry Hill Hospital Cherry Hill, New Jersey	Site Public Contact - (ONCTrialNow@jefferson.edu)
Jefferson Hospital Jefferson Hills, Pennsylvania	Site Public Contact - (ddefazio@wpahs.org)
Jefferson Torresdale Hospital Philadelphia, Pennsylvania	Site Public Contact - (ONCTrialNow@jefferson.edu)
Jersey City Medical Center Jersey City, New Jersey	Site Public Contact - (ctsucontact@westat.com)
Jewish General Hospital Montreal, Quebec
John H Stroger Jr Hospital of Cook County Chicago, Illinois
Kadlec Clinic Hematology and Oncology Kennewick, Washington	Site Public Contact - (research@kadlecmed.org)
Kaiser Permanente - Largo Medical Center Largo, Maryland	Site Public Contact - (Charmaine.A.Mckie@kp.org)
Kaiser Permanente Downtown Commons Sacramento, California	Site Public Contact - (kpoct@kp.org)
Kaiser Permanente Dublin Dublin, California
Kaiser Permanente Fresno Orchard Plaza Fresno, California
Kaiser Permanente Lutherville - Timonium Medical Center Lutherville, Maryland	Site Public Contact - (Charmaine.A.Mckie@kp.org)
Kaiser Permanente Medical Center - Santa Clara Santa Clara, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente Moanalua Medical Center Honolulu, Hawaii	Site Public Contact - (shelley.a.clark@kp.org)
Kaiser Permanente Northwest Portland, Oregon	Site Public Contact - (information@kpchr.org)
Kaiser Permanente San Leandro San Leandro, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente Tysons Corner Medical Center McLean, Virginia	Site Public Contact - (Charmaine.A.Mckie@kp.org)
Kaiser Permanente- Modesto MOB II Modesto, California
Kaiser Permanente-Capitol Hill Medical Center Washington D.C., District of Columbia	Site Public Contact - (Charmaine.A.Mckie@kp.org)
Kaiser Permanente-Caton Hill Medical Center Woodbridge, Virginia	Site Public Contact - (Charmaine.A.Mckie@kp.org)
Kaiser Permanente-Franklin Denver, Colorado	Site Public Contact - (KPCOIHRClinicalResearch@kp.org)
Kaiser Permanente-Fremont Fremont, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Fresno Fresno, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Gaithersburg Medical Center Gaithersburg, Maryland	Site Public Contact - (Charmaine.A.Mckie@kp.org)
Kaiser Permanente-Lone Tree Lone Tree, Colorado	Site Public Contact - (KPCOIHRClinicalResearch@kp.org)
Kaiser Permanente-Modesto Modesto, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Oakland Oakland, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Rock Creek Lafayette, Colorado	Site Public Contact - (KPCOIHRClinicalResearch@kp.org)
Kaiser Permanente-Roseville Roseville, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-San Francisco San Francisco, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Santa Rosa Santa Rosa, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Santa Teresa-San Jose San Jose, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-South Sacramento Sacramento, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-South San Francisco South San Francisco, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Vallejo Vallejo, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Walnut Creek Walnut Creek, California	Site Public Contact - (Kpoct@kp.org)
Kaiser Permanente-Woodlawn Medical Center Baltimore, Maryland	Site Public Contact - (Charmaine.A.Mckie@kp.org)
Kaiser San Rafael-Gallinas San Rafael, California	Site Public Contact - (Kpoct@kp.org)
Kapiolani Medical Center for Women and Children Honolulu, Hawaii
Katmai Oncology Group Anchorage, Alaska	Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org)
Kettering Medical Center Kettering, Ohio
Kingman Regional Medical Center Kingman, Arizona	Site Public Contact - (research@sncrf.org)
Kingston Health Sciences Centre Kingston, Ontario	Site Public Contact - (cc-clinicaltrials@kgh.kari.net)
Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Clinic Cancer Services - Sandpoint Sandpoint, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
LSU Health Sciences Center at Shreveport Shreveport, Louisiana	Site Public Contact - (LPost@lsuhsc.edu)
Lake Regional Hospital Osage Beach, Missouri	Site Public Contact - (clinicaltrials@lakeregional.com)
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York	Site Public Contact - (CancerTrials@nyulangone.org)
Lawrence Memorial Hospital Lawrence, Kansas	Site Public Contact - (Stephanie.Norris@LMH.ORG)
Legacy Cancer Institute Medical Oncology and Day Treatment Vancouver, Washington	Site Public Contact - (oncologyresearch@lhs.org)
Legacy Good Samaritan Hospital and Medical Center Portland, Oregon	Site Public Contact - (cancer@lhs.org)
Legacy Meridian Park Hospital Tualatin, Oregon
Legacy Mount Hood Medical Center Gresham, Oregon
Legacy Salmon Creek Hospital Vancouver, Washington
Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Cedar Crest Allentown, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Hazleton Hazleton, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lenox Hill Hospital New York, New York
Levine Cancer Institute - Huntersville Huntersville, North Carolina
Levine Cancer Institute - Rutherford Forest City, North Carolina
Levine Cancer Institute - Union West Matthews, North Carolina
Levine Cancer Institute-Ballantyne Charlotte, North Carolina
Levine Cancer Institute-Gaston Gastonia, North Carolina
Levine Cancer Institute-Rock Hill Rock Hill, South Carolina
Levine Cancer Institute-SouthPark Charlotte, North Carolina
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia	Site Public Contact - (underberga@sjchs.org)
Lexington Medical Center West Columbia, South Carolina	Site Public Contact - (research@lexhealth.org)
Licking Memorial Hospital Newark, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Logan Health Medical Center Kalispell, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Loma Linda University Medical Center Loma Linda, California
London Regional Cancer Program London, Ontario
Louisiana Hematology Oncology Associates Baton Rouge, Louisiana
Louisiana Hematology Oncology Associates LLC Baton Rouge, Louisiana
Loyola University Medical Center Maywood, Illinois
Luminis Health Anne Arundel Medical Center Annapolis, Maryland	Site Public Contact - (research@luminishealth.org)
Lyndon Baines Johnson General Hospital Houston, Texas
MD Anderson Cancer Center at Cooper - Moorestown Moorestown, New Jersey	Site Public Contact - (Majka-barbara@cooperhealth.edu)
MU Health - University Hospital/Ellis Fischel Cancer Center Columbia, Missouri
MU Health Care Goldschmidt Cancer Center Jefferson City, Missouri
Maimonides Medical Center Brooklyn, New York
Manhattan Eye Ear and Throat Hospital New York, New York
Margaret R Pardee Memorial Hospital Hendersonville, North Carolina	Site Public Contact - (pardeecancerresearch@unchealth.unc.edu)
Marion L Shepard Cancer Center - ECU Health Beaufort Hospital Washington, North Carolina
Markey Cancer Center at Lexington Clinic Lexington, Kentucky
Marshall Cancer Center Cameron Park, California	Site Public Contact - (cancerservices@marshallmedical.org)
Marshfield Medical Center - Minocqua Minocqua, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Weston Weston, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-EC Cancer Center Eau Claire, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Marshfield Marshfield, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Rice Lake Rice Lake, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-River Region at Stevens Point Stevens Point, Wisconsin	Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Mary Bird Perkins Cancer Center Baton Rouge, Louisiana
Mary Lanning Memorial Hospital Hastings, Nebraska
Mayo Clinic Hospital in Arizona Phoenix, Arizona
Mayo Clinic in Florida Jacksonville, Florida
Mayo Clinic in Rochester Rochester, Minnesota
McLeod Regional Medical Center Florence, South Carolina	Site Public Contact - (dorie.sturgill@mcleodhealth.org)
Mease Countryside Hospital Safety Harbor, Florida	Site Public Contact - (research.cto@baycare.org)
MedStar Georgetown University Hospital Washington D.C., District of Columbia
MedStar Southern Maryland Hospital Center Clinton, Maryland
Medical Center of Baton Rouge Baton Rouge, Louisiana	Site Public Contact - (Camille.Beck@Ochsner.org)
Medical College of Wisconsin Milwaukee, Wisconsin
Medical Oncology Hematology Consultants PA Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Medical University of South Carolina Charleston, South Carolina	Site Public Contact - (hcc-clinical-trials@musc.edu)
Medstar Washington Hospital Center Washington D.C., District of Columbia
Memorial Hospital Carthage, Illinois	Site Public Contact - (Jeffh@columbusccop.org)
Memorial Hospital East Shiloh, Illinois	Site Public Contact - (dschwab@wustl.edu)
Memorial Hospital North Colorado Springs, Colorado
Memorial Hospital West Pembroke Pines, Florida
Memorial Hospital of South Bend South Bend, Indiana
Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood, Florida	Site Public Contact - (OHR@mhs.net)
Menorah Medical Center Overland Park, Kansas	Site Public Contact - (aroland@kccop.org)
Mercy Cancer Center - Carmichael Carmichael, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Elk Grove Elk Grove, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Rocklin Rocklin, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Sacramento Sacramento, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Health - Perrysburg Hospital Perrysburg, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Health - Saint Anne Hospital Toledo, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mercy Hospital Cedar Rapids, Iowa
Mercy Hospital Cedar Rapids, Iowa	Site Public Contact - (mmcorc@healthpartners.com)
Mercy Hospital Oklahoma City Oklahoma City, Oklahoma
Mercy Hospital Saint Louis St Louis, Missouri
Mercy Hospital South St Louis, Missouri	Site Public Contact - (Danielle.Werle@mercy.net)
Mercy Hospital Springfield Springfield, Missouri
Mercy Oncology and Hematology - Clayton-Clarkson Ballwin, Missouri
Mercy San Juan Medical Center Carmichael, California	Site Public Contact - (ResearchInstituteInquiries@commonspirit.org)
Mercyhealth Hospital and Cancer Center - Janesville Janesville, Wisconsin	Site Public Contact - (oncologyclinicaltrials@mhemail.org)
Methodist Jennie Edmundson Hospital Council Bluffs, Iowa
Methodist Willowbrook Hospital Houston, Texas	Site Public Contact - (protocols@AllianceNCTN.org)
Miami Valley Cancer Care and Infusion Greenville, Ohio
Miami Valley Hospital North Dayton, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Miami Valley Hospital South Centerville, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Midstate Medical Center Meriden, Connecticut
Mills Health Center San Mateo, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Minnesota Oncology - Burnsville Burnsville, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology - Edina Edina, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Woodbury Woodbury, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Mission Hope Medical Oncology - Arroyo Grande Arroyo Grande, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Mission Hope Medical Oncology - Santa Maria Santa Maria, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Missouri Baptist Medical Center St Louis, Missouri
Missouri Baptist Sullivan Hospital Sullivan, Missouri
Mobile Infirmary Medical Center Mobile, Alabama
Monmouth Medical Center Long Branch, New Jersey	Site Public Contact - (mary.danish@rwjbh.org)
Monmouth Medical Center Southern Campus Lakewood, New Jersey	Site Public Contact - (mary.danish@rwjbh.org)
Montefiore Medical Center-Einstein Campus The Bronx, New York	Site Public Contact - (eskwak@montefiore.org)
Morristown Medical Center Morristown, New Jersey
Morton Plant Hospital Clearwater, Florida
Mount Carmel East Hospital Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Carmel Grove City Hospital Grove City, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Mount Sinai Chelsea New York, New York	Site Public Contact - (CCTO@mssm.edu)
Mount Sinai Hospital New York, New York	Site Public Contact - (CCTO@mssm.edu)
Mount Sinai Hospital Medical Center Chicago, Illinois	Site Public Contact - (suhi@sinai.org)
Mount Sinai Medical Center Miami Beach, Florida	Site Public Contact - (Yvonne.Enriquez@msmc.com)
Mount Sinai South Nassau Oceanside, New York	Site Public Contact - (crsu@mssm.edu)
Mount Sinai West New York, New York	Site Public Contact - (CCTO@mssm.edu)
Munson Medical Center Traverse City, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
MyMichigan Medical Center Saginaw Saginaw, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
MyMichigan Medical Center Tawas Tawas City, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas	Site Public Contact - (Emily.Carvell@bmhcc.org)
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, New York	Site Public Contact - (cancerclinicaltrials@cumc.columbia.edu)
NYU Langone Hospital - Brooklyn Brooklyn, New York	Site Public Contact - (david.wallach@nyulangone.org)
NYU Langone Hospital - Long Island Mineola, New York	Site Public Contact - (cancertrials@nyulangone.org)
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC Omaha, Nebraska
Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ Council Bluffs, Iowa
Nebraska Medicine-Bellevue Bellevue, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
Nebraska Medicine-Village Pointe Omaha, Nebraska
Nebraska Methodist Hospital Omaha, Nebraska
New Hampshire Oncology Hematology PA-Concord Concord, New Hampshire
Newark Beth Israel Medical Center Newark, New Jersey	Site Public Contact - (Christine.Kosmides@rwjbh.org)
North Memorial Medical Health Center Robbinsdale, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital Yakima, Washington	Site Public Contact - (Memorial-ClinicalTrials@yvmh.org)
NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois
NorthShore University HealthSystem-Glenbrook Hospital Glenview, Illinois
NorthShore University HealthSystem-Highland Park Hospital Highland Park, Illinois
Northern Westchester Hospital Mount Kisco, New York	Site Public Contact - (AMellor@northwell.edu)
Northside Hospital Atlanta, Georgia	Site Public Contact - (ClinicalTrials@northside.com)
Northside Hospital - Duluth Duluth, Georgia	Site Public Contact - (Clinical.trials@northside.com)
Northside Hospital - Gwinnett Lawrenceville, Georgia	Site Public Contact - (Clinical.trials@northside.com)
Northwell Health Cancer Institute at Huntington Greenlawn, New York
Northwell Health Imbert Cancer Center Bay Shore, New York
Northwell Health/Center for Advanced Medicine Lake Success, New York
Northwest Cancer Center - Crown Point Crown Point, Indiana	Site Public Contact - (CancerResearch@powershealth.org)
Northwest Cancer Center - Hobart Hobart, Indiana
Northwest Cancer Center - Valparaiso Valparaiso, Indiana	Site Public Contact - (CancerResearch@COMHS.org)
Northwest Oncology LLC Dyer, Indiana
Northwestern Medicine Cancer Center Delnor Geneva, Illinois	Site Public Contact - (Donald.Smith3@nm.org)
Northwestern Medicine Cancer Center Kishwaukee DeKalb, Illinois	Site Public Contact - (Donald.Smith3@nm.org)
Northwestern Medicine Cancer Center Warrenville Warrenville, Illinois	Site Public Contact - (Donald.Smith3@nm.org)
Northwestern Medicine Glenview Outpatient Center Glenview, Illinois
Northwestern Medicine Grayslake Outpatient Center Grayslake, Illinois
Northwestern Medicine Lake Forest Hospital Lake Forest, Illinois	Site Public Contact - (cancertrials@northwestern.edu)
Northwestern Medicine Oak Brook Oak Brook, Illinois	Site Public Contact - (nctnprogram_rhlccc@northwestern.edu)
Northwestern Medicine Orland Park Orland Park, Illinois	Site Public Contact - (nctnprogram_rhlccc@northwestern.edu)
Northwestern University Chicago, Illinois	Site Public Contact - (cancer@northwestern.edu)
Norwalk Hospital Norwalk, Connecticut	Site Public Contact - (jennifer.long@norwalkhealth.org)
Novant Health Cancer Institute - Huntersville Huntersville, North Carolina	Site Public Contact - (kashah@novanthealth.org)
Novant Health Cancer Institute - Kernersville Kernersville, North Carolina	Site Public Contact - (asmarrs@novanthealth.org)
Novant Health Cancer Institute - Matthews Matthews, North Carolina	Site Public Contact - (kashah@novanthealth.org)
Novant Health Cancer Institute - Mooresville Mooresville, North Carolina	Site Public Contact - (kashah@novanthealth.org)
Novant Health Cancer Institute - Mount Airy Mount Airy, North Carolina	Site Public Contact - (asmarrs@novanthealth.org)
Novant Health Cancer Institute - Rowan Salisbury, North Carolina	Site Public Contact - (kashah@novanthealth.org)
Novant Health Cancer Institute - Thomasville Thomasville, North Carolina	Site Public Contact - (pjordan@novanthealth.org)
Novant Health Forsyth Medical Center Winston-Salem, North Carolina	Site Public Contact - (pjordan@novanthealth.org)
Novant Health Presbyterian Medical Center Charlotte, North Carolina	Site Public Contact - (kashah@novanthealth.org)
Novant Health Presbyterian Medical Center Huntersville Huntersville, North Carolina
OSF Saint Anthony Medical Center Rockford, Illinois
OSF Saint Francis Hospital and Medical Group Escanaba, Michigan	Site Public Contact - (WI_research_admin@hshs.org)
Ochsner Hematology Oncology North Shore - Covington (West Region) Covington, Louisiana	Site Public Contact - (Cheryl.kesler@ochsner.org)
Ochsner High Grove Baton Rouge, Louisiana	Site Public Contact - (Camielle.beck@ochsner.org)
Ochsner LSU Health - Cancer Treatment Center Shreveport, Louisiana
Ochsner LSU Health Monroe Medical Center Monroe, Louisiana	Site Public Contact - (LPost@lsuhsc.edu)
Ochsner Medical Center Jefferson New Orleans, Louisiana	Site Public Contact - (Elisemarie.curry@ochsner.org)
Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto, Ontario
Ohio State University Comprehensive Cancer Center Columbus, Ohio	Site Public Contact - (Jamesline@osumc.edu)
OhioHealth Mansfield Hospital Mansfield, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
OhioHealth Marion General Hospital Marion, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
OhioHealth O'Bleness Hospital Athens, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
OhioHealth Pickerington Methodist Hospital Pickerington, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
OhioHealth Westerville Medical Campus/Westerville Cancer Center Westerville, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa, Oklahoma
Oncology Associates PC Omaha, Nebraska
Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa
Oncology Hematology Associates of Saginaw Valley PC Saginaw, Michigan
OptumCare Cancer Care at Charleston Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at Fort Apache Las Vegas, Nevada	Site Public Contact - (research@sncrf.org)
Oregon Health and Science University Portland, Oregon	Site Public Contact - (trials@ohsu.edu)
Orlando Health Cancer Institute Orlando, Florida	Site Public Contact - (CancerClinicalTrials@orlandohealth.com)
Orlando Health Cancer Institute - Lake Mary Lake Mary, Florida	Site Public Contact - (r-adultoncnewops@orlandohealth.com)
Ottawa Hospital and Cancer Center-General Campus Ottawa, Ontario
Overlook Hospital Summit, New Jersey
PCR Oncology Arroyo Grande, California	Site Public Contact - (research@sncrf.org)
PROncology San Juan,	Site Public Contact - (info@PRoncology.com)
Pacific Central Coast Health Center-San Luis Obispo San Luis Obispo, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Pali Momi Medical Center ‘Aiea, Hawaii
Park Nicollet Clinic - Saint Louis Park Saint Louis Park, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Parkland Health Center - Farmington Farmington, Missouri
Parkland Memorial Hospital Dallas, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
Parkview Regional Medical Center Fort Wayne, Indiana
Penn State Health Saint Joseph Medical Center Reading, Pennsylvania	Site Public Contact - (dward1@pennstatehealth.psu.edu)
Penn State Milton S Hershey Medical Center Hershey, Pennsylvania	Site Public Contact - (CTO@hmc.psu.edu)
Phelps Health Delbert Day Cancer Institute Rolla, Missouri
Phelps Memorial Hospital Center Sleepy Hollow, New York
Phoebe Putney Memorial Hospital Albany, Georgia
Physicians' Clinic of Iowa PC Cedar Rapids, Iowa
Pluta Cancer Center Rochester, New York	Site Public Contact - (ctsucontact@westat.com)
Pocono Medical Center East Stroudsburg, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Premier Blood and Cancer Center Dayton, Ohio
Presbyterian Kaseman Hospital Albuquerque, New Mexico	Site Public Contact - (WBurman@phs.org)
Presbyterian Rust Medical Center/Jorgensen Cancer Center Rio Rancho, New Mexico	Site Public Contact - (WBurman@phs.org)
Princeton Community Hospital Princeton, West Virginia
Prisma Health Cancer Institute - Butternut Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Easley Easley, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Eastside Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Faris Greenville, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Greer Greer, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Seneca Seneca, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Spartanburg Boiling Springs, South Carolina	Site Public Contact - (Kim.Williams3@prismahealth.org)
ProHealth D N Greenwald Center Mukwonago, Wisconsin	Site Public Contact - (research.institute@phci.org)
ProHealth Oconomowoc Memorial Hospital Oconomowoc, Wisconsin
ProMedica Flower Hospital Sylvania, Ohio	Site Public Contact - (PCIOncResearch@promedica.org)
Providence Cancer Institute Clackamas Clinic Clackamas, Oregon
Providence Newberg Medical Center Newberg, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Portland Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Saint Vincent Medical Center Portland, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Providence Willamette Falls Medical Center Oregon City, Oregon	Site Public Contact - (CanRsrchStudies@providence.org)
Queen's Cancer Cenrer - POB I Honolulu, Hawaii
Queen's Cancer Center - Kuakini Honolulu, Hawaii
Queen's Medical Center Honolulu, Hawaii
Queens Hospital Center Jamaica, New York
Reading Hospital West Reading, Pennsylvania
Regional Cancer Center-Lee Memorial Health System Fort Myers, Florida	Site Public Contact - (protocols@AllianceNCTN.org)
Regions Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson Franklin, Wisconsin	Site Public Contact - (AWRI.Inquiry@Ascension.org)
Renown Regional Medical Center Reno, Nevada	Site Public Contact - (Renown-CRD@renown.org)
Research Medical Center Kansas City, Missouri	Site Public Contact - (aroland@kccop.org)
Rhode Island Hospital Providence, Rhode Island
Riverside Methodist Hospital Columbus, Ohio	Site Public Contact - (Jennifer.Sexton@ohiohealth.com)
Robert Wood Johnson University Hospital Somerset Somerville, New Jersey	Site Public Contact - (Siby.Varughese@rwjbh.org)
Roswell Park Cancer Institute Buffalo, New York	Site Public Contact - (askroswell@roswellpark.org)
Rowan Regional Medical Center Salisbury, North Carolina
Rush-Copley Medical Center Aurora, Illinois	Site Public Contact - (RCMC_Cancer_Research@rush.edu)
Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey
SIH Cancer Institute Carterville, Illinois	Site Public Contact - (clinical.research@sih.net)
SSM Health Good Samaritan Mount Vernon, Illinois	Site Public Contact - (gayla.hall@ssmhealth.com)
Saint Alphonsus Cancer Care Center-Boise Boise, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Nampa Nampa, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Ontario Ontario, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Ann's Hospital Westerville, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Saint Anthony North Hospital Westminster, Colorado	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Anthony Regional Hospital Carroll, Iowa	Site Public Contact - (sbenson@iora.org)
Saint Catherine Hospital Garden City, Kansas	Site Public Contact - (protocols@AllianceNCTN.org)
Saint Charles Health System Bend, Oregon	Site Public Contact - (nosall@stcharleshealthcare.org)
Saint Francis Cancer Center Greenville, South Carolina	Site Public Contact - (Heather_Rich@bshsi.org)
Saint Francis Hospital Federal Way, Washington	Site Public Contact - (Heather_Rich@bshsi.org)
Saint Francis Medical Center Cape Girardeau, Missouri	Site Public Contact - (sfmc@sfmc.net)
Saint John's Cancer Institute Santa Monica, California
Saint John's Hospital - Healtheast Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint Joseph Hospital - Orange Orange, California
Saint Joseph's Hospital/Children's Hospital-Tampa Tampa, Florida	Site Public Contact - (jennifer.manns@baycare.org)
Saint Joseph's Regional Medical Center Paterson, New Jersey	Site Public Contact - (HallL@sjhmc.org)
Saint Joseph's/Candler - Bluffton Campus Bluffton, South Carolina	Site Public Contact - (underberga@sjchs.org)
Saint Luke's Cancer Institute - Boise Boise, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Fruitland Fruitland, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Meridian Meridian, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Nampa Nampa, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's Cancer Institute - Twin Falls Twin Falls, Idaho	Site Public Contact - (eslinget@slhs.org)
Saint Luke's East - Lee's Summit Lee's Summit, Missouri	Site Public Contact - (aroland@kccop.org)
Saint Luke's Hospital of Duluth Duluth, Minnesota	Site Public Contact - (kdean@slhduluth.com)
Saint Luke's Hospital of Kansas City Kansas City, Missouri	Site Public Contact - (aroland@kccop.org)
Saint Mary Medical Center Hobart, Indiana	Site Public Contact - (CancerResearch@COMHS.org)
Saint Mary's Oncology/Hematology Associates of West Branch West Branch, Michigan
Saint Patrick Hospital - Community Hospital Missoula, Montana	Site Public Contact - (amy.hanneman@providence.org)
Saint Vincent Hospital Erie, Pennsylvania
Saint Vincent Hospital Cancer Center Green Bay Green Bay, Wisconsin	Site Public Contact - (WI_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Oconto Falls Oconto Falls, Wisconsin	Site Public Contact - (WI_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Saint Mary's Green Bay, Wisconsin	Site Public Contact - (wi_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Sheboygan Sheboygan, Wisconsin	Site Public Contact - (wi_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Sturgeon Bay Sturgeon Bay, Wisconsin	Site Public Contact - (wi_research_admin@hshs.org)
Sainte Genevieve County Memorial Hospital Sainte Genevieve, Missouri
Salina Regional Health Center Salina, Kansas	Site Public Contact - (mleepers@srhc.com)
Salinas Valley Memorial Salinas, California	Site Public Contact - (tnielsen2@svmh.com)
San Juan City Hospital San Juan,
Sanford Bismarck Medical Center Bismarck, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Broadway Medical Center Fargo, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Cancer Center Oncology Clinic Sioux Falls, South Dakota	Site Public Contact - (OncologyClinicTrialsSF@sanfordhealth.org)
Sanford Cancer Center Worthington Worthington, Minnesota
Sanford Joe Lueken Cancer Center Bemidji, Minnesota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Roger Maris Cancer Center Fargo, North Dakota	Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org)
Sanford Thief River Falls Medical Center Thief River Falls, Minnesota
Sanford USD Medical Center - Sioux Falls Sioux Falls, South Dakota	Site Public Contact - (OncologyClinicalTrialsSF@SanfordHealth.org)
Saskatoon Cancer Centre Saskatoon, Saskatchewan
Schulze Family Foundation Cancer Clinic - Bonita Health Center Bonita Springs, Florida	Site Public Contact - (RCCR@leehealth.org)
Scott and White Memorial Hospital Temple, Texas
Sechler Family Cancer Center Lebanon, Pennsylvania	Site Public Contact - (doxenberg@wellspan.org)
Self Regional Healthcare Greenwood, South Carolina	Site Public Contact - (nmcgaha@selfregional.org)
Sidney Kimmel Cancer Center Washington Township Sewell, New Jersey	Site Public Contact - (ONCTrialNow@jefferson.edu)
Sidney and Lois Eskenazi Hospital Indianapolis, Indiana	Site Public Contact - (iutrials@iu.edu)
Sinai Hospital of Baltimore Baltimore, Maryland
Siteman Cancer Center at Christian Hospital St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center at West County Hospital Creve Coeur, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Siteman Cancer Center-South County St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
Skagit Regional Health Cancer Care Center Mount Vernon, Washington	Site Public Contact - (rcccclinicalresearch@skagitvalleyhospital.org)
Smilow Cancer Hospital Care Center - Guilford Guilford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center - Waterford Waterford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center - Westerly Westerly, Rhode Island	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Glastonbury Glastonbury, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Greenwich Greenwich, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Long Ridge Stamford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center-Fairfield Fairfield, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital Care Center-Trumbull Trumbull, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital-Derby Care Center Derby, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital-Torrington Care Center Torrington, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Smilow Cancer Hospital-Waterbury Care Center Waterbury, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Solinsky Center for Cancer Care Manchester, New Hampshire
South Carolina Cancer Specialists PC Hilton Head Island, South Carolina	Site Public Contact - (underberga@sjchs.org)
South Jordan Health Center South Jordan, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
Southern Illinois University School of Medicine Springfield, Illinois
Southern Ohio Medical Center Portsmouth, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Springfield Clinic Springfield, Illinois
Springfield Memorial Hospital Springfield, Illinois	Site Public Contact - (pallante.beth@mhsil.com)
Springfield Regional Cancer Center Springfield, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Stamford Hospital/Bennett Cancer Center Stamford, Connecticut
Stanford Cancer Center Emeryville Emeryville, California	Site Public Contact - (ccto-office@stanford.edu)
Stanford Cancer Center South Bay San Jose, California	Site Public Contact - (ccto-office@stanford.edu)
Stanford Cancer Institute Palo Alto Palo Alto, California
Staten Island University Hospital Staten Island, New York
Stony Brook University Medical Center Stony Brook, New York
Straub Clinic and Hospital Honolulu, Hawaii
Strecker Cancer Center-Belpre Belpre, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
Summa Health Medina Medical Center Medina, Ohio	Site Public Contact - (cancerresearch@summahealth.org)
Summa Health System - Akron Campus Akron, Ohio	Site Public Contact - (cancerresearch@summahealth.org)
Summa Health System - Barberton Campus Barberton, Ohio	Site Public Contact - (cancerresearch@summahealth.org)
Sutter Medical Center Sacramento Sacramento, California	Site Public Contact - (clinicalresearch@sutterhealth.org)
Swedish Cancer Institute-Edmonds Edmonds, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Cancer Institute-Issaquah Issaquah, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Swedish Covenant Hospital Chicago, Illinois
Swedish Medical Center-First Hill Seattle, Washington	Site Public Contact - (PCRC-NCORP@Swedish.org)
Tallahassee Memorial HealthCare Tallahassee, Florida
Tampa General Hospital Tampa, Florida
Tarrant County Hospital District/JPS Health Network Fort Worth, Texas
Terrebonne General Medical Center Houma, Louisiana
The Cancer Institute at Saint Francis Hospital East Hills, New York	Site Public Contact - (Stephanie.Solito@chsli.org)
The Cancer Institute of New Jersey Hamilton Hamilton, New Jersey
The Community Hospital Munster, Indiana
The Dana-Farber Cancer Institute at Londonderry Londonderry, New Hampshire	Site Public Contact - (protocols@AllianceNCTN.org)
The Hospital of Central Connecticut New Britain, Connecticut
The James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky
The Mark H Zangmeister Center Columbus, Ohio	Site Public Contact - (Jeffh@columbusccop.org)
The Philips Family Cancer Center Southampton, New York
The Queen's Medical Center - West Oahu ‘Ewa Beach, Hawaii	Site Public Contact - (rohta@queens.org)
The University of Kansas Cancer Center - Olathe Olathe, Kansas	Site Public Contact - (OlatheCCResearch@kumc.edu)
The Valley Hospital - Luckow Pavilion Paramus, New Jersey	Site Public Contact - (clinicaltrialsresearch@valleyhealth.com)
ThedaCare Cancer Care - Berlin Berlin, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - New London New London, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - Oshkosh Oshkosh, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - Shawano Shawano, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - Waupaca Waupaca, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
ThedaCare Regional Cancer Center Appleton, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
ThedaCare Regional Medical Center - Neenah Neenah, Wisconsin	Site Public Contact - (ResearchDept@thedacare.org)
Thomas Hospital Fairhope, Alabama
Thomas Jefferson University Hospital Philadelphia, Pennsylvania	Site Public Contact - (ONCTrialNow@jefferson.edu)
Three Rivers Community Hospital Grants Pass, Oregon
Tidelands Georgetown Memorial Hospital Georgetown, South Carolina	Site Public Contact - (broe@tidelandshealth.org)
Toledo Clinic Cancer Centers-Toledo Toledo, Ohio
Torrance Memorial Physician Network - Cancer Care Torrance, California	Site Public Contact - (courtney.steeneken@tmphysicians.com)
Touro Infirmary New Orleans, Louisiana	Site Public Contact - (emede1@lsuhsc.edu)
Tower Cancer Research Foundation Beverly Hills, California	Site Public Contact - (towercancerresearch@toweroncology.com)
Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus Elizabeth, New Jersey
Trinity Health Grand Rapids Hospital Grand Rapids, Michigan
Trinity Health IHA Medical Group Hematology Oncology - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Muskegon Hospital Muskegon, Michigan
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Oakland Hospital Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Mary Mercy Livonia Hospital Livonia, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Medical Center Moline, Illinois
Tufts Medical Center Boston, Massachusetts	Site Public Contact - (ContactUsCancerCenter@TuftsMedicalCenter.org)
Tufts Medical Center Cancer Center Stoneham Stoneham, Massachusetts	Site Public Contact - (NCCCR@Tuftsmedicalcenter.org)
UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California
UCHealth - Cherry Creek Denver, Colorado	Site Public Contact - (protocols@AllianceNCTN.org)
UCHealth Highlands Ranch Hospital Highlands Ranch, Colorado
UCHealth Lone Tree Health Center Lone Tree, Colorado	Site Public Contact - (protocols@AllianceNCTN.org)
UCHealth Memorial Hospital Central Colorado Springs, Colorado
UCHealth University of Colorado Hospital Aurora, Colorado
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California
UChicago Medicine Northwest Indiana Crown Point, Indiana	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
UF Health Cancer Institute - Gainesville Gainesville, Florida
UH Seidman Cancer Center at Lake Health Mentor Campus Mentor, Ohio	Site Public Contact - (CTUReferral@UHhospitals.org)
UH Seidman Cancer Center at UH Avon Health Center Avon, Ohio
UHHS-Chagrin Highlands Medical Center Beachwood, Ohio	Site Public Contact - (CTUReferral@UHhospitals.org)
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny, Iowa
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Laurel Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic Clive, Iowa
UI Healthcare Mission Cancer and Blood - Fort Dodge Fort Dodge, Iowa	Site Public Contact - (trials@missioncancer.com)
UM Baltimore Washington Medical Center/Tate Cancer Center Glen Burnie, Maryland
UNC Health Cancer Care Cary Cary, North Carolina
UNC Health Cancer Care Garner Garner, North Carolina
UNC Health Cancer Care Raleigh Raleigh, North Carolina	Site Public Contact - (CancCtrOncologyClinicalResearch@unchealth.unc.edu)
UNC Health Cancer Care Wakefield Raleigh, North Carolina	Site Public Contact - (CancCtrOncologyClinicalResearch@unchealth.unc.edu)
UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina	Site Public Contact - (cancerclinicaltrials@med.unc.edu)
UT MD Anderson - League City League City, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
UT MD Anderson - Sugar Land Sugar Land, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
UT MD Anderson - The Woodlands Conroe, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
UT MD Anderson - West Houston Houston, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
UT MD Anderson Cancer Center Houston, Texas
UT Southwestern Clinical Center at Richardson/Plano Richardson, Texas	Site Public Contact - (Suzanne.cole@utsouthwestern.edu)
UT Southwestern Simmons Cancer Center - RedBird Dallas, Texas	Site Public Contact - (canceranswerline@utsouthwestern.edu)
UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
UT Southwestern/Simmons Cancer Center-Fort Worth Fort Worth, Texas	Site Public Contact - (canceranswerline@UTSouthwestern.edu)
UW Cancer Center at ProHealth Care Waukesha, Wisconsin	Site Public Contact - (Chanda.miller@phci.org)
UW Health Carbone Cancer Center Rockford Rockford, Illinois	Site Public Contact - (lkline@uwhealth.org)
United Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
United Hospital Center Bridgeport, West Virginia	Site Public Contact - (cancertrialsinfo@hsc.wvu.edu)
University Cancer and Blood Center LLC Athens, Georgia
University Health Network-Princess Margaret Hospital Toronto, Ontario	Site Public Contact - (clinical.trials@uhn.on.ca)
University Health Truman Medical Center Kansas City, Missouri
University Medical Center New Orleans New Orleans, Louisiana	Site Public Contact - (emede1@lsuhsc.edu)
University of Alabama at Birmingham Cancer Center Birmingham, Alabama
University of Arkansas for Medical Sciences Little Rock, Arkansas
University of California Davis Comprehensive Cancer Center Sacramento, California
University of Chicago Comprehensive Cancer Center Chicago, Illinois	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
University of Chicago Medicine-Orland Park Orland Park, Illinois	Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu)
University of Cincinnati Cancer Center-UC Medical Center Cincinnati, Ohio	Site Public Contact - (cancer@uchealth.com)
University of Cincinnati Cancer Center-West Chester West Chester, Ohio	Site Public Contact - (cancer@uchealth.com)
University of Illinois Chicago, Illinois
University of Iowa Healthcare Cancer Services Quad Cities Bettendorf, Iowa	Site Public Contact - (katherine-daprile@uiowa.edu)
University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa
University of Kansas Cancer Center Kansas City, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center - Briarcliff Kansas City, Missouri
University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center - North Kansas City, Missouri	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center at North Kansas City Hospital North Kansas City, Missouri
University of Kansas Cancer Center-Overland Park Overland Park, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Health System Saint Francis Campus Topeka, Kansas
University of Kansas Hospital-Indian Creek Campus Overland Park, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas	Site Public Contact - (KUCC_Navigation@kumc.edu)
University of Kentucky/Markey Cancer Center Lexington, Kentucky
University of Maryland/Greenebaum Cancer Center Baltimore, Maryland
University of Michigan Health - Sparrow Lansing Lansing, Michigan	Site Public Contact - (harsha.trivedi@umhsparrow.org)
University of Michigan Health - West Wyoming, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
University of Michigan Rogel Cancer Center Ann Arbor, Michigan	Site Public Contact - (CancerAnswerLine@med.umich.edu)
University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota
University of Mississippi Medical Center Jackson, Mississippi
University of Nebraska Medical Center Omaha, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
University of New Mexico Cancer Center Albuquerque, New Mexico	Site Public Contact - (HSC-ClinicalTrialInfo@salud.unm.edu)
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma	Site Public Contact - (ou-clinical-trials@ouhsc.edu)
University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania	Site Public Contact - (PMCancerResearch@pennmedicine.upenn.edu)
University of Rochester Rochester, New York
University of South Alabama Mitchell Cancer Institute Mobile, Alabama	Site Public Contact - (pfrancisco@usouthal.edu)
University of Tennessee - Knoxville Knoxville, Tennessee
University of Utah Sugarhouse Health Center Salt Lake City, Utah	Site Public Contact - (cancerinfo@hci.utah.edu)
University of Vermont Medical Center Burlington, Vermont	Site Public Contact - (rpo@uvm.edu)
University of Vermont and State Agricultural College Burlington, Vermont	Site Public Contact - (rpo@uvm.edu)
University of Washington Medical Center - Montlake Seattle, Washington
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center Madison, Wisconsin	Site Public Contact - (clinicaltrials@cancer.wisc.edu)
University of Wisconsin Carbone Cancer Center - Johnson Creek Johnson Creek, Wisconsin	Site Public Contact - (clinicaltrials@cancer.wisc.edu)
University of Wisconsin Carbone Cancer Center - University Hospital Madison, Wisconsin	Site Public Contact - (clinicaltrials@cancer.wisc.edu)
UofL Health Medical Center Northeast Louisville, Kentucky	Site Public Contact - (ctoinfo@louisville.edu)
Upper Valley Medical Center Troy, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
VCU Massey Cancer Center at Stony Point Richmond, Virginia	Site Public Contact - (ctoclinops@vcu.edu)
VCU Massey Comprehensive Cancer Center Richmond, Virginia	Site Public Contact - (CTOclinops@vcu.edu)
Valley Health System Ridgewood Campus Ridgewood, New Jersey	Site Public Contact - (clinicaltrialsresearch@valleyhealth.com)
Valley Medical Center Renton, Washington	Site Public Contact - (research@valleymed.org)
Vanderbilt Breast Center at One Hundred Oaks Nashville, Tennessee
Vanderbilt University/Ingram Cancer Center Nashville, Tennessee
Vassar Brothers Medical Center Poughkeepsie, New York
Vince Lombardi Cancer Clinic - Oshkosh Oshkosh, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Sheboygan Sheboygan, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Two Rivers Two Rivers, Wisconsin	Site Public Contact - (ncorp@aurora.org)
Wake Forest University Health Sciences Winston-Salem, North Carolina
Wake Forest University at Clemmons Clemmons, North Carolina
Walter Reed National Military Medical Center Bethesda, Maryland
Washington University School of Medicine St Louis, Missouri	Site Public Contact - (info@siteman.wustl.edu)
WellSpan Health-York Cancer Center York, Pennsylvania
WellSpan Medical Oncology and Hematology Hanover, Pennsylvania
West Michigan Cancer Center Kalamazoo, Michigan	Site Public Contact - (crcwm-regulatory@crcwm.org)
West Virginia University Healthcare Morgantown, West Virginia	Site Public Contact - (cancertrialsinfo@hsc.wvu.edu)
Wexford Health and Wellness Pavilion Wexford, Pennsylvania	Site Public Contact - (Dawnmarie.DeFazio@ahn.org)
William E Kahlert Regional Cancer Center/Sinai Hospital Westminster, Maryland
Wilmot Cancer Institute at Webster Webster, New York
Women and Infants Hospital Providence, Rhode Island
Women's Diagnostic Center - Munster Munster, Indiana	Site Public Contact - (mnicholson@comhs.org)
Woodland Memorial Hospital Woodland, California	Site Public Contact - (ResearchInstituteInquiries@CommonSpirit.org)
Yale University New Haven, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Yale-New Haven Hospital North Haven Medical Center North Haven, Connecticut	Site Public Contact - (canceranswers@yale.edu)
Yolanda G Barco Oncology Institute Meadville, Pennsylvania	Site Public Contact - (ctsucontact@westat.com)
Zangmeister Center Grove City Grove City, Ohio
Zuckerberg San Francisco General Hospital San Francisco, California	Site Public Contact - (Paul.Couey@ucsf.edu)

Immune Registry for BK in Kidney Transplant Recipients

Contact(s):

Ambreen Azhar - ambreen.azhar@vcuhealth.org

Principal Investigator:

System ID: NCT06538961

Show full eligibility criteria

Interventions: OTHER: Blood samples: Main Study group, OTHER: Data Collection, OTHER: Urine Sample- Main Study group, OTHER: Urine sample- Sub-study group, OTHER: Blood sample: Sub-study group

Conditions: BK Virus Infection, Kidney Transplant, Complications

Keywords: Immune Registry, BK in Kidney Transplant Recipients

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	Ambreen Azhar - (ambreen.azhar@vcuhealth.org) Gelila Abebe - (gelila.abebe@vcuhealth.org)

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) (DISCOVER-HCM)

Contact(s):

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com - Clinical.Trials@bms.com

Principal Investigator:

System ID: NCT05489705

Show full eligibility criteria

Inclusion Criteria * ≥ 18 years of age at the time of informed consent. * Willing and able to provide written informed consent form (ICF) and any required privacy authorization prior to the initiation of study procedures (or in those situations where consent cannot be given by participants, consent provided by their legally acceptable representatives) United States Sub-Study * Diagnosis of obstructive HCM consistent with 2020 American Heart Association/American College of Cardiology (AHA/ACC) guidelines. * Obstructive HCM is defined clinically by the presence of increased LV wall thickness ≥ 15 mm (or ≥ 13 mm with positive family history of HCM) in a nondilated ventricular chamber that is not solely explained by abnormal loading conditions (eg, another cardiac or systemic disease) and peak LVOT gradient of ≥ 30 mmHg at rest or with provocation. * Has documented LVEF of ≥ 55% recorded by echocardiography within the last 6 months. * Symptoms consistent with NYHA functional class II-IV. * Receiving beta blocker (BB)s, non-dihydropyridine calcium. channel blockers (nonDHP CCBs), disopyramide, and/or mavacamten (once available) as part of routine clinical care; or currently receiving no treatment due to intolerance or failure of prior treatment (eg, BBs, non-DHP CCBs, or disopyramide) for obstructive HCM. European Sub-study * Diagnosis of obstructive HCM consistent with the most recent European Society of Cardiology (ESC) and American Heart Association/American College of Cardiology (AHA/ACC) guidelines * Documented LVEF of ≥55% recorded by TTE * Documented symptoms consistent with NYHA functional class II-III at enrollment or within 6 months prior to enrollment (if not available at enrollment). * As part of routine clinical care for obstructive HCM: receiving BBs, non-DHP CCBs, disopyramide; initiating mavacamten at enrollment; or currently receiving no treatment due to intolerance or failure of prior treatment (e.g., BBs, non-DHP CCBs, or disopyramide). Exclusion Criteria * Known phenocopy disease (e.g., Fabry disease, amyloidosis) or LV hypertrophy associated with hypertension. * Documentation of any fixed obstruction of the outflow tract such as aortic valve stenosis or replacement. * Prior treatment of obstructive HCM with invasive septal reduction (surgical myectomy or percutaneous alcohol septal ablation \[ASA\]) within 6 months prior to enrollment; participants with an unsuccessful myectomy or percutaneous ASA performed \> 6 months prior to enrollment may be enrolled. * Naïve to treatment for obstructive HCM (ie, never treated with BBs, nonDHP CCBs, or disopyramide). United States Sub-Study * Receiving an investigational therapeutic agent for obstructive HCM (eg, myosin-inhibitors other than mavacamten) in an interventional clinical trial at participant enrollment. * Previously or currently enrolled in a long-term safety extension study of mavacamten (eg, EXPLORER-HCM \[ClinicalTrials.gov, NCT03470545\], MAVA-LTE \[NCT03723655\], PIONEER-OLE \[NCT03496168\], VALORHCM \[NCT04349072\], or MAVERICK \[NCT03442764\]) European Sub-study * Receiving an investigational therapeutic agent or any cardiac myosin inhibitor and/or modulators for obstructive HCM at patient enrolment * Previously or currently enrolled in other HCM registry studies (e.g., TORCH, REMY, EU-PASS) * Previously or currently enrolled in a study of mavacamten (e.g., EXPLORER-HCM \[ClinicalTrials.gov, NCT03470545\], MAVA-LTE \[NCT03723655\], PIONEER-OLE \[NCT03496168\], VALOR-HCM \[NCT04349072\], MAVERICK \[NCT03442764\], or MEMENTO \[NCT2264899\]) * Previously treated with mavacamten

Interventions: DRUG: Mavacamten, DRUG: Non-mavacamten symptomatic oHCM therapy

Conditions: Obstructive Hypertrophic Cardiomyopathy

Keywords: Obstructive hypertrophic cardiomyopathy, Obstructive HCM (oHCM), Mavacamten, Heart failure, oHCM

I'm interested

Share via email

Show 101 locations

Study Locations

Hide all locations

Location	Contacts
Alaska Heart Institute Anchorage, Alaska
BI Research Center Houston, Texas
Bassett Medical Center Cooperstown, New York
Baylor Scott & White Medical Centre - Temple Temple, Texas
Baylor Scott & White Research Institute Plano, Texas
Baylor Scott & White The Heart Hospital Plano Plano, Texas
CHI Health Reseach Center Omaha, Nebraska
CHU Amiens-Picardie Amiens,
CHU De Poitiers - Hopital De La Miletrie Poitiers, Vienne
CHU Nantes Hopital Nord Laennec Saint-Herblain, Loire Atlantique
Cardiology Associates Research, LLC Tupelo, Mississippi
Carilion Clinic; Virginia Tech-Carilion School of Medicine Roanoke, Virginia
Centre Hospitalier Haguenau Haguenau, Bas Rhin
Christ Hospital Health Network Cincinnati, Ohio
Duke University Health System Durham, North Carolina
Focus Clinical Research Charlotte, North Carolina
Franciscan Physician Network-Indiana Heart Physicians Indianapolis, Indiana
Geisinger Health System Wilkes-Barre, Pennsylvania
Hackensack University Medical Center Hackensack, New Jersey
Harvard (Massachusetts General Hospital) Boston, Massachusetts
Harvard Medical School - Brigham and Women's Hospital (BWH) Boston, Massachusetts
Henry Ford Health System Detroit, Michigan
Hospital Clinico San Carlos Madrid,
Hospital Clinico Universitario Virgen de la Victoria Málaga,
Hospital Fundacion Son Llatzer Palma de Mallorca, Balearic Islands
Hospital Universitario Central de Asturias Oviedo, Principality of Asturias
Hospital Universitario Puerta de Hierro Majadahonda Majadahonda, Madrid, Comunidad de
Hospital Universitario Virgen de la Arrixaca El Palmar,
Hospital Universitario de Burgos Burgos,
Hôpital Saint Vincent-de-Paul Lille, Nord
Hôpital Sainte Musse Toulon, Var
Immanuel Klinikum Bernau Bernau, State of Berlin
Imperial College Healthcare NHS Trust London, Greater London
Indiana. University Indianapolis, Indiana
KH St.Josef Braunau am Inn Braunau am Inn,
Kardiologische und angiologische Praxen im Spreebogen Berlin,
Keck School of Medicine of USC-Usc Los Angeles, California
Kepler Universitätsklinikum Linz Linz,
LKH-Univ. Klinikum Graz Graz,
Leeds General Infirmary West Yorkshire,
Liverpool Heart and Chest Hospital Liverpool, Merseyside
Local Institution - 0001 Warsaw,
Local Institution - 0001 Warsaw,
Local Institution - 0002 Katowice,
Local Institution - 0002 Katowice,
Local Institution - 0003 Cleveland, Ohio
Local Institution - 0004 ABB, Buenos Aires F.D.
Local Institution - 0009 New York, New York
Local Institution - 0026 Morristown, New Jersey
Local Institution - 0033 Kansas City, Missouri
Local Institution - 0037 La Jolla, California
Local Institution - 0045 Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0046 Suwon, Kyǒnggi-do
Local Institution - 0059 Baltimore, Maryland
Local Institution - 0065 Jacksonville, Florida
Local Institution - 0067 Hartford, Connecticut
Local Institution - 0076 Lancaster, Pennsylvania
Local Institution - 0083 Ahmedabad, Gujarat
Local Institution - 0084 Klagenfurt,
Local Institution - 0085 Gainesville, Florida
Local Institution - 0088 Innsbruck,
Local Institution - 0101 Erlangen, Bavaria
Local Institution - 0102 Madrid,
Local Institution - 0110 Glasgow, Glasgow City
Local Institution - 0113 London, Greater London
Local Institution - 0117 Montpellier,
Medical College of Wisconsin, Inc (PI Address) Milwaukee, Wisconsin
Medstar Health Research Institute Baltimore, Maryland
Medstar Washington Hospital Center Washington D.C., District of Columbia
Minneapolis Heart Institute Foundation Minneapolis, Minnesota
Mount Sinai Hospital New York, New York
North Texas Cardiology Center Dallas, Texas
Ostalb-Klinikum Aalen Aalen, Baden-Wurttemberg
Pima Heart and Vascular Tucson, Arizona
Praxisklinik Herz Und Gefasse-Klinikum Weisser Hirsch Dresden, Saxony
Prisma Health - Upstate Greenville, South Carolina
Research & Cardiovascular Corp Ponce,
Saint Francis Hospital Federal Way, Washington
Saint Thomas Health Nashville, Tennessee
Spectrum Health Medical Group Grand Rapids, Michigan
St. Luke's Mid-America Heart Institute Kansas City, Missouri
St. Luke's University Health Network Bethlehem, Pennsylvania
Stanford Health Care Hospital & Clinics Palo Alto, California
The Methodist Hospital, Methodist Cancer Cencer Houston, Texas
The Rector and Visitors of the Univ of Virginia Charlottesville, Virginia
Tristar Centennial Medical Ctr Nashville, Tennessee
UAMS Little Rock, Arkansas
UC Denver, AMC Aurora, Colorado
Universitaetsklinikum Leipzig Aoer Leipzig, Saxony
Universitatsklinikum Muenster Münster, North Rhine-Westphalia
University Hospital of Wales Cardiff,
University Hospitals Cleveland Medical Center Cleveland, Ohio
University Of Manchester Manchester, Greater Manchester
University of California San Francisco Medical Center San Francisco, California
University of Chicago Dept of Medicine Chicago, Illinois
University of Pittsburgh Pittsburgh, Pennsylvania
VCU Medical Center Richmond, Virginia
Virginia Mason Medical Center Seattle, Washington
WMCHealth Advanced Physician Services Hawthorne, New York
WVU Hospitals Morgantown, West Virginia
Washington University St Louis, Missouri

The Impact of Chronic E-Cigarette Usage on Microvascular Health

Contact(s):

Paula Rodriguez Miguelez - prodriguezmig@vcu.edu

Principal Investigator:

System ID: NCT06860698

Show full eligibility criteria

Interventions: OTHER: E-cig use

Conditions: E-Cig Use

Keywords: Microvascular Health

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	Paula Rodriguez Miguelez - (prodriguezmig@vcu.edu)

ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy (ASHBY)

Contact(s):

Massey IIT Research Operations - masseyepd@vcu.edu

Principal Investigator:

System ID: NCT06185205

Show full eligibility criteria

Inclusion Criteria:

* Female * New diagnosis of ductal carcinoma in situ (DCIS) and/or invasive breast carcinoma per histologic evaluation * Age 45-79 at diagnosis * Previous lumpectomy with surgical margins histologically free of invasive tumor and DCIS as determined by the pathologist. * T stage of Tis, T1, or T2. * T2 tumors must be ≤3 cm in maximum diameter * If the tumor is human epidermal growth factor receptor 2 (HER2)-positive, the patient must receive HER2-directed therapy. * For patients with invasive breast cancer, an axillary staging procedure must be performed (either sentinel node biopsy alone or axillary dissection \[with a minimum of 6 axillary nodes removed\]) and the axillary node\[s\] must be pathologically negative. * Note: N0(i+) is not an exclusion criterion. * Note: Patients meeting all of the following criteria are not required to undergo the axillary staging procedure: * ≥70 years of age * estrogen receptor, Her2 = human epidermal growth factor receptor 2, PR = progesterone receptor negative (ER+PR+HER2-) * G1-2 * Tumor ≤2 cm in size * Agrees to comply with aromatase inhibitor recommendation * Ability to understand and the willingness to sign a written informed consent document in English

Exclusion Criteria:

* Pregnant or breastfeeding * Active collagen-vascular disease * Paget's disease of the breast * History of DCIS or invasive breast cancer prior to the current diagnosis * Prior breast or thoracic radiation therapy (RT) for any condition * Multicentric carcinoma (DCIS or invasive) * Synchronous bilateral invasive or non-invasive breast cancer * Surgical margins that cannot be microscopically assessed or that are positive * Excision cavity that cannot be clearly delineated per the treating investigator * Any of the dosimetric treatment criteria defined in Section 6.1 have not been met. Patients who become ineligible due to inability to meet dosimetric criteria should not receive treatment as - defined in this protocol and will come off the study. Any subsequent adjuvant radiation will be delivered at the discretion of the treating physician * Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements

Interventions: DRUG: Accelerated partial breast irradiation

Conditions: Breast Cancer

Keywords: Breast Cancer, Ductal Carcinoma in situ (DCIS), Irradiation

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	Massey CTO Breast Team - (masseyctbrst@vcu.edu)

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Contact(s):

Raymond Comenzo, MD - raymond.comenzo@tuftsmedicine.org

Principal Investigator:

System ID: NCT06365060

Show full eligibility criteria

Conditions: Smoldering Multiple Myeloma

Keywords: SMM, AL Amyloidosis

I'm interested

Share via email

Show 13 locations

Study Locations

Hide all locations

Location	Contacts
Atrium Health Levine Cancer Institute Charlotte, North Carolina	Courtney Schepel - (courtney.schepel@atriumhealth.org)
Cedars-Sinai Medical Center Los Angeles, California
Cleveland Clinic Florida, Weston Hospital Weston, Florida
Columbia University Irving Medical Center New York, New York	CUIMC Navigators - (cancerclinicaltrials@cumc.columbia.edu)
Memorial Sloan Kettering Cancer Center New York, New York	Bayley Axelrod - (axelrodb@mskcc.org)
The Ohio State University Comprehensive Cancer Center Columbus, Ohio
Tufts Medical Center Boston, Massachusetts	Denis Toskic - (denis.toskic@tuftsmedicine.org)
UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina	Kendall Conder - (Kendall_Conder@med.unc.edu)
UT Southwestern, Harold C. Simmons Comprehensive Cancer Center Dallas, Texas
University of Alabama Hospital Birmingham, Alabama	Megan Maier - (mmaier@uabmc.edu)
University of California, San Francisco San Francisco, California	Jane Greenaway - (jane.greenaway@ucsf.edu)
University of Utah, Huntsman Cancer Hospital Salt Lake City, Utah	Sharmilee Nuli - (sharmilee.nuli@hci.utah.edu)
VCU Medical Center Richmond, Virginia	Tyler Phillips - (phillipst5@vcu.edu)

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis (AMS05)

Contact(s):

ctrrecruit@vcu.edu

Principal Investigator:

System ID: NCT05285891

Show full eligibility criteria

Inclusion Criteria:

• Have at least one clinical episode that satisfies McDonald 2017 criteria for early Multiple sclerosis (MS) with a dissemination in time that can be met clinically, by Magnetic Resonance Imaging (MRI), or based on oligoclonal band (OCB) positivity
• Have a length of disease duration, from first symptom, of ≤ 3 years at time of informed consent
• For women of childbearing potential: Agreement to remain abstinent (refrain from heterosexual intercourse) or use effective methods of contraception during the treatment period and for at least 6 months after the last dose of study drug:
• A woman is considered to be of childbearing potential if she is postmenarcheal, has not reached a postmenopausal state (≥12 continuous months of amenorrhea with no identified cause other than menopause), and has not undergone surgical sterilization (removal of ovaries and/or uterus)
• Examples of contraceptive methods include bilateral tubal ligation, male sterilization, established hormonal contraceptives that inhibit ovulation, hormone- releasing intrauterine devices, and copper intrauterine devices
• The reliability of sexual abstinence should be evaluated in relation to the duration of the clinical trial and the preferred and usual lifestyle of the participant. Periodic abstinence (e.g., calendar, ovulation, symptothermal, or post ovulation methods) and withdrawal are not acceptable methods of contraception
• Barrier methods must always be supplemented with the use of a spermicide

Exclusion Criteria:

• Inability or unwillingness of a participant to give written informed consent or comply with study protocol
• History of primary progressive multiple sclerosis (PPMS), progressive relapsing multiple sclerosis (PRMS), or secondary progressive multiple sclerosis (SPMS)
• Any metallic material or electronic device in the body, or condition that precludes the participant from undergoing MRI
• Known presence or history of other neurological disorders, including but not limited to the following: * Ischemic cerebrovascular disorders, including but not limited to transient ischemic attack, subarachnoid hemorrhage, cerebral thrombosis, cerebral embolism, or cerebral hemorrhage * CNS or spinal cord tumor, metabolic or infectious cause of myelopathy, genetically inherited progressive CNS disorder, CNS sarcoidosis, or systemic autoimmune disorders potentially causing progressive neurologic disease or affecting ability to perform the study assessments
• Pregnancy or lactation • Female participants of childbearing potential must have a negative urine pregnancy test at screening
• Any concomitant disease that may require chronic systemic treatment with corticosteroids or immunosuppressants during the course of the study
• Lack of peripheral venous access
• History of severe allergic or anaphylactic reactions to humanized or murine monoclonal antibodies
• Significant, inadequately controlled (e.g., diagnostic evaluations indicated or change in medications warranted) disease, such as cardiovascular (including cardiac arrhythmia), pulmonary (including obstructive pulmonary disease), renal, hepatic, endocrine, and gastrointestinal or any other significant disease that in the opinion of the investigator may preclude participant from participating in the study
• Functional status of New York Heart Association (NYHA) Class III or higher for heart failure at the screening visit
• Known active bacterial, viral, fungal, mycobacterial infection or other infection (including tuberculosis (TB) or atypical mycobacterial disease but excluding limited superficial fungal or viral infections of the skin or nails) or any severe episode of infection requiring hospitalization or treatment with IV antibiotics within 4 weeks prior to Mo 0/Day 0 infusion or oral antibiotics within 2 weeks prior to Mo 0/Day 0 infusion
• Active or chronic infection with human immunodeficiency virus (HIV), syphilis or TB (see laboratory tests below)
• Evidence of past hepatitis B (including treated hepatitis B) or untreated hepatitis C infection (treated hepatitis C is not considered exclusionary). Hepatitis B surface antibody following hepatitis B immunization is not considered to be evidence of past infection (see laboratory tests below).
• Known active malignancy or active monitoring for recurrence of malignancy, including solid tumors and hematological malignancies, except basal cell, in situ squamous cell carcinoma of the skin, and in situ carcinoma of the cervix or the uterus that have been excised with clear margins
• Substance use disorder, including the recurrent use of alcohol and/or drugs within the past year associated with clinically significant impairment associated with failure to meet major responsibilities at work, school, or home
• Receipt of live or live-attenuated vaccines within 4 weeks prior to Mo 0/Day 0 infusion
• Contraindications to or severe intolerance of oral or IV corticosteroids, including IV methylprednisolone administered according to the country label, including: * Psychosis not controlled by a treatment * Hypersensitivity to any of the constituents or excipients of the preceding steroids
• Current or prior treatment with the following MS DMTs: fingolimod and other S1P receptor modulators, cladribine, natalizumab, anti-CD20 molecules, alemtuzumab, and chemotherapeutic agents
• Treatment with fumarates within 30 days prior to collection of Mo 0/Day 0 mechanistic samples, Mo 0/Day 0 MRI, and Mo 0/Day 0 infusion
• (a) Current or prior treatment with any approved or experimental immunomodulatory therapies, unless reviewed and approved by the SAC (Section 3.6), or (b) Treatment with any experimental procedure for MS (e.g., treatment for chronic cerebrospinal venous insufficiency)
• Systemic corticosteroid therapy within 4 weeks prior to the collection of screening mechanistic samples and the screening MRI
• Systemic corticosteroid therapy within 4 weeks prior to the Mo 0/Day 0 infusion
• Screening laboratory test results as follows: * Positive infection screening tests for: i. Hepatitis B surface antigen (HbsAg) or hepatitis B core antibody (HbcAb) ii. Hepatitis C (HCV) antibody if positive screen for HCV RNA Polymerase Chain Reaction (PCR) iii. Rapid plasma reagin (RPR) * A reactive RPR test unless followed by a subsequent negative RPR OR * A reactive RPR test unless successful completion of treatment has been documented as well as a consultation with and clearance by infectious disease department iv. HIV v. At or within twelve months of screening: * Positive QuantiFERON®-TB Gold test or positive purified protein derivative tuberculin skin test (PPD) (\>5mm induration, regardless of Bacille Calmette-Guerin (BCG) vaccine administration) unless completion of treatment has been documented for active TB OR * An indeterminate QuantiFERON®-TB Gold test unless followed by a subsequent negative PPD or negative QuantiFERON®-TB Gold test as well as a consultation with and clearance by infectious disease department * Levels of serum immunoglobulin G (IgG) \< 3.3g/L * Estimated glomerular filtration rate (eGFR) \< 60 mL/min/1.73 m2 using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation * Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≥ 2.0 x the upper limit of normal (ULN) * Platelet count \< 100,000 plt/µL (\<100 x 10⁹/L) * Hemoglobin \< 10 g/dL * Absolute neutrophil count \< 1.5 x 10⁹/L * Absolute lymphocyte count \< 1.2 x 10⁹/L
• Past or current medical problems or findings from physical examination or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements, or that may impact the quality or interpretation of the data obtained from the study.

Interventions: DRUG: Ocrelizumab, DRUG: Placebo for Ocrelizumab

Conditions: Multiple Sclerosis

Keywords: Ocrelizumab, Multiple sclerosis, Relapse

I'm interested

Share via email

Show 13 locations

Study Locations

Hide all locations

Location	Contacts
Icahn School of Medicine at Mount Sinai New York, New York	Nicole Graziano - (nicole.graziano@mssm.edu)
Massachusetts General Hospital Boston, Massachusetts	Aisha Seard - (aseard@mgh.harvard.edu)
MedStar Georgetown University Hospital Washington D.C., District of Columbia	David Pisfil - (ddp39@georgetown.edu)
Northwestern University Chicago, Illinois	Caroline Gebczak - (caroline.gebczak@northwestern.edu) Dylan Rice - (dylan.rice@northwestern.edu)
Oklahoma Medical Research Foundation Oklahoma City, Oklahoma	Kellie Kraus - (kellie-kraus@omrf.org)
RWJ Barnabas Health Livingston, New Jersey	Joshua-Daniel Bishop-Mbachu - (Joshua-Daniel.Bishop-Mbachu@rwjbh.org)
The University of Texas Health Science Center at Houston, McGovern Medical School Houston, Texas	Tanya Khan - (Tanya.S.Khan@uth.tmc.edu)
University of Massachusetts Memorial Medical Center Worcester, Massachusetts	Irina Radu - (irina.radu@umassmed.edu) Mariana Kurban - (mariana.kurban@umassmed.edu)
University of Pennsylvania, Perelman School of Medicine Philadelphia, Pennsylvania	Kristen Fleming - (Kristen.fleming@pennmedicine.upenn.edu)
University of Rochester Medical Center Rochester, New York	Jennifer Voelkl - (jenniferm_voelkl@urmc.rochester.edu)
University of Texas Southwestern Medical Center Dallas, Texas	Manuel Huichapa - (manuel.huichapa@utsouthwestern.edu)
Virginia Commonwealth University School of Medicine Richmond, Virginia	Aarati Pokharel - (Aarati.Pokharel@vcuhealth.org)
Yale School of Medicine New Haven, Connecticut	Katerina Palma - (Katerina.palma@yale.edu)

ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) (ASCEND)

Contact(s):

Kelli McDonough, MS - kellimcd@umich.edu

Principal Investigator:

System ID: NCT05388708

Show full eligibility criteria

Interventions: DEVICE: ECMO support, OTHER: PROSpect protocolized therapies

Conditions: Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation

Keywords: ARDS, Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation, ECMO, Extracorporeal Life Support, ECLS, Pediatric, Quality of Life, Functional Status

I'm interested

Share via email

Show 99 locations

Study Locations

Hide all locations

Location	Contacts
Akron Children's Hospital Akron, Ohio	Patricia Raimer, MD - (PRaimer@akronchildrens.org)
Alder Hey Children's Hospital Liverpool,	Marie Horan - (marie.horan@alderhey.nhs.uk)
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois	Bria Coates, MD - (b-coates@northwestern.edu)
Arkansas Children's Hospital Little Rock, Arkansas	Matthew Malone, MD - (MPMalone@uams.edu)
Atrium Health Wake Forest Baptist \| Brenner Children's Hospital Winston-Salem, North Carolina	Alan Woodruff, MD - (agwoodru@wakehealth.edu)
Boston Children's Hospital Boston, Massachusetts	Sally Vitali, MD - (Sally.Vitali@childrens.harvard.edu)
Cardinal Glennon Children's Hospital St Louis, Missouri	Erik Madsen, MD - (erik.madsen@ssmhealth.com)
Children's Healthcare of Atlanta Atlanta, Georgia	Heather Viamonte, MD - (heather.chandler@choa.org)
Children's Hospital Colorado Aurora, Colorado	John Kim, MD - (John.Kim@childrenscolorado.org)
Children's Hospital and Vall d' Hebron Women's Hospital Barcelona,	Joan Balcells Ramirez - (joanbalcells@me.com)
Children's Hospital of Michigan Detroit, Michigan	Mina Hafzala, MD - (MHafzala@dmc.org)
Children's Hospital of Orange County Orange, California	Adam Schwarz, MD - (ASchwarz@choc.org)
Children's Hospital of Philadelphia Philadelphia, Pennsylvania	Adam Himebaugh, MD - (himebaugha@chop.edu)
Children's Hospital of Richmond at VCU Richmond, Virginia
Children's Medical Center Dallas Dallas, Texas	Archana Dhar, MD - (archana.dhar@UTSouthwestern.edu)
Children's Memorial Hermann Hospital Houston, Texas	Sonia Labarinas, MD - (sonia.labarinas@uth.tmc.edu)
Children's Mercy Kansas City, Missouri	Asdis Wagner, MD - (dfwagner@cmh.edu)
Children's Minnesota Hospital Minneapolis, Minnesota	Mark Eikenberry, MD - (Mark.Eikenberry@childrensmn.org)
Children's Nebraska Omaha, Nebraska	Santosh Kaipa, MD - (skaipa@childrensnebraska.org)
Children's Of Alabama Birmingham, Alabama	Robert Richter, MD - (rrichter@peds.aub.edu)
Children's Wisconsin Milwaukee, Wisconsin	Adam Szadkowski, MD - (aszadkowski@mcw.edu)
Cincinnati Children's Hospital Medical Center Cincinnati, Ohio	Ranjit Chima, MD - (Ranjit.Chima@cchmc.org)
Cleveland Clinic Children's Hospital Cleveland, Ohio	Karen Lidsky, MD - (lidskyk@ccf.org)
Cohen Children's Medical Center Queens, New York	Todd Sweberg, MD - (tsweberg@northwell.edu)
Comer Children's Hospital Chicago, Illinois	Karen Fauman, MD - (krfauman@pds.bsd.uchigago.edu)
Connecticut Children's Medical Center Hartford, Connecticut	Allison Cowl, MD - (acowl@connecticutchildrens.org)
Dell Children's Medical Center Austin, Texas	Samantha Dallefeld, MD - (samantha.dallefeld@ascension.org)
Duke Children's Hospital & Health Center Durham, North Carolina	Palen Mallory, MD - (palen.powelson@duke.edu)
ECMO Centrum Karolinska Stockholm,	Lars Broman - (lars.broman@sll.se)
Evelina London Children's Hospital London,	Jonathan Lillie - (jonathan.lillie@gstt.nhs.uk)
Freeman Hospital Newcastle upon Tyne, England	Judit Llevadias - (judit.llevadias@nhs.uk)
Fundación Cardiovascular de Colombia Piedecuesta, Santander Department	Leonardo Salazar - (demotucordis@gmail.com)
Great Ormond Street Hospital For Children London,	Timothy Thiruchelvam - (timothy.thiruchelvam@gosh.nhs.uk)
Hasbro Children's Providence, Rhode Island	Ranna Rozenfeld, MD - (ranna_rozenfeld@brown.edu)
Hassenfeld Children's Hospital at NYU Langone New York, New York	Arun Chopra, MD - (arun.chopra@nyulangone.org)
Helen DeVos Children's Hospital Grand Rapids, Michigan	Elizabeth Rosner, MD - (Elizabeth.Rosner@helendevoschildrens.org)
Hospital Gregorio Maranon Madrid,	Laura Butragueno Laiseca - (laura.butragueno@salud.madrid.org)
Hospital de Santa Maria Lisbon,	Francisco Abecasis - (francisco@abecasis.name)
Inova L.J. Murphy Children's Hospital Falls Church, Virginia	Jeremy Lamkin, MD - (Jeremy.Lamkin@inova.org)
Istituto Giannina Gaslini Genova, Genoa	Andrea Moscatelli - (andreamoscatelli@me.com)
John R. Oishei Children's Hospital Buffalo, New York	Ryan Breuer, MD - (rbreuer@upa.chob.edu)
Johns Hopkins Children's Center Baltimore, Maryland	Mela Bembea, MD - (mbembea1@jhmi.edu)
Kapi'olani Medical Center for Women & Children Honolulu, Hawaii	Len Tanaka, MD - (lent@hawaii.edu)
Le Bonheur Children's Hospital Memphis, Tennessee	Hitesh Sandhu, MD - (hsandhu@uthsc.edu)
Leicester Children's Hospital Leicester,	Claire Westrope - (claire.westrope@uhl-tr.nhs.uk)
Loma Linda University Children's Hospital Loma Linda, California	Merrick Lopez, MD - (MLopez@llu.edu)
Lucile Packard Children's Hospital Stanford Stanford, California	Timothy Cornell, MD - (tcornell@stanford.edu)
M Health Fairview Masonic Children's Hospital Minneapolis, Minnesota
MUSC Shawn Jenkins Children's Hospital Charleston, South Carolina	Elise Zivick, MD - (emrath@musc.edu)
Mayo Eugenio Litta Children's Hospital Rochester, Minnesota	Jeffrey Weatherhead, MD - (Weatherhead.Jeffrey@mayo.edu)
Medical City Children's Hospital Dallas, Texas	JJ Fanning, MD - (jfanning@pacant.com)
Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee	Kevin Johnson, MD - (k.johnson@vumc.org)
N.C. Children's Hospital Chapel Hill, North Carolina	Katherine Clement, MD - (katherine_clement@med.unc.edu)
Nationwide Children's Hospital Columbus, Ohio	Joshua Frazier, MD - (joshua.frazier@nationwidechildrens.org)
Nemours Children's Hospital, Delaware Wilmington, Delaware	Marisa Meyer, MD - (Marisa.Meyer@nemours.org)
Nemours Children's Hospital, Florida Orlando, Florida	Timothy Maul, MD - (timothy.maul@nemours.org)
NewYork-Presbyterian Komansky Children's Hospital New York, New York	Umesh Joashi, MD - (ucj4001@med.cornell.edu)
NewYork-Presbyterian Morgan Stanley Children's Hospital New York, New York	Eva Cheung, MD - (ec2335@cumc.columbia.edu)
Nicklaus Children's Hospital Miami, Florida
Norton Children's Hospital Louisville, Kentucky	Deanna Tzanetos, MD - (deanna.tzanetos@louisville.edu)
OHSU Doernbecher Children's Hospital Portland, Oregon	Amit Mehta, MD - (mehtaa@ohsu.edu)
OSF Healthcare Children's Hospital of Illinois Peoria, Illinois	Agnieszka Kulikowska, MD - (akmd@uic.edu)
Ochsner LSU Health Shreveport Shreveport, Louisiana	Steve Conrad, MD - (SConrad@lsuhsc.edu)
Oklahoma Children's Hospital OU Health Oklahoma City, Oklahoma	Christine Allen, MD - (Christine-Allen@ouhsc.edu)
Orlando Health Arnold Palmer Hospital for Children Orlando, Florida	Nicole Slone, MD - (Nicole.Slone@orlandohealth.com)
Penn State Health Children's Hospital Hershey, Pennsylvania	Elizabeth Kerris, MD - (ekerris@pennstatehealth.psu.edu)
Perth Children's Hospital Perth, Western Australia	Simon Erickson - (simon.erickson@health.wa.gov.au)
Phoenix Children's Hospital Phoenix, Arizona	Erin Kreml, MD - (ekreml@phoenixchildrens.com)
Pontificia Universidad Santiago,	Javier Kattan, MD - (kattan@med.puc.cl)
Primary Children's Hospital Salt Lake City, Utah	Anna Hubbard, MD - (anna.hubbard@hsc.utah.edu)
Queensland Children's Hospital South Brisbane, Queensland	Adrian Mattke - (adrian.mattke@health.qld.gov.au)
Riley Hospital for Children Indianapolis, Indiana	Matt Friedman, MD - (friedmml@iu.edu)
Royal Brompton Hospital London,	Justin Wang - (Q.Wang@rbht.nhs.uk)
Royal Hospital for Children Glasgow, Scotland	Mark Davidson - (mark.davidson3@ggc.scot.nhs.uk)
Sanford Children's Hospital Sious Falls, South Dakota	Jody Huber, MD - (jody.huber@sanfordhealth.org)
Sant Joan de Deu Barcelona Hospital Barcelona,	Susana Segura Matute - (ssegura@sjdhospitalbarcelona.org)
Seattle Children's Hospital Seattle, Washington	Thomas Brogan, MD - (thomas.brogan@seattlechildrens.org)
Southampton Children's Hospital Southampton,
St. Louis Children's Hospital St Louis, Missouri	Ahmed Said, MD - (said_a@wustl.edu)
Starship Children's Hospital Grafton, Auckland	John Beca - (johnbeca@adhb.govt.nz)
Stollery Children's Hospital Edmonton, Alberta	Laurance Lequier - (Laurance.Lequier@albertahealthservices.ca)
Texas Children's Hospital Houston, Texas	Andrea Ontaneda, MD - (amontan1@texaschildrens.org)
The Children's Hospital at Westmead Westmead, New South Wales	Nithesh Singhal - (nitesh.singhal@health.nsw.gov.au)
The Hospital for Sick Children Toronto, Ontario	Anne Marie Guerguerian - (anne-marie.guerguerian@sickkids.ca)
The Royal Children's Hospital Melbourne Parkville,	Warwick Butt - (warwick.butt@rch.org.au)
UCLA Mattel Children's Hospital Los Angeles, California	Neeraj Srivastava, MD - (neerajsrivastava@mednet.ucla.edu)
UCSF Benioff Children's Hospital - San Francisco San Francisco, California	Shan Ward, MD - (shan.ward@ucsf.edu)
UCSF Benioff Children's Hospital Oakland Oakland, California	Mandeep Chadha, MD - (Mandeep.Chadha@ucsf.edu)
UF Health Shands Children's Hospital Gainesville, Florida	Kourtney Guthrie, MD - (ksnodgrass@ufl.edu)
UNM Children's Hospital Albuquerque, New Mexico	Senan Hadid, MD - (shadid@salud.umn.edu)
UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania	Nahmah Kim-Campbell, MD - (nahmah.kim-campbell@chp.edu)
UVA Children's Hospital Charlottesville, Virginia	Gary Fang, MD - (GYF2N@hscmail.mcc.virginia.edu)
UW Health American Family Children's Hospital Madison, Wisconsin	Charlie Bergstrom, MD - (cpbergstrom@wisc.edu)
University Health Women's & Children's Hospital San Antonio, Texas	Veronica Armijo-Garcia, MD - (mirelesv@uthscsa.edu)
University of Iowa Health Care Stead Family Children's Hospital Iowa City, Iowa	Kari Wellnitz, MD - (kari-wellnitz@uiowa.edu)
University of Maryland Children's Hospital Baltimore, Maryland
University of Michigan - Mott Children's Hospital Ann Arbor, Michigan	Kelli McDonough, MS - (kellimcd@umich.edu)
Valley Children's Hospital Madera, California	Harry Kallas, MD - (HKallas@valleychildrens.org)
Yale New Haven Children's Hospital New Haven, Connecticut	Josep Panisello, MD - (josep.panisello@yale.edu)

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis (NOSES)

Contact(s):

Lead Project Coordinator - researchfammed@georgetown.edu

Principal Investigator:

System ID: NCT06076304

Show full eligibility criteria

Interventions: DRUG: amoxicillin/clavulanate potassium, DRUG: Placebo, DRUG: Budesonide nasal spray

Conditions: Sinus Infection, Acute Sinusitis

Keywords: sinusitis, antibiotics, intranasal corticosteroids, saline nasal irrigation, comparative effectiveness

I'm interested

Share via email

Show 7 locations

Study Locations

Hide all locations

Location	Contacts
Georgetown University Medical Center Washington D.C., District of Columbia
Medstar Health Research Institute Baltimore, Maryland
Penn State College of Medicine Hershey, Pennsylvania
University of California, Los Angeles Los Angeles, California
University of Washington Seattle, Washington
University of Wisconsin-Madison Madison, Wisconsin
Virginia Commonwealth University Richmond, Virginia

Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005)

Contact(s):

Jennifer Raymond - Jennifer.Raymond@vcuhealth.org

Principal Investigator:

System ID: NCT05989620

Show full eligibility criteria

Conditions: LGMD1B, LGMD1C, LGMD1D, LGMD1E, LGMD1F, LGMD1G, LGMD1H, LGMD2A, LGMD2B, LGMD2C, LGMD2D, LGMD2E, LGMD2F, LGMD2G, LGMD2I, LGMD2J, LGMD2K, LGMD2L, LGMD2M, LGMD2N, LGMD2O, LGMD2P, LGMD2Q, LGMD2S, LGMD2T, LGMD2U, LGMD2W, LGMD2X, LGMD2Y

Keywords: Muscular Dystrophy, Myotonic Dystrophy, Limb Girdle Muscular Dystrophy, LGMD, LOPD, Late Onset Pompe Disease

I'm interested

Share via email

Show 1 location

Study Locations

Hide all locations

Location	Contacts
Virginia Commonwealth University Richmond, Virginia	Levi Headrick - (levi.headrick@vcuhealth.org)

Pre-Operative Window of ET to Inform RT Decisions (POWER II) (POWER II)

Contact(s):

Meagan Miller - aey8fc@uvahealth.org

Principal Investigator:

System ID: NCT06507618

Show full eligibility criteria

Interventions: DRUG: Tamoxifen, Letrozole, Anastrozole, or Exemestane

Conditions: Breast Cancer Female

Keywords: breast cancer, endocrine therapy, radiation, letrozole, anastrozole, exemestane, tamoxifen, survey, questionnaire, geriatric

I'm interested

Share via email

Show 6 locations

Study Locations

Hide all locations

Location	Contacts
INOVA Schar Cancer Fairfax, Virginia
Riverside Health System Newport News, Virginia
University of Virginia Charlottesville, Virginia	Meagan Miller - (aey8fc@uvahealth.org)
University of Virginia Community Health Culpeper, Virginia	Ali Mahjoub - (AM3CG@uvahealth.org)
Virginia Commonwealth University Richmond, Virginia	Deja Wortham - (worthamdn@vcu.edu)
Yale University New Haven, Connecticut	Cameron Groshek - (cameron.groshek@yale.edu)

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Contact(s):

ctrrecruit@vcu.edu

Principal Investigator:

System ID: NCT06470243

Show full eligibility criteria

Inclusion Criteria:

* STEP 1 SCREENING REGISTRATION: NOTE: All participants must have biopsy tissue submitted to MD Anderson Cancer Center prior to randomization for alteration assessment. Participants must have determination of their AVPC-Molecular Pathologic Signature immunohistochemistry (MSIHC) status from central assessment by the MD Anderson Clinical Pathology Laboratory using Clinical Laboratory Improvement Act (CLIA) certified immunohistochemistry (IHC) assays for TP53, RB1 and PTEN. In addition, while not mandated, CLIA certified next generation sequencing (NGS) of tumor deoxyribonucleic acid (DNA) and/or circulating tumor derived DNA (ctDNA) assessment of AVPC-MS marker status will be collected from participants for whom it is available * STEP 1 SCREENING REGISTRATION: Participants must have a histologically confirmed diagnosis of prostate cancer at the time of step 1 registration * STEP 1 SCREENING REGISTRATION: Participants must have castrate-resistant prostate cancer and metastatic disease by bone scan and/or CT/MRI (i.e., soft tissue, visceral, lymph node) * STEP 1 SCREENING REGISTRATION: Participants may have received any prior therapy, but one must be docetaxel or contain docetaxel in either the castrate-sensitive and/or castrate resistant disease state * STEP 1 SCREENING REGISTRATION: Participants must be ≥ 18 years of age at the time of step 1 screening registration * STEP 1 SCREENING REGISTRATION: Participants must have solid tumor biopsy material (formalin-fixed paraffin-embedded (FFPE) tissue blocks and/or 10 cut slides on four-micron thick unstained positive charged slides of FFPE tissue) available for submission for alterations in TP53, RB1 and PTEN by IHC using CLIA certified assays in the MD Anderson Clinical Pathology Laboratory. This specimen is required for central assessment of the AVPC-MSIHC regardless of whether the site has already locally evaluated the AVPC-MS status * STEP 1 SCREENING REGISTRATION: Tumor samples submitted for analysis must have been collected within 12 months prior to step 1 screening registration. Samples from metastatic lesions collected in the castrate-resistant disease state are preferable but not mandatory. Samples obtained during the hormone-naive disease state are acceptable if collected within 12 months of step 1 screening registration. If more than one tumor sample exists, the sample obtained closest to the date of registration should be submitted to MDACC for analysis * NOTE: Sites will receive an email from Southwest Oncology Group (SWOG) Statistics and Data Management Center containing participant results of Aggressive Variant Prostate Cancer Molecular Signature (AVPC-MS) assessment within 5-12 business days after tissue submission to MD Anderson Clinical Pathology Laboratory. The participant's AVPC-MS signature result (positive or negative) is required BEFORE randomization on to step 2. If sites receive a non-evaluable AVPC-MS signature result, SWOG Statistics and Data Management Center will provide instructions for resubmission * STEP 1 SCREENING REGISTRATION: NOTE: As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system * STEP 1 SCREENING REGISTRATION: Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines. Documentation of informed consent via remote consent is allowed * For participants with impaired decision-making capabilities, legally authorized representatives may sign and give informed consent on behalf of study participants in accordance with applicable federal, local, and Central Institutional Review Board (CIRB) regulations * STEP 2 RANDOMIZATION: NOTE: Participants must be registered to step 2 randomization within 70 days after registration to step 1. Participants must plan to start protocol therapy no more than 14 days after step 2 randomization * STEP 2 RANDOMIZATION: Participants must have castrate levels of testosterone with a baseline level \< 50ng/dL within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants must have evidence for metastatic prostate cancer by bone scan and/or CT/MRI (i.e., soft tissue, visceral, lymph node). Visceral and/or soft-tissue metastases must be ≥ 1.0 cm in diameter and lymph nodes must be \> 1.5 cm diameter in the short axis. Scans must be obtained within 28 days prior to randomization * NOTE: All disease must be assessed and documented on the baseline/pre-registration tumor assessment form * STEP 2 RANDOMZIATION: Participants must have progressive disease (PD) in the opinion of the treating investigator according to any of the following criteria * Progression in measurable disease (RECIST 1.1 criteria). Patient with measurable disease must have at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be at least 10 mm when measured by computed tomography (CT) \[CT scan thickness no greater than 5 mm\] or magnetic resonance imaging (MRI). Lymph nodes should be ≥ 15 mm in short axis. Previously irradiated lesions, primary prostate lesion and bone lesions will be considered non-measurable disease * Progression in bone as evidenced by: * Appearance of 2 or more new bone lesions on bone scan (BS). If equivocal, they must be confirmed by other imaging modalities (CT; MRI), and/or repeat BS \> 4 weeks later * Appearance of a new lytic lesion(s) and/or increasing size of an existing lesion by CT/MRI, since AVPC tumors may produce lytic bone lesions that are not detected on conventional bone scans * Rising prostate-specific antigen (PSA) defined (Prostate Cancer Working Group 2 \[PCWG2\]) as at least two consecutive rises in PSA to be documented over a reference value (measure 1) taken at least one week apart. The first rising PSA (measure 2) should be taken at least 7 days after the reference value. A third confirmatory PSA measure is required (2nd beyond the reference level) to be greater than the second measure and it must be obtained at least 7 days after the 2nd measure. If this is not the case, a fourth PSA measure is required to be taken and be greater than the 2nd measure. In case of progression based on rising PSA only, the first rising PSA (measure 2) must be obtained within 6 months of initiation of androgen receptor (AR) targeted therapy (≤ 6 months) * Clinical progression. Increasing symptoms unequivocally attributed to disease progression as judged by the treating physician * STEP 2 RANDOMIZATION: Participants must not have received prior cabazitaxel or carboplatin * STEP 2 RANDOMIZATION: Participants must not be receiving treatment on another therapeutic clinical trial at the time of randomization. Chemotherapies, bone targeting therapies, immunotherapies and clinical trial agents must be discontinued ≥ 21 days prior to randomization. Stereotactic radiation (SART) must be discontinued ≥ 3 days prior to randomization * STEP 2 RANDOMIZATION: Participants must not be receiving radiation therapy or kyphoplasty-vertebroplasty within 14 days prior to randomization or major surgery (e.g., open abdominal, pelvic, thoracic, orthopedic or neurosurgery) within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants must not have untreated fractures and/or cord compression * STEP 2 RANDOMIZATION: Participants must not have symptomatic uncontrolled brain metastases. Properly treated brain metastases (i.e., with stereotactic radiation) within 14 days are allowed * STEP 2 RANDOMIZATION: Participants must have Zubrod performance status of 0 - 2 within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants must have a complete medical history and physical exam within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Absolute neutrophil count ≥ 1.5 x 10\^3/uL (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Platelets ≥ 100 x 10\^3/uL (unless clinical evidence of bone marrow infiltration by tumor in which case \> 75 x 10\^3/uL are allowed) (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Total bilirubin ≤ institutional upper limit of normal (ULN) with the exception of isolated hyperbilirubinemia due to Gilbert's syndrome or if the participant has liver metastases and/or acute tumor associated illness \< 4x ULN (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 3 × institutional ULN (or if participant has liver metastases and/or acute tumor-associated illness, ≤ 4x institutional ULN) (within 28 days prior to step 2 randomization) * STEP 2 REGISTRATION: Participants must have a calculated creatinine clearance ≥ 30 mL/min using the Cockcroft-Gault Formula. This specimen must have been drawn and processed within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants with peripheral neuropathy must have ≤ grade 2 peripheral neuropathy (Common Terminology Criteria for Adverse Events \[CTCAE\] version 5.0) (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Participants who are of reproductive potential must have agreed to use an effective contraceptive method with details provided as a part of the consent process. A person who has semen likely to contain sperm is considered to be of "reproductive potential." In addition to routine contraceptive methods, "effective contraception" also includes refraining from sexual activity that might result in pregnancy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) including vasectomy with testing showing no sperm in the semen * STEP 2 RANDOMIZATION: Participants must not have a prior or concurrent malignancy whose natural history or treatment (in the opinion of the treating physician) has the potential to interfere with the safety or efficacy assessment of the treatment regimen * STEP 2 RANDOMIZATION: Participants with known human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy at registration and have undetectable viral load test on the most recent test results obtained within 6 months prior to registration * STEP 2 RANDOMIZATION: Participants must be offered the opportunity to participate in specimen banking. With participant consent, specimens must be collected and submitted via the SWOG Specimen Tracking System

Interventions: PROCEDURE: Biospecimen Collection, PROCEDURE: Bone Scan, DRUG: Cabazitaxel, DRUG: Carboplatin, PROCEDURE: Chest Radiography, PROCEDURE: Computed Tomography, PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Positron Emission Tomography, DRUG: Prednisone

Conditions: Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8

I'm interested

Share via email

Show 174 locations

Study Locations

Hide all locations

Location	Contacts
Abbott-Northwestern Hospital Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Armes Family Cancer Center Findlay, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
BJC Outpatient Center at Sunset Hills Sunset Hills, Missouri
Beebe Health Campus Rehoboth Beach, Delaware	Site Public Contact - (research@beebehealthcare.org)
Beebe Medical Center Lewes, Delaware	Site Public Contact - (research@beebehealthcare.org)
Beebe South Coastal Health Campus Millville, Delaware	Site Public Contact - (research@beebehealthcare.org)
Benefis Sletten Cancer Institute Great Falls, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Billings Clinic Cancer Center Billings, Montana	Site Public Contact - (research@billingsclinic.org)
Billings Clinic-Cody Cody, Wyoming	Site Public Contact - (research@billingsclinic.org)
Blanchard Valley Hospital Findlay, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Bozeman Health Deaconess Hospital Bozeman, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Cambridge Medical Center Cambridge, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Cancer Care Center of O'Fallon O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Care Specialists of Illinois - Decatur Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Cancer Center of Western Wisconsin New Richmond, Wisconsin	Site Public Contact - (mmcorc@healthpartners.com)
Caro Cancer Center Caro, Michigan	Site Public Contact - (lori.srebinski@ascension.org)
Centralia Oncology Clinic Centralia, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Christiana Care - Union Hospital Elkton, Maryland	Site Public Contact - (frank.crum@christianacare.org)
Christiana Care Health System-Christiana Hospital Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Christiana Care Health System-Concord Health Center Chadds Ford, Pennsylvania	Site Public Contact - (lbarone@christianacare.org)
Christiana Care Health System-Wilmington Hospital Wilmington, Delaware	Site Public Contact - (lbarone@christianacare.org)
Community Hospital of Anaconda Anaconda, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Community Medical Center Toms River, New Jersey	Site Public Contact - (mccinfo@mtcancer.org)
Crossroads Cancer Center Effingham, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Dayton Physician LLC - Englewood Dayton, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Dayton Physicians LLC - Troy Troy, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Dayton Physicians LLC-Atrium Franklin, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Dayton Physicians LLC-Miami Valley South Centerville, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Dayton Physicians LLC-Wayne Greenville, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Decatur Memorial Hospital Decatur, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Fairview Clinics and Surgery Center Maple Grove Maple Grove, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Lakes Medical Center Wyoming, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Northland Medical Center Princeton, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Fairview Southdale Hospital Edina, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Genesee Cancer and Blood Disease Treatment Center Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Genesee Hematology Oncology PC Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Genesys Hurley Cancer Institute Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Great Falls Clinic Great Falls, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Great Lakes Cancer Management Specialists-Doctors Park East China, Michigan	Site Public Contact - (kforman1@hfhs.org)
Great Lakes Cancer Management Specialists-Macomb Medical Campus Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Great Lakes Cancer Management Specialists-Macomb Professional Building Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Greater Dayton Cancer Center Kettering, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
HSHS Saint Elizabeth's Hospital O'Fallon, Illinois	Site Public Contact - (morganthaler.jodi@mhsil.com)
Health Partners Inc Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Helen F Graham Cancer Center Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Hematology Oncology Consultants-Clarkston Clarkston, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Hennepin County Medical Center Minneapolis, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Henry Ford Health Saint John Hospital Detroit, Michigan	Site Public Contact - (Kkeenan1@hfhs.org)
Henry Ford Madison Heights Hospital - Breast Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Academic Grosse Pointe Woods, Michigan	Site Public Contact - (kforman1@hfhs.org)
Henry Ford Saint John Hospital - Breast Grosse Pointe Woods, Michigan	Site Public Contact - (karen.forman@ascension.org)
Henry Ford Warren Hospital - Breast Macomb Macomb, Michigan	Site Public Contact - (kforman1@hfhs.org)
Highlands Oncology Group Springdale, Arkansas	Site Public Contact - (research@hogonc.com)
Highlands Oncology Group - Fayetteville Fayetteville, Arkansas	Site Public Contact - (research@hogonc.com)
Highlands Oncology Group - Rogers Rogers, Arkansas	Site Public Contact - (research@hogonc.com)
Holy Cross Hospital Silver Spring, Maryland	Site Public Contact - (eileen.georgi@holy-cross.com)
Hope Cancer Center Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Hurley Medical Center Flint, Michigan	Site Public Contact - (wstrong@ghci.org)
Huron Gastroenterology PC Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Idaho Urologic Institute-Meridian Meridian, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Illinois CancerCare - Washington Washington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Canton Canton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Carthage Carthage, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Dixon Dixon, Illinois
Illinois CancerCare-Eureka Eureka, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Galesburg Galesburg, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Kewanee Clinic Kewanee, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Macomb Macomb, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Ottawa Clinic Ottawa, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peru Peru, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Princeton Princeton, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Indu and Raj Soin Medical Center Beavercreek, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Kalispell Regional Medical Center Kalispell, Montana	Site Public Contact - (mccinfo@mtcancer.org)
Kettering Medical Center Kettering, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Clinic Cancer Services - Sandpoint Sandpoint, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Lakeview Hospital Stillwater, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Cedar Crest Allentown, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Hazleton Hazleton, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Lyndon Baines Johnson General Hospital Houston, Texas
M D Anderson Cancer Center Houston, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
MD Anderson League City League City, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
MD Anderson West Houston Houston, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
MD Anderson in Sugar Land Sugar Land, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
MD Anderson in The Woodlands Conroe, Texas	Site Public Contact - (askmdanderson@mdanderson.org)
Medical Oncology Hematology Consultants PA Newark, Delaware	Site Public Contact - (lbarone@christianacare.org)
Memorial Hospital of Carbondale Carbondale, Illinois	Site Public Contact - (clinical.research@sih.net)
Memorial Medical Center Modesto, California	Site Public Contact - (pallante.beth@mhsil.com)
Mercy Hospital Cedar Rapids, Iowa
Mercy Hospital Cedar Rapids, Iowa	Site Public Contact - (mmcorc@healthpartners.com)
Methodist Medical Center of Illinois Peoria, Illinois	Site Public Contact - (andersonj@illinoiscancercare.com)
Michigan Healthcare Professionals Pontiac Pontiac, Michigan	Site Public Contact - (Emily.Crofts@trinity-health.org)
Minnesota Oncology - Burnsville Burnsville, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Maplewood Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Woodbury Woodbury, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Missouri Baptist Medical Center St Louis, Missouri
Missouri Baptist Sullivan Hospital Sullivan, Missouri
Monticello Cancer Center Monticello, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
MyMichigan Medical Center Saginaw Saginaw, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
MyMichigan Medical Center Tawas Tawas City, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Nebraska Medicine-Bellevue Bellevue, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
Nebraska Medicine-Village Pointe Omaha, Nebraska
New Ulm Medical Center New Ulm, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Newland Medical Associates-Clarkston Clarkston, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Newland Medical Associates-Pontiac Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
North Memorial Medical Health Center Robbinsdale, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Northwestern Medicine Cancer Center Delnor Geneva, Illinois	Site Public Contact - (Donald.Smith3@nm.org)
Northwestern Medicine Cancer Center Kishwaukee DeKalb, Illinois	Site Public Contact - (Donald.Smith3@nm.org)
Northwestern Medicine Cancer Center Warrenville Warrenville, Illinois	Site Public Contact - (Donald.Smith3@nm.org)
Northwestern Medicine Glenview Outpatient Center Glenview, Illinois
Northwestern Medicine Grayslake Outpatient Center Grayslake, Illinois
Northwestern Medicine Lake Forest Hospital Lake Forest, Illinois	Site Public Contact - (cancertrials@northwestern.edu)
Northwestern Medicine Orland Park Orland Park, Illinois	Site Public Contact - (nctnprogram_rhlccc@northwestern.edu)
Northwestern University Chicago, Illinois	Site Public Contact - (cancer@northwestern.edu)
Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa
Oncology Hematology Associates of Saginaw Valley PC Saginaw, Michigan	Site Public Contact - (lori.srebinski@ascension.org)
Oncology Hematology Care Inc-Kenwood Cincinnati, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Orion Cancer Care Findlay, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Park Nicollet Clinic - Saint Louis Park Saint Louis Park, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Parkland Health Center - Farmington Farmington, Missouri
Pocono Medical Center East Stroudsburg, Pennsylvania	Site Public Contact - (Morgan_M.Horton@lvhn.org)
Regions Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Reid Health Richmond, Indiana	Site Public Contact - (clinical.trials@daytonncorp.org)
Rice Memorial Hospital Willmar, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Ridgeview Medical Center Waconia, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
SIH Cancer Institute Carterville, Illinois	Site Public Contact - (clinical.research@sih.net)
Saint Alphonsus Cancer Care Center-Baker City Baker City, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Boise Boise, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho	Site Public Contact - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Nampa Nampa, Idaho	Site Public Contact - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Ontario Ontario, Oregon	Site Public Contact - (mccinfo@mtcancer.org)
Saint Elizabeth Boardman Hospital Boardman, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Saint Elizabeth Youngstown Hospital Youngstown, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Saint Francis Medical Center Cape Girardeau, Missouri	Site Public Contact - (sfmc@sfmc.net)
Saint Francis Regional Medical Center Shakopee, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint John Macomb-Oakland Hospital Warren, Michigan	Site Public Contact - (kforman1@hfhs.org)
Saint John's Hospital - Healtheast Maplewood, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
Saint Joseph Warren Hospital Warren, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Saint Mary's Oncology/Hematology Associates of Marlette Marlette, Michigan	Site Public Contact - (lori.srebinski@ascension.org)
Saint Mary's Oncology/Hematology Associates of West Branch West Branch, Michigan	Site Public Contact - (lori.srebinski@ascension.org)
Sainte Genevieve County Memorial Hospital Sainte Genevieve, Missouri
Southeast Cancer Center Cape Girardeau, Missouri
Southern Illinois University School of Medicine Springfield, Illinois
Springfield Clinic Springfield, Illinois
The West Clinic - Wolf River Germantown, Tennessee	Site Public Contact - (afletcher@westclinic.com)
Tibor Rubin VA Medical Center Long Beach, California
Trinity Health IHA Medical Group Hematology Oncology - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital Chelsea, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus Ypsilanti, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Brighton Brighton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Canton Canton, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Oakland Hospital Pontiac, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Mary Mercy Livonia Hospital Livonia, Michigan	Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
United Hospital Saint Paul, Minnesota	Site Public Contact - (mmcorc@healthpartners.com)
University of Illinois Chicago, Illinois
University of Michigan Health - Sparrow Lansing Lansing, Michigan	Site Public Contact - (harsha.trivedi@umhsparrow.org)
University of Mississippi Medical Center Jackson, Mississippi
University of Nebraska Medical Center Omaha, Nebraska	Site Public Contact - (unmcrsa@unmc.edu)
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma	Site Public Contact - (ou-clinical-trials@ouhsc.edu)
VCU Massey Cancer Center at Stony Point Richmond, Virginia	Site Public Contact - (ctoclinops@vcu.edu)
Valley Radiation Oncology Peru, Illinois
Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia	Site Public Contact - (CTOclinops@vcu.edu)
Wayne Hospital Greenville, Ohio	Site Public Contact - (clinical.trials@daytonncorp.org)
Welch Cancer Center Sheridan, Wyoming	Site Public Contact - (mccinfo@mtcancer.org)
Western Illinois Cancer Treatment Center Galesburg, Illinois

Search Results

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Study Locations

Email this study information to me

Contact the study team